Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             923 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 2.140 ABERRANT DIFFUSION TENSOR MRI CHANGES IN SENSORIMOTOR AREA OF DYT6 PRIMARY DYSTONIA Cheng, F.B.
 2012
 18 S2 p. S111-
1 p.
 artikel
2 2.366 ABNORMAL HAND MOVEMENT OF ALIEN HAND SYNDROME IS RELATED TO DISINHIBITION OF CORTICAL MOTOR CIRCUIT Jung, H.-Y.
 2012
 18 S2 p. S157-
1 p.
 artikel
3 2.025 A CASE OF ATYPICAL STIFF PERSON SYNDROME INVESTIGATED WITH [18F]-FLUMAZENIL PET Kim, J.-M.
 2012
 18 S2 p. S97-
1 p.
 artikel
4 1.248 A CASE OF HEMICHOREA AS A RARE MANIFESTATION OF POLYCYTHEMIA VERA Ma, H.I.
 2012
 18 S2 p. S58-S59
2 p.
 artikel
5 1.322 A CASE STUDY FOR DIFFERENTIAL ANALYSIS ON MULTIPLE SCLEROSIS IN HUMAN LOCOMOTION Yu, H.
 2012
 18 S2 p. S77-
1 p.
 artikel
6 2.024 ACCELERATED INTRANEURONAL CATECHOLAMINE LOSS RELATED TO DECREASED VESICULAR UPTAKE IN PATIENTS WITH LEWY BODY DISEASES Goldstein, D.S.
 2012
 18 S2 p. S97-
1 p.
 artikel
7 2.138 A COMPARATIVE FOLLOW-UP FMRI STUDY FOR A SIMPLE MOTOR TASK IN PD AND MSA Saxena, M.
 2012
 18 S2 p. S111-
1 p.
 artikel
8 1.024 A COMPARISON OF CLINICAL AND OBJECTIVE MEASURES OF FREEZING OF GAIT Moore, S.
 2012
 18 S2 p. S16-
1 p.
 artikel
9 1.016 ACOUSTIC ANALYSIS OF SPEECH DYSRHYTHMIA IN PARKINSON DISEASE PATIENTS Podemski, R.
 2012
 18 S2 p. S14-
1 p.
 artikel
10 1.257 A CROSSOVER STUDY OF A TRADITIONAL ASIAN HERBAL MEDICINE FOR HUNTINGTON'S DISEASE Iwasaki, K.
 2012
 18 S2 p. S61-
1 p.
 artikel
11 2.146 ACTIGRAPHIC ASSESSMENT OF PERIODIC LEG MOVEMENTS IN PATIENTS WITH RESTLESS LEGS SYNDROMEV Poncini, M.A.
 2012
 18 S2 p. S113-
1 p.
 artikel
12 3.347 ACTIVATED MICROGLIAL FACILITATE IRON-INDUCED SELECTIVE AND PROGRESSIVE DOPAMINERGIC NEURODEGENERATION Yan, Z.
 2012
 18 S2 p. S230-S231
2 p.
 artikel
13 3.5.1 ACUPUNCTURE AND PARKINSON'S DISEASE Liu, A.
 2012
 18 S2 p. S163-
1 p.
 artikel
14 1.316 ACUTE CEREBELLAR ATAXIA DURING STROKE LIKE EPISODE IN CNS GNATHOSTOMIASIS Singmaneesakulchai, S.
 2012
 18 S2 p. S76-
1 p.
 artikel
15 1.073 ACUTE DOPAMINERGIC DEPLETION IN HEALTHY SUBJECTS IMPAIRS EXECUTIVE CONTROL Ramdani-Beauvir, C.
 2012
 18 S2 p. S28-
1 p.
 artikel
16 3.203 ADENOVIRUS VECTOR MEDIATED 14-3-3γ GENE TRANSFER PROTECTS DOPAMINERGIC NEURONS IN MODELS OF PARKINSON'S DISEASE Chen, X.
 2012
 18 S2 p. S204-
1 p.
 artikel
17 2.7.4 ADULT AUTOLOGOUS STEM CELLS: POTENTIAL DISEASE-MODIFYING STRATEGY FOR PARKINSON'S DISEASE Melamed, E.
 2012
 18 S2 p. S84-S85
2 p.
 artikel
18 1.12.2 ADVANCES IN CSF BIOMARKERS OF PARKINSON'S DISEASE LeWitt, P.
 2012
 18 S2 p. S5-S6
2 p.
 artikel
19 2.279 ADVERSE EVENTS TO ANTIPARKINSONIAN MEDICATIONS IN PARKINSONIAN AND NON-PARKINSONIAN PATIENTS Perez-Lloret, S.
 2012
 18 S2 p. S135-
1 p.
 artikel
20 2.231 ADX48621, A MGLUR5 NEGATIVE ALLOSTERIC MODULATOR ALLEVIATES L-DOPA-INDUCED CHOREA AND DYSTONIA IN THE MPTP MACAQUE MODEL OF PARKINSON'S DISEASE Keywood, C.
 2012
 18 S2 p. S122-
1 p.
 artikel
21 2.212 AFFITOPE® BASED VACCINES: A NOVEL AND SAFE IMMUNOTHERAPEUTIC STRATEGY FOR PARKINSON'S DISEASE Weninger, H.
 2012
 18 S2 p. S117-
1 p.
 artikel
22 3.359 A GAMMA BAND SPECIFIC INVOLVEMENT OF THE SUBTHALAMIC NUCLEUS IN SWITCHING IN VERBAL FLUENCY IN PARKINSON'S DISEASE Anzak, A.
 2012
 18 S2 p. S233-
1 p.
 artikel
23 2.3.3 A GENOME-WIDE ANALYSIS IN THE EUROPEAN HD POPULATION Landwehrmeyer, G.B.
 2012
 18 S2 p. S83-
1 p.
 artikel
24 1.091 A LARGE RANDOMISED TRIAL ASSESSING QUALITY OF LIFE IN PATIENTS WITH EARLY PD: RESULTS FROM PD MED EARLY Gray, R.
 2012
 18 S2 p. S32-
1 p.
 artikel
25 1.092 A LARGE RANDOMISED TRIAL ASSESSING QUALITY OF LIFE IN PATIENTS WITH LATER PD: RESULTS FROM PD MED LATER Clarke, C.E.
 2012
 18 S2 p. S33-
1 p.
 artikel
26 2.7.2 ALLIED HEALTH STRATEGIES, REHABILITATION AND EXERCISE THERAPY FOR PATIENTS WITH PARKINSON'S DISEASE van Wegen, E.E.H.
 2012
 18 S2 p. S84-
1 p.
 artikel
27 3.120 ALPHA-SYNUCLEIN PROMOTES CLATHRIN-MEDIATED NMDA RECEPTOR ENDOCYTOSIS AND ATTENUATES NMDA-INDUCED DOPAMINERGIC CELL DEATH Yu, S.
 2012
 18 S2 p. S194-
1 p.
 artikel
28 3.9.2 ALS-PARKINSONISM-DEMENTIA COMPLEX OF KII AND OTHER RELATED DISEASES IN JAPAN Kaji, R.
 2012
 18 S2 p. S165-
1 p.
 artikel
29 3.139 ALTERATIONS IN MARKERS OF AGING IN SUBSTANTIA NIGRA OF MICE LACKING GLUTATHIONE S-TRANSFERASE PI (GSTPI) Jiao, Y.
 2012
 18 S2 p. S199-
1 p.
 artikel
30 3.221 AMANTADINE PROTECTS DOPAMINE NEURONS BY A DUAL ACTION: REDUCING ACTIVATION OF MICROGLIA AND INDUCING EXPRESSION OF GNDF IN ASTROGLIA Ossola, B.
 2012
 18 S2 p. S208-S209
2 p.
 artikel
31 1.252 AMÉRICO NEGRETTE AND HUNTINGTON'S DISEASE Teive, H.A.G.
 2012
 18 S2 p. S59-S60
2 p.
 artikel
32 2.119 AN ALGORITHM FOR THE DIAGNOSIS IN PATIENTS PRESENTING PARKINSONISM AND COGNITIVE DEFICITS IN NEUROLOGICAL AND GERIATRIC PRACTICES Latxague, C.
 2012
 18 S2 p. S106-
1 p.
 artikel
33 1.007 ANALYSIS OF AGE OF ONSET AND EPIDEMIOLOGICAL FACTORS IN PARKINSONS DISEASE Ravan, A.A.
 2012
 18 S2 p. S11-S12
2 p.
 artikel
34 3.025 ANALYSIS OF EXON REARRANGEMENTS IN PARK2, SNCA AND PINK1 GENES IN PATIENTS WITH PARKINSON'S DISEASE FROM RUSSIA Semenova, E.
 2012
 18 S2 p. S175-
1 p.
 artikel
35 1.038 ANALYSIS OF FACTORS CORRELATED TO CONSTIPATION IN PATIENTS WITH PARKINSON'S DISEASE Tan, H.
 2012
 18 S2 p. S19-
1 p.
 artikel
36 3.007 ANALYSIS OF GENE EXPRESSION IN PERIPHERAL BLOOD IN PATIENTS WITH PARKINSON'S DISEASE Filatova, E.
 2012
 18 S2 p. S171-
1 p.
 artikel
37 3.058 ANALYSIS OF LRRK2 VARIANT IN ESSENTIAL TREMOR Tan, E.K.
 2012
 18 S2 p. S183-
1 p.
 artikel
38 1.029 ANALYSIS OF NON-MOTOR SYMPTOMS OF PARKINSON'S DISEASE Meng, L.
 2012
 18 S2 p. S17-
1 p.
 artikel
39 1.043 ANALYSIS OF SAWLOWING SOUNDS THROUGH SONAR DOPPLER IN PATIENTS WITH PARKINSONS DISEASE Santos, R.S.
 2012
 18 S2 p. S20-
1 p.
 artikel
40 3.061 ANALYSIS OF SERUM MICRORNAS IN SCA3/MJD PATIENTS Shi, Y.T.
 2012
 18 S2 p. S184-
1 p.
 artikel
41 2.370 ANALYSIS OF SURGICAL INTRATHECAL [I.T.] BACLOFEN [ITB] IMPLANT RESULTS EMPHASIZING REVISION SURGERY IN A MIXED PEDIATRIC/ADULT POPULATION Awaad, Y.
 2012
 18 S2 p. S158-S159
2 p.
 artikel
42 3.076 AN EARLY ONSET SOUTH INDIAN PARKINSON'S DISEASE PATIENT WITH NOVEL C.798_799INSA MUTATION - A CASE VIGNETTE Vishwanathan, P.
 2012
 18 S2 p. S188-
1 p.
 artikel
43 2.289 A NEW TREATMENT ALGORITHM FOR TARDIVE DYSKINESIA OR DYSTONIA van Harten, P.N.
 2012
 18 S2 p. S138-
1 p.
 artikel
44 3.149 AN EXPERIMENTAL STUDY OF ESTABLISHING PD DYSKINESIA MODEL THROUGH COMPLETE DAMAGE TO SUBSTANTIA NIGRA IN RATS Chen, C.
 2012
 18 S2 p. S201-
1 p.
 artikel
45 3.7.4 ANIMAL MODELS FOR LRRK2 PATHOGENESIS Li, C.
 2012
 18 S2 p. S164-
1 p.
 artikel
46 3.7.3 ANIMAL MODELS OF PD Przedborski, S.
 2012
 18 S2 p. S164-
1 p.
 artikel
47 2.134 AN OLD LEGEND TOWER OF HANOI AS A TOOL OF THE NEUROPSYCHOLOGICAL ASSESSMENT IN PATIENTS WITH PARKINSON'S DISEASE Obereigneru, R.
 2012
 18 S2 p. S110-
1 p.
 artikel
48 3.123 A NOVEL BAC α-SYNUCLEIN-GFP TRANSGENIC MOUSE MODEL FOR IMAGING OF α-SYNUCLEIN AGGREGATION Hansen, C.
 2012
 18 S2 p. S194-S195
2 p.
 artikel
49 1.311 A NOVEL CASE OF RESTLESS LEG SYNDROME (RLS) DUE TO INTRACEREBRAL HAEMORRHAGE Chandra, B.
 2012
 18 S2 p. S75-
1 p.
 artikel
50 3.065 A NOVEL MISSENSE MUTATION IN THAP1 IN TWO AUSTRALIAN PATIENTS WITH PRIMARY DYSTONIA Newman, J.R.B.
 2012
 18 S2 p. S185-
1 p.
 artikel
51 3.206 A NOVEL NEUROPROTECTIVE THERAPY FOR PARKINSON'S DISEASE USING A VIRAL NON-CODING RNA THAT PROTECTS MITOCHONDRIAL COMPLEX I ACTIVITY Kuan, W.-L.
 2012
 18 S2 p. S204-S205
2 p.
 artikel
52 3.122 A NOVEL SERIES OF HUMAN ALPHA-SYNUCLEIN BAC TRANSGENIC MOUSE MODELS TO DISSECT IN VIVO PATHOGENIC MECHANISMS IN PARKINSON'S DISEASE (PD) Weitz, T. Murphy
 2012
 18 S2 p. S194-
1 p.
 artikel
53 3.024 A NOVEL SUBSTRATE OF PINK1 IMPLICATED IN THE AUTOPHAGY AND APOPTOSIS PATHWAYS Arena, G.
 2012
 18 S2 p. S175-
1 p.
 artikel
54 1.104 ANTIBODIES AGAINST GM1, GD1B AND GQ1B IN PATIENTS WITH PARKINSON'S DISEASE Hatzifilippou, E.
 2012
 18 S2 p. S36-
1 p.
 artikel
55 1.140 ANTI OXIDANT AND ANTI CATALEPTIC ACTIVITY OF SMILAX ZEYLANICA LINN Shaik, R.A.
 2012
 18 S2 p. S45-
1 p.
 artikel
56 2.221 ANTIOXIDANT EFFECT OF RASAGILINE IS NOT DEPENDENT ON INHIBITION OF DOPAMINE OXIDATIVE METABOLISM BY MAO IN RAT STRIATUM IN VIVO Aluf, Y.
 2012
 18 S2 p. S120-
1 p.
 artikel
57 1.139 ANTI-PARKINSONIAN EFFECTS OF ADX48621 A MGLUR5 NEGATIVE ALLOSTERIC MODULATOR (NAM), IN THE RAT HALOPERIDOL INDUCED CATALEPSY MODEL Keywood, C.
 2012
 18 S2 p. S45-
1 p.
 artikel
58 2.364 ANTI-SPASTIC EFFECTS OF THE DIRECT APPLICATION OF VIBRATORY STIMULI IN POST-STROKE PATIENTS: A RANDOMIZED CONTROLLED STUDY Matsumoto, S.
 2012
 18 S2 p. S157-
1 p.
 artikel
59 1.041 A PATIENT PRESENTING WITH ACUTE COLONIC PSEUDO-OBSTRUCTION AS A COMPLICATION OF PARKINSON'S DISEASE Sharma, N. Nikhil
 2012
 18 S2 p. S20-
1 p.
 artikel
60 1.220 A PATIENT WITH SJÖGREN SYNDROME WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND TRIGEMINAL SENSORY NEUROPATHY AND PARKINSONISM (CASE REPORT) Nazarbaghi, S.
 2012
 18 S2 p. S51-
1 p.
 artikel
61 2.150 A POSSIBLE NEW BIOMARKER FOR PARKINSON'S DISEASE: PHARMACOLOGICAL MRI (PHMRI) TO DISCRIMINATE ANIMALS WITH MPTP-VERSUS AGE-RELATED PARKINSONISM IN RHESUS MONKEYS Zhang, Z.
 2012
 18 S2 p. S114-
1 p.
 artikel
62 2.128 APPLICATION OF H-MRS IN PARKINSON'S DISEASE AND SPINOCEREBELLAR ATAXIA Chen, Y.
 2012
 18 S2 p. S108-
1 p.
 artikel
63 2.317 APPLICATION OF NEURO-NAVIGATION SYSTEM IN TARGET CO-ORDINATE CALCULATION FOR SUBTHALAMIC DEEP BRAIN STIMULATION Qiao, L.
 2012
 18 S2 p. S145-
1 p.
 artikel
64 2.110 APPLICATION OF “SNIFFIN' STICKS” ODOR IDENTIFICATION TEST IN CHINESE PATIENTS WITH PARKINSON'S DISEASE: A MATCHED CASE-CONTROL STUDY Chen, W.
 2012
 18 S2 p. S104-
1 p.
 artikel
65 1.120 A PROSPECTIVE STUDY OF STATIN USE AND RISK OF PARKINSON DISEASE Gao, X.
 2012
 18 S2 p. S40-
1 p.
 artikel
66 1.299 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY COMPARING THE EFFICACY, SAFETY AND TOLERABILITY OF LEVODOPA-CARBIDOPA IN PATIENTS WITH X-LINKED DYSTONIA-PARKINSONISM (XDP) Jamora, R.D.
 2012
 18 S2 p. S71-S72
2 p.
 artikel
67 2.012 ARE FP-CIT ABNORMALITIES IN PARKINSON'S DISEASE AND PARKINSON'S DISEASE DEMENTIA CONSISTENT WITH THE BRAAK HYPOTHESIS? Birchall, J.
 2012
 18 S2 p. S93-S94
2 p.
 artikel
68 2.127 A RESEACH OF BLOOD PLASMA A-SYNUCLEIN PROTEIN CONCENTRATION IN PATIENT WITH PARKINSON DISEASE Jiao, L.
 2012
 18 S2 p. S108-
1 p.
 artikel
69 3.241 ARSENIC INDUCED DOPAMINERGIC DEFICITS AND PROTECTION BY CURCUMIN IN RATS Yadav, R.S.
 2012
 18 S2 p. S213-S214
2 p.
 artikel
70 1.110 ASSESSING HYPERSEXUALITY IN PARKINSON'S DISEASE: VALIDATION OF A SCREENING INSTRUMENT de Chazeron, I.
 2012
 18 S2 p. S37-
1 p.
 artikel
71 2.109 ASSESSMENT OF FINE MOTOR CONTROL IN PARKINSON'S DISEASE WITH THE NEUROSKILL™ ANALYSIS OF HANDWRITING DYNAMICS Shrairman, R.
 2012
 18 S2 p. S103-S104
2 p.
 artikel
72 3.005 ASSOCIATION BETWEEN ESTROGEN RECEPTOR GENE POLYMORPHISMS AND PARKINSON'S DISEASE IN HAN CHINESE POPULATION Chen, R.
 2012
 18 S2 p. S170-
1 p.
 artikel
73 1.061 ASSOCIATION BETWEEN FATIGUE AND DEPRESSION IN PARKINSON'S DISEASE Mao, C.-J.
 2012
 18 S2 p. S25-
1 p.
 artikel
74 3.039 ASSOCIATION OF 5-59A/G POLYMORPHISM IN INTRON REGION OF HTRA2 GENE WITH PARKINSON'S DISEASE Zhao, X.Y.
 2012
 18 S2 p. S178-
1 p.
 artikel
75 3.053 ASSOCIATION OF CATECHOL-O-METHYLTRANSFERASE POLYMORPHISMS WITH PARKINSON'S DISEASE AND MOTOR COMPLICATIONS Yin, B.
 2012
 18 S2 p. S182-
1 p.
 artikel
76 1.106 ASSOCIATION OF ESSENTIAL TREMOR AND PARKINSON'S DISEASE IN FAMILIES: A CLINICAL INVESTIGATION LINKING THE TWO Al-Shaikh, R. Hanna
 2012
 18 S2 p. S36-
1 p.
 artikel
77 3.016 ASSOCIATION OF GWAS SINGLE-NUCLEOTIDE POLYMORPHISMS WITH PD IN CHINESE PATIENTS Chen, P.Y.
 2012
 18 S2 p. S173-
1 p.
 artikel
78 3.040 ASSOCIATION OF INTRON RS12138592 A/G POLYMORPHISM OF UBIQUITIN SPECIFIC PROTEASES (USP24) GENE WITH PARKINSON DISEASE Lin, Z.
 2012
 18 S2 p. S179-
1 p.
 artikel
79 3.017 ASSOCIATION OF MUTATIONS IN THE GLUCOCEREBROSIDASE GENE WITH PARKINSON DISEASE IN A KOREAN POPULATION Kim, Y.J.
 2012
 18 S2 p. S173-
1 p.
 artikel
80 3.019 ASSOCIATION OF PARKINSON'S DISEASE WITH SIX SNPS LOCATED ON FOUR PARK S GENES IN NORTHERN HAN CHINESE POPULATION Zhou, Y.
 2012
 18 S2 p. S173-S174
2 p.
 artikel
81 3.056 ASSOCIATIONS BETWEEN GCH1 POLYMORPHISMS AND PRIMARY DYSTONIA AND PARKINSON'S DISEASE IN AN AUSTRALIAN CASE-CONTROL SERIES Newman, J.R.B.
 2012
 18 S2 p. S182-S183
2 p.
 artikel
82 1.055 A STUDY OF CLINICAL VARIABLES IN PARKINSON'S DISEASE AFFECTING SLEEP QUALITY Verma, R.
 2012
 18 S2 p. S23-
1 p.
 artikel
83 1.254 ASYMMETRIC CHOREA AS PRESENTING SYMPTOM IN GRAVES'DISEASE Lee, H.-W.
 2012
 18 S2 p. S60-
1 p.
 artikel
84 3.062 ATAXIN-2 INTERMEDIATE POLYGLUTAMINE EXPANSIONS CONTRIBUTE TO RISK OF ALS AND OF EARLY ONSET HEREDITARY PD Gispert, S.
 2012
 18 S2 p. S184-
1 p.
 artikel
85 1.310 ATHEROSCLEROSIS IN PATIENTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME Baik, J.S.
 2012
 18 S2 p. S74-S75
2 p.
 artikel
86 3.071 ATYPICAL HEREDITARY HYPEREKPLEXIA CAUSED BY HETEROZYGOUS DELETION MUTATION IN THE GLRA1 EXON-1 Yoon, W.T.
 2012
 18 S2 p. S186-S187
2 p.
 artikel
87 1.285 AUDIT OF THE ACTUAL PERFORMANCE OF RECHARGEABLE MEDTRONIC IMPLANTABLE PULSE GENERATOR (ACTIVA-RC) FOR DEEP BRAIN STIMULATION (DBS) THERAPY IN DYSTONIA Naushahi, M.J.
 2012
 18 S2 p. S68-
1 p.
 artikel
88 2.367 AUGMENTING THE CARTESIAN MEDICAL DISCOURSE WITH AN UNDERSTANDING OF THE PERSON'S LIFE WORLD, LIVED BODY, LIFE STORY AND SOCIAL IDENTITY Sunvisson, H.
 2012
 18 S2 p. S158-
1 p.
 artikel
89 1.270 A UNIQUE REDOX-SENSING SENSOR-II MOTIF IN TORSINA PLAYS A CRITICAL ROLE IN NUCLEOTIDE AND PARTNER BINDING Zhu, L.
 2012
 18 S2 p. S64-
1 p.
 artikel
90 Author Index 2012
 18 S2 p. S235-S250
16 p.
 artikel
91 3.072 AUTISM SPECTRUM DISORDER ASSOCIATED WITH LOW BRAIN SEROTONIN AND MUTATIONS IN THE SEROTONIN TRANSPORTER SLC29A 4 AND IN SEROTONIN RELATED GENES Adamsen, D.
 2012
 18 S2 p. S187-
1 p.
 artikel
92 2.104 AUTOMATIC ASSESSMENT OF BRADYKINESIA IN PD PATIENTS Pastorino, M.
 2012
 18 S2 p. S102-
1 p.
 artikel
93 2.102 AUTOMATIC ASSESSMENT OF THE MOTOR STATE OF PARKINSON'S DISEASE PATIENTS Czyzewski, A.
 2012
 18 S2 p. S101-S102
2 p.
 artikel
94 3.003 AUTOMATIC DETECTION OF PARKINSON'S DISEASE SUB-PHENOTYPES: GENOME-WIDE ASSOCIATION Agam, A.
 2012
 18 S2 p. S170-
1 p.
 artikel
95 1.035 AUTONOMIC SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE: A CLINICAL INVESTIGATION Cao, C.
 2012
 18 S2 p. S18-S19
2 p.
 artikel
96 3.329 AUTOPHAGY INVOLVED IN THE AGE RELATED SENSITIVITY OF PARKINSON'S DISEASE Yang, Y.-P.
 2012
 18 S2 p. S226-
1 p.
 artikel
97 3.070 AUTOSOMAL DOMINANT CORTICAL MYOCLONUS AND EPILEPSY (ADCME) - NEW MUTATION IN POLISH FAMILY? Budrewicz, S.
 2012
 18 S2 p. S186-
1 p.
 artikel
98 1.1.1 AUTOSOMAL DOMINANT PARKINSONISM Hattori, N.
 2012
 18 S2 p. S1-
1 p.
 artikel
99 1.1.3 AUTOSOMAL DOMINANT PARKINSON'S DISEASE Wszolek, Z.K.
 2012
 18 S2 p. S1-
1 p.
 artikel
100 1.1.2 AUTOSOMAL RECESSIVE PARKINSONISM Bonifati, V.
 2012
 18 S2 p. S1-
1 p.
 artikel
101 1.1.4 AUTOSOMAL RECESSIVE PARKINSON'S DISEASE Wu, R.M.
 2012
 18 S2 p. S1-
1 p.
 artikel
102 3.248 BAG5 INTERACTS WITH THE PARKINSON-ASSOCIATED PROTEIN PINK1 AND PROTECTS AGAINST OXIDATIVE MITOCHONDRIAL DAMAGE Guo, J.
 2012
 18 S2 p. S215-
1 p.
 artikel
103 3.211 BEE VENOM ATTENUATES MPP+-INDUCED NEUROTOXICITY IN HUMAN NEUROBLASTOMA SH-SY5Y CELLS Doo, A.-R.
 2012
 18 S2 p. S206-
1 p.
 artikel
104 1.068 BEHAVIORAL CHANGES IN PARKINSON'S DISEASE Petrovic, M.
 2012
 18 S2 p. S26-S27
2 p.
 artikel
105 3.228 BEHAVIORAL EFFECTS OF A NOVEL DIPEPTIDE MIMETIC OF THE NERVE GROWTH FACTOR IN RODENT MODELS OF PARKINSON'S DISEASE Povarnina, P.
 2012
 18 S2 p. S210-
1 p.
 artikel
106 2.218 BERBERINE ATTENUATES CALYCULIN A-INDUCED CYTOTOXICITY AND TAU HYPERPHOSPHORYLATION IN HEK293 CELLS Yu, G.
 2012
 18 S2 p. S119-
1 p.
 artikel
107 3.345 BETAHISTINE AMELIORATES BEHAVIORAL MANIFESTATION IN THE 6-OHDA-INDUCING RAT MODEL OF PARKINSON'S DISEASE Jia, F.
 2012
 18 S2 p. S230-
1 p.
 artikel
108 3.334 BETAHISTINE IS EFFECTIVE IN CONTROLLING SPASMS AND IMPROVES LEARNING AND MNEMONIC ABILITY IN NMDA-INDUCING INFANTILE SPASMS RAT MODEL Jia, F.
 2012
 18 S2 p. S227-
1 p.
 artikel
109 2.309 BILATERAL SUBTHALAMIC NUCLEUS STIMULATION VERSUS PREOPERATIVE MEDICAL THERAPY IN PARKINSON'S DISEASE: A SYSTEMATIC REVIEW OF STUDIES WITH ONE YEAR FOLLOW-UP Xian, W.
 2012
 18 S2 p. S143-
1 p.
 artikel
110 1.5.4 BIOMARKERS FOR EARLY DIAGNOSIS OF PD Xu, P.
 2012
 18 S2 p. S3-S4
2 p.
 artikel
111 3.246 BLOCKING DRP-1 FUNCTION IS NEUROPROTECTIVE IN ANIMAL MODELS OF PARKINSON'S DISEASE Rappold, P.
 2012
 18 S2 p. S215-
1 p.
 artikel
112 2.330 BODY WEIGHT GAIN AND METABOLIC CHANGES AFTER DEEP BRAIN STIMULATION IN PATIENTS WITH PARKINSON'S DISEASE Rieu, I.
 2012
 18 S2 p. S149-
1 p.
 artikel
113 1.230 BOTULINUM TOXIN TREATMENT IN PATIENTS WITH ESSENTIAL TREMOR Vohanka, S.
 2012
 18 S2 p. S54-
1 p.
 artikel
114 2.242 BRAIN AND PERIPHERAL LEVODOPA PHARMACOKINETICS IN THE CYNOMOLGUS MONKEY FOLLOWING ADMINISTRATION OF OPICAPONE, A NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR Bonifacio, M.J.
 2012
 18 S2 p. S125-
1 p.
 artikel
115 2.018 BRAIN GLUCOSE METABOLISM OF VISUAL PATHWAYS IN PARKINSON'S DISEASE WITH HALLUCINATION Park, H.K.
 2012
 18 S2 p. S95-
1 p.
 artikel
116 2.121 BROAD-BAND DIRECTIONAL EEG CONNECTIVITY CHANGES DURING MOTOR PREPARATION PREDICTS PARKINSON'S DISEASE SEVERITY Chiang, J.
 2012
 18 S2 p. S106-S107
2 p.
 artikel
117 1.292 BTA TREATMENT OF DIFFERENT TYPES OF OROMANDIBULAR DYSTONIA Charnukha, T.
 2012
 18 S2 p. S70-
1 p.
 artikel
118 2.270 BUPROPION ON FREEZING OF GAIT IN PARKINSON'S DISEASE Park, Y.S.
 2012
 18 S2 p. S133-
1 p.
 artikel
119 3.142 CAENORHABDITIS ELEGANS AS A MODEL SYSTEM OF PARKINSON DISEASE FOR HIGH-CONTENT SCREENING Lehtonen, S.
 2012
 18 S2 p. S199-
1 p.
 artikel
120 3.042 CAFFEINE-MEDIATED RISK OF PARKINSON'S DISEASE IS GREATER IN SLOW NAT2 GENOTYPE CARRIERS: CLINICAL, GENETIC AND MOLECULAR STUDY Lim, J.-W.
 2012
 18 S2 p. S179-
1 p.
 artikel
121 2.343 CAN A PATIENT WITH COMPLEX MIXED DEMENTIA BE APPROPRIATELY APPROVED FOR DBS? Jaffe, L.
 2012
 18 S2 p. S152-
1 p.
 artikel
122 3.045 CANNABINOID CB2 RECEPTOR GENE EXPRESSION DIFFERENCES IN PARKINSON'S DISEASE POST-MORTEM BRAIN SAMPLES AND LYMPHOCYTES FROM RECENTLY DIAGNOSED AND NON-TREATED PATIENTS Navarrete, F.
 2012
 18 S2 p. S180-
1 p.
 artikel
123 2.125 CARDIAC 123I-METAIODOBENZYLGUANIDINE SCINTIGRAPHY IN PARKINSON'S DISEASE (PD) PATIENTS WITH SCANS WITHOUT EVIDENCE OF DOPAMINERGIC DEFICIT (SWEDDS) Jang, W.
 2012
 18 S2 p. S107-
1 p.
 artikel
124 2.010 CASE CONTROL DIFFUSION TENSOR IMAGING TRACTOGRAPHY STUDIES IN POSTURAL INSTABILITY GAIT DISORDER PARKINSONISM Chan, L.-L.
 2012
 18 S2 p. S93-
1 p.
 artikel
125 1.262 CASE PRESENTATION: THE COEXISTENCE OF PSYCHOLOGICAL AND SOMATIC FACTORS IN A PATIENT WITH PAROXYSMAL DYSKINESIA Sajin, V.
 2012
 18 S2 p. S62-
1 p.
 artikel
126 1.274 CASE REPORT: NEUROFERRITINOPATHY WITH EARLY BULBAR INVOLVEMENT Petchrutchatachart, S.
 2012
 18 S2 p. S65-
1 p.
 artikel
127 1.243 CASE SERIES: ANTI-NMDAR ENCEPHALITIS - A SYNAPTIC AUTOIMMUNE DISORDER Chai, C.H.
 2012
 18 S2 p. S57-
1 p.
 artikel
128 1.315 4 CASES REPORT OF CEREBELLAR ATAXIA-ACANTHOCYTOSIS Jiang, Y.
 2012
 18 S2 p. S75-S76
2 p.
 artikel
129 3.314 CD200-CD200R DYSFUNCTION EXACERBATES MICROGLIA ACTIVATION AND DOPAMINERGIC NEURODEGENERATION IN RAT MODEL OF PARKINSON'S DISEASE Zhang, S.
 2012
 18 S2 p. S222-S223
2 p.
 artikel
130 3.217 CDNF PROTECTS THE NIGROSTRIATAL DOPAMINE SYSTEM AND PROMOTES RECOVERY AFTER MPTP TREATMENT IN MICE Airavaara, M.
 2012
 18 S2 p. S207-S208
2 p.
 artikel
131 3.104 CELL-DEATH PATHWAYS DOWNSTREAM OF MITOCHONDRIA IN HUMAN DOPAMINERGIC NEURON DEGENERATION Pöltl, D.
 2012
 18 S2 p. S190-
1 p.
 artikel
132 1.317 CEREBELLAR ATAXIA DUE TO AUTOIMMUNE DISEASE Mercan, M.
 2012
 18 S2 p. S76-
1 p.
 artikel
133 1.227 CEREBELLAR GABA-B RECEPTORS IN ESSENTIAL TREMOR Luo, C.
 2012
 18 S2 p. S53-
1 p.
 artikel
134 2.036 CEREBRAL GLUCOSE METABOLISM IN PROGRESSIVE SUPRANUCLEAR PALSY Ma, A.
 2012
 18 S2 p. S100-
1 p.
 artikel
135 2.126 CEREBRAL PATHOLOGIES STUDY BY MEANS OF MAGNETIC ENCEPHALOGRAPHY DATA Makhortykh, S.A.
 2012
 18 S2 p. S108-
1 p.
 artikel
136 3.18.1 CERTAIN ISSUES AND OUR SUGGESTIONS IN THE PHARMACEUTICAL TREATMENT OF WILSON DISEASE Liang, X.-L.
 2012
 18 S2 p. S168-S169
2 p.
 artikel
137 3.2.4 CHALLENGING NEW CLINICAL APPLICATIONS Chen, L.
 2012
 18 S2 p. S162-
1 p.
 artikel
138 2.130 CHANGE IN GLUTATHIONE-S-TRANSFERASE-PI EXPRESSION IN BLOOD OF PARKINSON'S DISEASE PATIENTS FOLLOWING EXPOSURE TO OXIDATIVE STRESS: POTENTIAL USE AS A BIOMARKER Korff, A.
 2012
 18 S2 p. S109-
1 p.
 artikel
139 3.313 CHANGES IN BEHAVIORAL RESPONSE TO PAIN IN ROTENONE MODEL OF PARKINSON'S DISEASE IN AGED RATS Ljubisavljevic, M.
 2012
 18 S2 p. S222-
1 p.
 artikel
140 1.298 CHANGES IN SENSORIMOTOR NETWORK ACTIVATIONS AFTER BOTULINUM TOXIN TYPE A INJECTIONS IN PATIENTS WITH CERVICAL DYSTONIA. A FUNCTIONAL MRI STUDY Nevrly, M.
 2012
 18 S2 p. S71-
1 p.
 artikel
141 3.135 CHANGES OF THE PKA/PP2A/CDK5/DARPP-32 PATHWAY IN 6-OHDA-LESIONED RATS FOLLOWING LONG-TERM TREATMENT WITH L-DOPA Jin, L.
 2012
 18 S2 p. S198-
1 p.
 artikel
142 2.135 CHARACTERISING NON MOTOR PATTERNS OF EARLY MORNING OFF PERIODS IN PARKINSON'S DISEASE: AN INTERNATIONAL STUDY Rizos, A.
 2012
 18 S2 p. S110-
1 p.
 artikel
143 3.006 CHARACTERIZATION OF A LIBRARY OF CLONES ISOLATED FROM A HUMAN VENTRAL MESENCEPHALIC NEURAL STEM CELL LINE GENERATING DOPAMINERGIC NEURONS Ramos-Moreno, T.
 2012
 18 S2 p. S170-S171
2 p.
 artikel
144 2.034 CHARACTERIZATION OF PUTAMINAL ABNORMALITIES IN THE PARKINSON VARIANT OF MSA BY SUSCEPTIBILITY-WEIGHTED IMAGING Lee, J.-H.
 2012
 18 S2 p. S100-
1 p.
 artikel
145 2.210 CHEMICALLY MODIFIED PEPTIDES FOR INHIBITING α-SYNUCLEIN AGGREGATION Zhou, F.M.
 2012
 18 S2 p. S117-
1 p.
 artikel
146 3.231 CHEMICALS POSSESSING A NEUROTROPHIN-LIKE ACTIVITY ON DOPAMINERGIC NEURONS IN PRIMARY CULTURE Raisman-Vozari, R.
 2012
 18 S2 p. S211-
1 p.
 artikel
147 1.17.1 CHOREA AND RELATED DISORDER Zhang, B.
 2012
 18 S2 p. S8-
1 p.
 artikel
148 1.244 CHOREOATHETOSIS CAUSED BY NUCLEUS CAUDATE ISCHEMIA Şenol, M.G.
 2012
 18 S2 p. S57-S58
2 p.
 artikel
149 2.213 CHRONIC L-DOPA TREATMENT IMPAIRS MOTOR LEARNING IN A UNILATERAL 6-HYDROXY-DOPAMINE RAT MODEL OF PARKINSON'S DISEASE Murphy, E.M.
 2012
 18 S2 p. S117-S118
2 p.
 artikel
150 1.011 CIRCULATING VITAMIN D LEVELS, VITAMIN D BINDING PROTEIN GENE POLYMORPHISMS, AND SEVERITY OF PARKINSON'S DISEASE Noya, M.
 2012
 18 S2 p. S12-S13
2 p.
 artikel
151 3.3.1 CLASSIFICATION OF MYOCLONUS Carr, J.
 2012
 18 S2 p. S162-S163
2 p.
 artikel
152 2.139 CLINICAL AND MRI, 18F-FDG PET DIAGNOSTIC CHARACTERISTICS OF 23 PROGRESSIVE SUPRANUCLEAR PALSY Wang, F.X.
 2012
 18 S2 p. S111-
1 p.
 artikel
153 1.111 CLINICAL AND NEUROPSYCHOLOGICAL CHARACTERIZATION OF PATIENTS WITH PARKINSON'S DISEASE AND DOPAMINE DYSREGULATION SYNDROME Cilia, R.
 2012
 18 S2 p. S37-S38
2 p.
 artikel
154 1.046 CLINICAL CORRELATES OF APATHY IN EARLY PARKINSON DISEASE: THE ANIMO STUDY Cubo, E.
 2012
 18 S2 p. S21-
1 p.
 artikel
155 1.201 CLINICAL FEATURES AND DIFFERENTIATION OF ATYPICAL PARKINSONIAN SYNDROMES Chen, L.
 2012
 18 S2 p. S46-S47
2 p.
 artikel
156 1.082 CLINICAL FEATURES OF PARKINSON'S DISEASE DEMENTIA Adwan, Z.
 2012
 18 S2 p. S30-
1 p.
 artikel
157 1.005 CLINICAL HETEROGENEITY IN PATIENTS WITH EARLY-STAGE PARKINSON'S DISEASE: A CLUSTER ANALYSIS Feng, T.
 2012
 18 S2 p. S11-
1 p.
 artikel
158 2.331 CLINICAL IMPACT OF THALAMOTOMY AND DEEP BRAIN THALAMIC STIMULATOR IN MOVEMENT DISORDERS NOT RESPONDING TO MEDICATION Maurice, C.
 2012
 18 S2 p. S149-
1 p.
 artikel
159 3.15.4 CLINICAL MANAGEMENT OF PAIN AND FATIGUE IN PD Albanese, A.
 2012
 18 S2 p. S168-
1 p.
 artikel
160 1.207 CLINICAL, NEUROPHYSIOLOGICAL AND NEUROPSYCHOPHYSIOLOGICAL FINDINGS IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY Petrov, I.
 2012
 18 S2 p. S48-
1 p.
 artikel
161 2.004 CLINICAL OUTCOME OF DRUG-INDUCED PARKINSONISM CAN BE PREDICTED WITH TRANSCRANIAL MIDBRAIN SONOGRAPHY Kwon, D.-Y.
 2012
 18 S2 p. S92-
1 p.
 artikel
162 1.208 CLINICAL PAIN AND EXPERIMENTAL PAIN SENSITIVITY IN PROGRESSIVE SUPRANUCLEAR PALSY Stamelou, M.
 2012
 18 S2 p. S48-
1 p.
 artikel
163 3.15.3 CLINICAL RATING SCALES Relja, M.
 2012
 18 S2 p. S168-
1 p.
 artikel
164 2.028 CLINICAL RESEARCH OF [11 C]CFT DOPAMINE TRANSPORTER PET IMAGING IN PARKINSON'S DISEASE Xian, W.
 2012
 18 S2 p. S98-
1 p.
 artikel
165 1.012 CLINICAL SCENARIO OF PATIENTS WITH PARKINSONISM: A MONGOLIAN STUDY Sosorburam, T.
 2012
 18 S2 p. S13-
1 p.
 artikel
166 1.028 CLINICAL STUDY OF NON-MOTOR SYMPTOMS IN PARKINSON DISEASE Ye, M.
 2012
 18 S2 p. S17-
1 p.
 artikel
167 2.350 CLINICAL STUDY ON INSOMNIA EVALUATION OF RELATIVE FACTORS AND REHABILITATION INTERVENTION IN PATIENTS WITH PARKINSON'S DISEASE Zhang, X.
 2012
 18 S2 p. S153-
1 p.
 artikel
168 1.121 CNS INFECTIONS, SEPSIS, AND RISK OF PARKINSON DISEASE Chen, H.
 2012
 18 S2 p. S40-
1 p.
 artikel
169 1.205 COEXISTENCE OF ALS/ET/PD AND ALS/ET/MSA IN TWO DIFFERENT FAMILIES He, X.
 2012
 18 S2 p. S48-
1 p.
 artikel
170 2.238 COFFEE OR CHOCOLATE, WHAT DO YOU LIKE TO DRINK WITH YOUR L-DOPA? Jimenez-Botello, L.C.
 2012
 18 S2 p. S124-
1 p.
 artikel
171 1.14.2 COGNITIVE DEFICITS IN PARKINSON'S DISEASE: VARIABILITY, EVOLUTION, AND EFFECT OF DOPAMINERGIC MEDIATION Monchi, O.
 2012
 18 S2 p. S7-
1 p.
 artikel
172 1.070 COGNITIVE IMPAIRMENT AND DEPRESSION IN PATIENTS WITH PARKINSON'S DISEASE Qu, X.
 2012
 18 S2 p. S27-
1 p.
 artikel
173 1.202 COGNITIVE IMPAIRMENT IN CEREBELLAR TYPE MULTIPLE SYSTEM ATROPHY Lee, M.-S.
 2012
 18 S2 p. S47-
1 p.
 artikel
174 2.148 COGNITIVE-MOTIVATIONAL DEFICITS IN ADHD: DEVELOPMENT OF A CLASSIFICATION SYSTEM Gupta, R.
 2012
 18 S2 p. S113-
1 p.
 artikel
175 3.338 COLLAGEN CELL CARRIER FOR NEURAL CELL CULTURES Zhang, Y.
 2012
 18 S2 p. S228-
1 p.
 artikel
176 3.145 COMBINED TREATMENT OF ACUPUNCTURE WITH LEVODOPA ALLEVIATES LEVODOPA-INDUCED DYSKINESIA ON A 6-OHDA-INDUCED PARKINSON'S DISEASE MOUSE MODEL Kim, S.-N.
 2012
 18 S2 p. S200-
1 p.
 artikel
177 2.288 COMBINED ZOLPIDEM AND CARBIDOPA/LEVODOPA TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY (PSP): A CASE REPORT WITH VIDEO DOCUMENTATION Chen, S.
 2012
 18 S2 p. S137-S138
2 p.
 artikel
178 Committees 2012
 18 S2 p. iv-
1 p.
 artikel
179 3.114 COMMON DIFFERENTIALLY EXPRESSED PROTEINS IN SUBSTANTIA NIGRA OF MOUSE MODELS WITH CHRONIC PARKINSON'S DISEASE INDUCED BY ROTENONE AND MPTP Zhou, C.
 2012
 18 S2 p. S192-S193
2 p.
 artikel
180 2.006 COMPARASION STUDY OF VOLUME OF OLFACTORY BULB BY MRI BETWEEN PARKINSON'S DISEASE AND THE NORMAL PERSON Shao, M.
 2012
 18 S2 p. S92-
1 p.
 artikel
181 1.008 COMPARATIVE CHARACTERIZATION OF BIOCHEMICAL DISORDERS, DEPENDING ON THE STAGE OF PARKINSON'S DISEASE Matmurodov, R.J.
 2012
 18 S2 p. S12-
1 p.
 artikel
182 1.251 COMPARING THE DYNAMIC RELATIONSHIP OF VOLUNTARY AND INVOLUNTARY MOVEMENTS BETWEEN DYSKINETIC PARKINSON'S PATIENTS AND CHOREIC HUNTINGTON'S PATIENTS Duval, C.
 2012
 18 S2 p. S59-
1 p.
 artikel
183 1.137 COMPARISON OF ENDOTHELIAL PROGENITOR CELLS IN PARKINSON'S DISEASE PATIENTS TREATED WITH LEVODOPA AND LEVODOPA/COMT INHIBITOR Lee, P.H.
 2012
 18 S2 p. S44-
1 p.
 artikel
184 3.132 COMPARISON OF FOUR GDNF-VARIANTS IN THE 6-OHDA RAT MODEL OF PARKINSON'S DISEASE Piltonen, M.H.
 2012
 18 S2 p. S197-
1 p.
 artikel
185 2.029 COMPARISON OF PIB(−) LEWY BODY DEMENTIA, PIB(+) LEWY BODY DEMENTIA AND ALZHEIMER DISEASE: NEUROPSYCHIATRIC, [11C]PIB AND [18F]FDG PET FINDINGS Lee, C.S.
 2012
 18 S2 p. S98-
1 p.
 artikel
186 3.067 COMPOUD HETEROZYGOUS ATP7B MUTATIONS LEADING TO HYPOCERULOPLASMINEMIA BUT NOT CLINICAL WILSON'S DISEASE IN AN ADULT PATIENT Teive, H.A.G.
 2012
 18 S2 p. S185-S186
2 p.
 artikel
187 2.241 COMPUTATION OF BINDING AFFINITY OF CATECHOL-O-METHYLTRANSFERASE-OPICAPONE COMPLEXES Palma, N.
 2012
 18 S2 p. S125-
1 p.
 artikel
188 2.19.3 CONTINUOUS DOPAMINERGIC STIMULATION THERAPY WITH LEVODOPA CARBIDOPA INTESTINAL GEL INFUSION: THE LATEST EVIDENCE Odin, P.
 2012
 18 S2 p. S90-
1 p.
 artikel
189 2.113 CONTRAST SENSITIVITY VISUAL ACUITY IS DEFICIENT IN PARKINSON'S DISEASE AND DEGRADES MOTOR PERFORMANCE Swigler, C.
 2012
 18 S2 p. S104-S105
2 p.
 artikel
190 3.131 CONTRIBUTION OF NITRERGIC TRANSMISSION TO THE MODULATION OF L-DOPA ACTIVITY IN THE 6-OHDA MODEL OF PARKINSON'S DISEASE. THERAPEUTIC IMPLICATIONS Czarnecka, A.
 2012
 18 S2 p. S197-
1 p.
 artikel
191 1.237 CONVULSIVE SYNDROME IN CHILDREN WITH THE HEMORRHAGIC STROKE Issayeva, R.
 2012
 18 S2 p. S55-S56
2 p.
 artikel
192 1.049 CORRELATION BETWEEN CLINICAL CHARACTERISTICS AND SLEEP DISTURBANCES IN PARKINSON'S DISEASE Sung, Y.-H.
 2012
 18 S2 p. S22-
1 p.
 artikel
193 1.093 CORRELATION BETWEEN NON MOTOR SYMPTOMS, UNIFIED PARKINSON'S DISEASE RATING SCALE SCORE AND QUALITY OF LIFE Vuletic, V.
 2012
 18 S2 p. S33-
1 p.
 artikel
194 1.081 CORRELATION BETWEEN SEVERITY OF COGNITIVE DEFICIT AND MOTOR SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE Butkovic-Soldo, S.
 2012
 18 S2 p. S30-
1 p.
 artikel
195 1.328 CORRELATION BETWEEN THE TIMED UP AND GO TEST AND SIT-TO-STAND TEST IN PATIENTS WITH SPINAL CORD INJURY (SCI) Srisim, K.
 2012
 18 S2 p. S78-S79
2 p.
 artikel
196 1.203 CORRELATION OF MIDBRAIN ATROPHY WITH QUANTITATIVE BALANCE IMPAIRMENT IN PROGRESSIVE SUPRANUCLEAR PALSY Pal, P.
 2012
 18 S2 p. S47-
1 p.
 artikel
197 2.316 CORRELATION OF RCBF AND SURGICAL OUTCOME IN PARKINSON DISEASE: OBJECTIVE EVALUATION USING STEREOTACTIC EXTRACTION ESTIMATION ANALYSIS IN 123I-IMP SPECT Kajita, Y.
 2012
 18 S2 p. S145-
1 p.
 artikel
198 1.326 CORRELATION OF THE 10-METER WALK TEST (10MWT) AND 6-MINUTE WALK TEST (6MINWT) IN PATIENTS WITH SPINAL CORD INJURY (SCI) Neawla, S.
 2012
 18 S2 p. S78-
1 p.
 artikel
199 3.251 CORTICAL INHIBITION AND IMPROVEMENT OF MOTOR PERFORMANCE BY LOW-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OVER M1 IN PARKINSON'S DISEASE Ma, X.
 2012
 18 S2 p. S216-
1 p.
 artikel
200 1.142 COST ANALYSIS OF THE TREATMENTS FOR PATIENTS WITH COMPLICATED PARKINSON'S DISEASE: SCOPE STUDY Valldeoriola, F.
 2012
 18 S2 p. S46-
1 p.
 artikel
201 2.144 CSF BIOMARKERS OF CENTRAL CATECHOLAMINE DEFICIENCY IN THE DIAGNOSIS OF PARKINSON DISEASE AND OTHER SYNUCLEINOPATHIES Goldstein, D.S.
 2012
 18 S2 p. S112-
1 p.
 artikel
202 2.131 CSF CLUSTERIN IS ASSOCIATED WITH COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE BIOMARKERS IN PARKINSON'S DISEASE PATIENTS van Dijk, K.D.
 2012
 18 S2 p. S109-
1 p.
 artikel
203 3.301 CYTOKINES ASSOCIATED WITH PARKINSON'S DISEASE Huang, Y.
 2012
 18 S2 p. S219-
1 p.
 artikel
204 2.281 DARKENING OF WHITE HAIR IN PARKINSON'S DISEASE INDUCED BY LEVODOPA RICH MUCUNA PRURIENS (VELVET BEANS) EXTRACT POWDER Munhoz, R.P.
 2012
 18 S2 p. S135-S136
2 p.
 artikel
205 3.318 D3 DOPAMINE RECEPTOR FACILITATES INFILTRATION OF CD4+ T-CELLS AND NEURODEGENERATION OF SUBSTANTIA NIGRA IN A MOUSE MODEL OF PARKINSON'S DISEASE Velozo, H. Gonzalez
 2012
 18 S2 p. S223-S224
2 p.
 artikel
206 3.229 DECREASED LEVEL OF NURR1 IN HETEROZYGOUS YOUNG ADULT MICE LEADS TO EXACERBATED ACUTE AND LONG-TERM TOXICITY AFTER REPEATED METHAMPHETAMINE EXPOSURE Luo, Y.
 2012
 18 S2 p. S210-
1 p.
 artikel
207 1.250 DECREASED METABOLISM OF THE CORTEX PREDICTS THE RATE OF PROGRESSION IN EARLY-STAGE HUNTINGTON'S DISEASE Shin, H.E.
 2012
 18 S2 p. S59-
1 p.
 artikel
208 1.115 DECREASED MOTOR CORTICAL INHIBITION AND INCREASED FACILITATION IN PARKINSON'S DISEASE Ni, Z.
 2012
 18 S2 p. S39-
1 p.
 artikel
209 2.132 DECREASED NURR1 AND PITX3 GENE EXPRESSION IN CHINESE PATIENTS WITH PARKINSON'S DISEASE Liu, H.-M.
 2012
 18 S2 p. S109-
1 p.
 artikel
210 3.240 DECREASED SEROTONERGIC RECEPTORS REGULATION IN 6-HYDROXYDOPAMINE LESIONED RATS: NEUROPROTECTION BY CO-MITOGENIC SEROTONIN AND GABA IN COMBINATION WITH BONE MARROWS CELLS Korah, P.K.
 2012
 18 S2 p. S213-
1 p.
 artikel
211 3.319 DEEP BRAIN STIMULATION AND ON-LINE EXECUTIVE CONTROL IN PARKINSON'S DISEASE Hasbroucq, T.
 2012
 18 S2 p. S224-
1 p.
 artikel
212 3.2.3 DEEP BRAIN STIMULATION - CHALLENGING NEW STRUCTURAL TARGETS Uitti, R.J.
 2012
 18 S2 p. S162-
1 p.
 artikel
213 2.321 DEEP BRAIN STIMULATION FOR MOVEMENT DISORDERS IN A SERIES OF 276 PATIENTS Yuqing, Z.
 2012
 18 S2 p. S146-
1 p.
 artikel
214 2.322 DEEP BRAIN STIMULATION IN CHINA: PRESENT AND FUTURE Hu, W.-H.
 2012
 18 S2 p. S146-S147
2 p.
 artikel
215 2.338 DEEP BRAIN STIMULATION IN 10 PATIENTS WITH SEVERE GILLES DE LA TOURETTE SYNDROME Li, J.
 2012
 18 S2 p. S151-
1 p.
 artikel
216 2.372 DEEP BRAIN STIMULATION IN TOURETTE'S SYNDROME: A DESCRIPTION OF 3 PATIENTS WITH EXCELLENT OUTCOME Savica, R.
 2012
 18 S2 p. S159-
1 p.
 artikel
217 2.323 DEEP BRAIN STIMULATION OF THE DORSAL STRIATUM FOR TINNITUS Cheung, S.W.
 2012
 18 S2 p. S147-
1 p.
 artikel
218 2.313 DEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS IMPROVES SENSE OF WELL-BEING IN PARKINSON'S DISEASE McDonald, L.M.
 2012
 18 S2 p. S144-
1 p.
 artikel
219 2.320 DEEP BRAIN STIMULATION — OUR EXPERIENCE FROM KELANTAN, NORTH EASTERN STATE OF MALAYSIA Bhaskar, S.
 2012
 18 S2 p. S146-
1 p.
 artikel
220 1.108 DEEP STUDY: A LARGE EPIDEMIOLOGICAL SURVEY ABOUT WEARING OFF IN PARKINSON DISEASE Stocchi, F.
 2012
 18 S2 p. S37-
1 p.
 artikel
221 2.033 DEFAULT MODE NETWORK AND EXTRASTRIATE VISUAL RESTING STATE NETWORK IN PATIENTS WITH PARKINSON'S DISEASE DEMENTIA Rektorová, I.
 2012
 18 S2 p. S99-
1 p.
 artikel
222 1.213 DELAYED APPEARANCE OF VASCULAR PARKINSONISM SIX YEARS AFTER A PUTAMINAL INFARCTION Ahn, T.-B.
 2012
 18 S2 p. S49-S50
2 p.
 artikel
223 1.100 DEMENTIA, NONMOTOR SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE Eun, M.-Y.
 2012
 18 S2 p. S35-
1 p.
 artikel
224 2.021 DEMENTIA WITH LEWY BODIES CAN BE WELL-DIFFERENTIATED FROM ALZHEIMER'S DISEASE BY MEASUREMENT OF BRAIN ACETYLCHOLIN ESTERASE ACTIVITY BY PET Shimada, H.
 2012
 18 S2 p. S96-
1 p.
 artikel
225 3.059 DE NOVO MUTATED ATAXIN-2 INTERMEDIATE-LENGTH POLYGLUTAMINE ASSOCIATED WITH FAMILIAR ALS AND PARKINSONISM/ESSENTIAL TREMOR Laffita, J.
 2012
 18 S2 p. S183-
1 p.
 artikel
226 1.211 DEPRESSION IN THE ELDERLY ASSOCIATED TO VASCULAR PARKINSONISM: A CASE REPORT Soler, C.
 2012
 18 S2 p. S49-
1 p.
 artikel
227 3.343 DEREGULATED MIRNA-184 INDUCES CELL CYCLE RE-ENTRY AND APOPTOSIS OF POSTMITOTIC DOPAMINERGIC NEURONS VIA REGULATION OF E2F IN PARKINSON DISEASE Zhang, Z.
 2012
 18 S2 p. S229-S230
2 p.
 artikel
228 3.262 DEREGULATION OF GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS AT DIFFERENT STAGES OF THE PARKINSON'S DISEASE Mutez, E.
 2012
 18 S2 p. S218-
1 p.
 artikel
229 2.137 DETERMINANTS OF CORTICAL EXCITABILITY CHANGES IN PARKINSON'S DISEASE Antczak, J.
 2012
 18 S2 p. S111-
1 p.
 artikel
230 3.333 DETERMINATION OF COPPER AS TRACE METAL IN BLOOD SERUM OF MALARIAL PATIENTS BY ATOMIC ABSORPTION SPECTROSCOPY Baloch, S.
 2012
 18 S2 p. S227-
1 p.
 artikel
231 1.143 DEVELOPMENT OF A TIME-RESOLVED FRET IMMUNOASSAY FOR α-SYNUCLEIN QUANTIFICATION SUITABLE FOR CLINICAL SAMPLE ANALYSIS AND HIGH-THROUGHPUT TRANSLATIONAL RESEARCH Bidinosti, M.
 2012
 18 S2 p. S46-
1 p.
 artikel
232 2.271 DEVELOPMENT OF INHALED APOMORPHINE FOR PATIENTS WITH FLUCTUATING PARKINSON'S DISEASE: DOSE-FINDING RESULTS Grosset, D.
 2012
 18 S2 p. S133-
1 p.
 artikel
233 3.260 D-β-HYDROXYBUTYRATE IS NEUROPROTECTIVE IN MOUSE MODELS OF HUNTINGTON'S DISEASE Lim, S.
 2012
 18 S2 p. S218-
1 p.
 artikel
234 2.105 DIAGNOSIS AND MONITORING OF PARKINSON'S DISEASE PATIENTS BASED ON MOTOR SIGNALS Pastor-Sanz, L.
 2012
 18 S2 p. S102-
1 p.
 artikel
235 1.7.2 DIAGNOSIS OF PD Brooks, D.J.
 2012
 18 S2 p. S4-
1 p.
 artikel
236 1.040 DIETARY HABITS AND ANTHROPOMETRIC PARAMETERS IN AFRICAN PARKINSON'S DISEASE PATIENTS Barichella, M.
 2012
 18 S2 p. S20-
1 p.
 artikel
237 2.111 DIFFERENCES IN OLFACTORY FUNCTION BETWEEN PARKINSON'S DISEASE AND VASCULAR PARKINSONISM Iijima, M.
 2012
 18 S2 p. S104-
1 p.
 artikel
238 1.128 DIFFERENTIAL MITOCHONDRIAL PROTEIN EXPRESSION WITHIN SINGLE GLYCINERGIC NEURONS OF THE PEDUNCULOPONTINE NUCLEUS OF PARKINSON'S DISEASE PATIENTS Pienaar, I.S.
 2012
 18 S2 p. S42-
1 p.
 artikel
239 3.032 DIFFERENTIAL REGULATION OF NMDA RECEPTOR FUNCTION BY DJ-1 AND PINK1 Wan, Q.
 2012
 18 S2 p. S177-
1 p.
 artikel
240 2.005 DIFFERENT SIGNALS OF MAGNETIC RESONANCE IMAGING AND ULTRASOUND FROM PARKINSONIAN SUBSTANTIA NIGRA AND CONTROL – IS IRON THE CAUSE? Galazka-Friedman, J.
 2012
 18 S2 p. S92-
1 p.
 artikel
241 2.009 DIFFUSION TENSOR IMAGING AND TRACTOGRAPHY OF THE NIGROSTRIATAL AND MESOLIMBIC PATHWAYS IN PARKINSON DISEASE Gupta, R.
 2012
 18 S2 p. S93-
1 p.
 artikel
242 2.011 DIFFUSION TENSOR IMAGING STUDY IN PARKINSON'S DISEASE WITH IMPULSE CONTROL DISORDERS Meco, G.
 2012
 18 S2 p. S93-
1 p.
 artikel
243 2.301 DIRECT TARGETING THE SUBTHALAMIC NUCLEUS WITH 3.0T MR IMAGING FOR DEEP BRAIN STIMULATION Shi, Y.-C.
 2012
 18 S2 p. S141-
1 p.
 artikel
244 1.124 DISTRIBUTION OF MICROGLIA IN THE POSTNATAL MURINE NIGROSTRIATAL SYSTEM Sharaf, A.
 2012
 18 S2 p. S41-
1 p.
 artikel
245 3.020 DJ-1 BASED PEPTIDE AS A NOVEL NEUROPROTECTIVE STRATEGY IN PARKINSON'S DISEASE Lev, N.
 2012
 18 S2 p. S174-
1 p.
 artikel
246 1.075 DOES NEUROINFLAMMATION AFFECT DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON'S DISEASE? Song, I.-U.
 2012
 18 S2 p. S28-
1 p.
 artikel
247 1.14.3 DOPAMINE DEPENDENCY AND PUNDING Rabey, J.M.
 2012
 18 S2 p. S7-S8
2 p.
 artikel
248 2.274 DOPAMINE DYSREGULATION SYNDROME WITH SEROTONIN SYNDROME IN PARKINSON'S DISEASE: CASE REPORT Ren, D.D.
 2012
 18 S2 p. S134-
1 p.
 artikel
249 3.344 DOPAMINE RECEPTOR D2 MODULATES INNATE IMMUNITY AND SUPPRESSES NEUROINFLAMMATION Zhou, J.
 2012
 18 S2 p. S230-
1 p.
 artikel
250 1.019 DOPAMINE RESPONSIVE AND NON-RESPONSIVE GAIT PARAMETERS IN PARKINSON'S DISEASE Martin, W.
 2012
 18 S2 p. S14-S15
2 p.
 artikel
251 1.264 DOPA-RESPONSIVE DYSTONIA PRESENTING AS WRITER'S CRAMP Luca, C.
 2012
 18 S2 p. S63-
1 p.
 artikel
252 3.150 DROSOPHILA MODEL TO DISSECT THE SIGNALING PATHWAYS MEDIATING THE TOXICITY OF FUNGAL VOCS IN DOPAMINERGIC NEURONS: VOCS AND PARKINSON'S DISEASE? Inamdar, A.A.
 2012
 18 S2 p. S201-
1 p.
 artikel
253 3.335 DUAL-RESONANCE GENERATED BY SK-CURRENT AND H-CURRENT AT HYPERPOLARIZED MEMBRANE POTENTIALS AT THETA FREQUENCY IN RAT SNC NEURONS Xue, W.-N.
 2012
 18 S2 p. S227-S228
2 p.
 artikel
254 1.309 DUAL TASK WALKING EFFECT ON GAIT CHARACTERISTICS IN PROGRESSIVE SUPRANUCLEAR PALSY PATIENTS Radovanovic, S.
 2012
 18 S2 p. S74-
1 p.
 artikel
255 3.331 DYSFUNCTIONAL AUTOPHAGY CONTRIBUTES TO LPS-STIMULATED INFLAMMATION IN MACROPHAGES Cao, L.-D.
 2012
 18 S2 p. S227-
1 p.
 artikel
256 2.229 DYSKINESIA IN PARKINSON'S DISEASE — IMPAIRMENTS OF INHIBITION DURING VOLUNTARY CONTRACTION. A TRANSCRANIAL MAGNETIC STIMULATION (TMS) STUDY Filipović, S.R.
 2012
 18 S2 p. S122-
1 p.
 artikel
257 3.16.1 DYSTONIA Wan, X.H.
 2012
 18 S2 p. S168-
1 p.
 artikel
258 3.1.2 DYSTONIA: PHENOMENOLOGY LeDoux, M.S.
 2012
 18 S2 p. S161-
1 p.
 artikel
259 3.9.4 DYSTONIA, WILSON'S DISEASE Bhatt, M.
 2012
 18 S2 p. S165-
1 p.
 artikel
260 2.341 EARLY, POSTOPERATIVE MICROLESION EFFECT AS A PREDICTOR OF SUBTHALAMIC DEEP BRAIN STIMULATION EFFECTIVENESS FOR PARKINSON'S DISEASE Tykocki, T.
 2012
 18 S2 p. S151-
1 p.
 artikel
261 Editorial Board 2012
 18 S2 p. i-
1 p.
 artikel
262 2.368 “EDUTOUR” AND “E-TOUR” A NEW PSYCO-EDUCATIONAL PROGRAMME FOR TOURETTE'S SYNDROME AND THEIR FAMILIES Bayes, A.
 2012
 18 S2 p. S158-
1 p.
 artikel
263 2.120 EEG AND TRANSCRANIAL DOPPLEROGRAFY OF MIDDLE CEREBRAL ARTERY IN ASSESSMENT OF PATHOGENESIS OF PARKINSON'S DISEASE Askhonov, U.
 2012
 18 S2 p. S106-
1 p.
 artikel
264 1.282 EFFECTIVENESS OF BOTULINUM TOXIN TYPE A IN TREATMENT OF “PISA SYNDROME”: CASE REPORT Sichinava, D.
 2012
 18 S2 p. S67-
1 p.
 artikel
265 1.258 EFFECT OF CAFFEIC ACID, ROFECOXIB AND THEIR COMBINATION AGAINST INTRASTRIATAL QUINOLINIC ACID INDUCED OXIDATIVE, MITOCHONDRIAL AND HISTOLOGICAL ALTERATIONS Mishra, J.
 2012
 18 S2 p. S61-
1 p.
 artikel
266 2.209 EFFECT OF CD4 AND CD8 ON MPTP INDUCED PAKINSON DISEASE IN C57BL/6 MICE Zhang, Y.
 2012
 18 S2 p. S116-S117
2 p.
 artikel
267 3.109 EFFECT OF CHRONIC ADMINISTRATION OF SODIUM SALICYLATE ON THE MOTOR FUNCTIONS IN THE ROTENONE INDUCED PD MODEL Nehru, B.
 2012
 18 S2 p. S191-
1 p.
 artikel
268 1.325 EFFECT OF LEVETIRACETAM MONOTHERAPY ON EPILEPTIC TODDLERS WITH CEREBRAL PALSY: A OPEN, PROSPECTIVE, SHORT-TERM AND CONTROLLED CLINICAL TRIAL Jia, F.
 2012
 18 S2 p. S78-
1 p.
 artikel
269 3.233 EFFECT OF MCI-186 ON THE INTRACELLULAR CALCIUM AND MEMBRANE FLUIDITY IN THE RATS WITH PARKINSON'S DISEASE Ming, Y.
 2012
 18 S2 p. S211-
1 p.
 artikel
270 2.022 EFFECT OF PRAMIPEXOLE ON REGIONAL CEREBRAL BLOOD FLOW IN PARKINSON'S DISEASE Hirano, S.
 2012
 18 S2 p. S96-
1 p.
 artikel
271 2.237 EFFECT OF TETRAHYDROBIOPTERIN AND PHARMACOLOGICAL CHAPERONES ON TYROSINE HYDROXYLASE; CORRECTION OF NEUROTRANSMITTER DEFICIENCIES Ying, M.
 2012
 18 S2 p. S124-
1 p.
 artikel
272 3.127 EFFECT OF UNILATERAL LESION WITH THE SELECTIVE PROTEASOME INHIBITOR LACTACYSTIN ON ROTATIONAL BEHAVIOR AND DA METABOLISM IN RATS Konieczny, J.
 2012
 18 S2 p. S196-
1 p.
 artikel
273 2.326 EFFECTS OF BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON IMPULSE CONTROL AND REPETITIVE BEHAVIOR DISORDERS IN PARKINSON'S DISEASE Jeon, B.S.
 2012
 18 S2 p. S147-S148
2 p.
 artikel
274 3.152 EFFECTS OF COMPOUND REHMANNIA FORMULA ON THE AMINO ACID NEUROTRANSMITTER CONTENT IN THE BRAIN OF THE LEVODOPA-INDUCED DYSKINESIAS RATS Zhang, C.-G.
 2012
 18 S2 p. S202-
1 p.
 artikel
275 2.354 EFFECTS OF DIFFERENT EXERCISES IN THE PATIENTS WITH PARKINSON'S DISEASE Cheon, S.-M.
 2012
 18 S2 p. S154-
1 p.
 artikel
276 2.220 EFFECTS OF ENGRAFTED HAIR FOLLICLE STEM CELLS IN ALZHEIMER'S DISEASE RATS Nobakht, M.
 2012
 18 S2 p. S119-
1 p.
 artikel
277 3.352 EFFECTS OF GREEN TEA EXTRACT (GTE) ON HALOPERIDOL (HAL) INDUCED NEUROLEPTIC ANXIETY SYNDROME (NAS) AND PARKINSONISM IN RATS Malik, T.
 2012
 18 S2 p. S231-S232
2 p.
 artikel
278 2.291 EFFECTS OF INITIAL POLYTHERAPY ON SPASMS AND EEG IN NEWLY DIAGNOSED WEST SYNDROME Jia, F.
 2012
 18 S2 p. S138-
1 p.
 artikel
279 3.315 EFFECTS OF INTRAVENTRICULAR TRANSPLANTATION OF BONE MARROW STEM CELLS ON BEHAVIOR AND COGNITION IN 6-OHDA LESIONED RATS Gu, P.
 2012
 18 S2 p. S223-
1 p.
 artikel
280 2.293 EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PARKINSONISM OF MULTIPLE SYSTEM ATROPHY: CLINICAL, ELECTROPHYSIOLOGICAL AND FUNCTIONAL MRI STUDY Wang, H.
 2012
 18 S2 p. S139-
1 p.
 artikel
281 3.219 EFFECTS OF THE NOVEL ANTIPARKINSONIAN DRUG HEMANTANE AND AMANTADINE ON MEMORY AND LEARNING IN RATS WITH INTRACEREBRAL POSTTRAUMATIC HAEMATOMA Kotelnikova, S.
 2012
 18 S2 p. S208-
1 p.
 artikel
282 3.245 EFFECTS OF URATE OXIDASE TRANSGENE OR KNOCKOUT IN A MOUSE MODEL OF PARKINSON'S DISEASE Chen, X.
 2012
 18 S2 p. S214-S215
2 p.
 artikel
283 2.327 EFFICACY OF CHRONIC BILATERAL STN-DBS ON ALTERED EYE-TO-FOOT CO-ORDINATION IN STANDING ADVANCED PARKINSONIAN PATIENTS DURING LARGE GAZE AND WHOLE-BODY REORIENTATIONS Naushahi, M.J.
 2012
 18 S2 p. S148-
1 p.
 artikel
284 2.249 EFFICACY OF RASAGILINE IN COMBINATION WITH DOPAMINE AGONIST THERAPY: RESULTS FROM A POST-MARKETING OBSERVATIONAL STUDY IN PATIENTS WITH PARKINSON'S DISEASE Reichmann, H.
 2012
 18 S2 p. S127-
1 p.
 artikel
285 2.334 EFFICACY OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION FOR LEG TREMOR CONTROL IN PARKINSON'S DISEASE Hedera, P.
 2012
 18 S2 p. S150-
1 p.
 artikel
286 3.259 ELECTRO-ACUPUNCTURE PROTECTS DOPAMINERGIC NEURONS FROM IRON RELATED OXIDATIVE STRESS-MEDIATED DAMAGE IN MEDIAL FOREBRAIN BUNDLE-LESIONED RATS Yu, Y.-P.
 2012
 18 S2 p. S218-
1 p.
 artikel
287 1.319 ELECTRONYSTAGMOGRAPHY FINDINGS IN SPINOCEREBELLAR ATAXIA TYPE 3 AND 2 Santos, R.S.
 2012
 18 S2 p. S76-S77
2 p.
 artikel
288 3.108 ELECTROPHYSIOLOGY OF NEOSTRIATAL NEURONS IN A RAT MODEL OF PARKINSON'S DISEASE INDUCED BY PARAQUAT AND MANEB He, D.
 2012
 18 S2 p. S191-
1 p.
 artikel
289 2.12.4 ENDOCANNABINOIDS IN STRIATAL PLASTICITY Lovinger, D.
 2012
 18 S2 p. S86-
1 p.
 artikel
290 1.117 ENDOTOXIN AND RISK OF PARKINSONISM AMONG WOMEN TEXTILE WORKERS IN SHANGHAI, CHINA: STUDY DESIGN AND ENROLLMENT PROGRESS Wang, X.
 2012
 18 S2 p. S39-
1 p.
 artikel
291 1.312 ENDURANCE PERFORMANCE IN ELDERLY WITH DIFFERENT DEGREES OF KYPHOSIS AS DETERMINED BY THE OCCIPUT-WALL DISTANCE (OWD) Wongsa, S.
 2012
 18 S2 p. S75-
1 p.
 artikel
292 3.082 ENHANCED SPONTANEOUS APOPTOSIS OF PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH PARKINSON'S DISEASE ASSOCIATED WITH MUTATIONS IN THE GLUCOCEREBROSIDASE GENE Usenko, T.S.
 2012
 18 S2 p. S189-
1 p.
 artikel
293 3.144 ENHANCEMENT OF THE SYNAPTIC DOPAMINE AVAILABILITY BY ACUPUNCTURE TREATMENT TO IMPROVE MOTOR FUNCTION IN A MOUSE MODEL OF PARKINSON'S DISEASE Kim, S.-N.
 2012
 18 S2 p. S200-
1 p.
 artikel
294 3.117 ENVIRONMENTALLY-INDUCED SYNUCLEINOPATHY IN A NOVEL PROGRESSIVE RAT MODEL OF PARKINSONISM Yarowsky, P.
 2012
 18 S2 p. S193-
1 p.
 artikel
295 3.15.1 EPIDEMIOLOGY AND PHENOMENOLOGY Zhang, Z.
 2012
 18 S2 p. S167-S168
2 p.
 artikel
296 2.1.3 EPIDEMIOLOGY, DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS IN PARKINSON'S DISEASE TREMOR Baumann, C.R.
 2012
 18 S2 p. S81-
1 p.
 artikel
297 2.206 EPIGALLOCAETECHIN GALLATE (EGCG) INHIBITS A-SYNUCLEIN AGGREGATION: A POTENTIAL AGENT FOR PARKINSON DISEASE Zhang, Y.
 2012
 18 S2 p. S116-
1 p.
 artikel
298 3.073 EPIGENETIC DNA-METHYLATION IN THE CORE ATAXIN-2 GENE PROMOTER: NOVEL PHYSIOLOGICAL AND PATHOLOGICAL IMPLICATIONS Laffita, J.
 2012
 18 S2 p. S187-
1 p.
 artikel
299 2.122 EQUALLY SEVERE ABNORMALITIES IN ANAL SPHINCTER EMG IN PATIENTS WITH PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY IN EARLY STAGE Linder, J.
 2012
 18 S2 p. S107-
1 p.
 artikel
300 1.131 ERK PATHWAY IS INVOLVED IN SNCA INDUCED MITOCHONDRIAL DYNAMIC DISORDERS BY REGULATING DLP1 Yaxing, G.
 2012
 18 S2 p. S43-
1 p.
 artikel
301 1.5.2 ERK PATHWAY IS INVOLVED IN SNCA INDUCED MITOCHONDRIAL DYNAMIC DISORDERS BY REGULATING DLP1 Liu, J.
 2012
 18 S2 p. S3-
1 p.
 artikel
302 3.204 ERYTHROPOIETIN PREVENTS L-DOPA NEUROTOXICITY THROUGH ANTIOXIDANT EFFECT AND THE ACTIVATION OF THE PI3K PATHWAY Koh, S.-H.
 2012
 18 S2 p. S204-
1 p.
 artikel
303 2.13.3 ESSENTIAL TREMOR: PHENOTYPES Teive, H.A.G.
 2012
 18 S2 p. S87-
1 p.
 artikel
304 3.358 ESTABLISHMENT OF 2-DE OF CEREBROSPINAL FLUID AND PRIMARY STUDY OF CSF PROTEOME OF PARKINSON'S DISEASE Li, H.
 2012
 18 S2 p. S233-
1 p.
 artikel
305 3.156 ETHOSUXIMIDE REDUCES ALLODYNIA AND HYPERALGESIA AND POTENTIATE MORPHINE EFFECTS IN CHRONIC CONSTRICTION INJURY MODEL OF NEUROPATHIC PAIN Banafshe, H.R.
 2012
 18 S2 p. S203-
1 p.
 artikel
306 3.126 EVALUATION OF DRUGS ACTING ON CB1-A2A RECEPTOR OLIGOMERS IN RAT MODELS OF PARKINSON'S DISEASE Simola, N.
 2012
 18 S2 p. S195-
1 p.
 artikel
307 1.030 EVALUATION OF NON MOTOR SYMPTOMS IN PARKINSON'S PATIENTS IN A TERTIARY CARE CENTRE Ravan, A.A.
 2012
 18 S2 p. S17-
1 p.
 artikel
308 1.045 EVALUATION OF REACTION TIME IN PARKINSON DISEASE Herranz, A.
 2012
 18 S2 p. S21-
1 p.
 artikel
309 3.113 EVALUATION OF ROTENONE TO PRODUCE AN EXPERIMENTAL MODEL FOR PARKINSON'S DISEASE. A NEUROPROTECTIVE EFFECT OF COENZYME Q-10 Shehata, A.M.
 2012
 18 S2 p. S192-
1 p.
 artikel
310 3.151 EVALUATION OF TWO EXPERIMENTAL DESIGNS FOR LEVODOPA-INDUCED DYSKINESIA IN A RAT MODEL OF PARKINSON'S DISEASE Ivanova, E.
 2012
 18 S2 p. S201-S202
2 p.
 artikel
311 3.069 EXOME SEQUENCING IDENTIFIES NOVEL SACSIN GENE MUTATIONS IN A CHINESE FAMILY Shen, L.
 2012
 18 S2 p. S186-
1 p.
 artikel
312 3.346 EXPERIMENTAL STUDY ON IMPLANTATION OF NOGGIN MODIFIED RBMSCS IN A RAT MODEL OF PARKINSON'S DISEASE Zhu, X.
 2012
 18 S2 p. S230-
1 p.
 artikel
313 1.275 EXTRA-OCULAR MOVEMENT ABNORMALITIES IN WILSON'S DISEASE Bagchi, M.
 2012
 18 S2 p. S65-S66
2 p.
 artikel
314 1.233 EXTRAPYRAMIDAL DISORDERS IN PATIENTS WITH SYMPTOMATIC EPILEPSY Myasnikova, N.
 2012
 18 S2 p. S54-
1 p.
 artikel
315 1.003 FACILITATING CLINICAL RESEARCH: THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS (NINDS) AND STROKE PARKINSON'S DISEASE COMMON DATA ELEMENTS PROJECT Tanner, C.M.
 2012
 18 S2 p. S10-S11
2 p.
 artikel
316 1.102 FACTORS ASSOCIATED WITH FUNCTIONAL PERFORMANCE IN ELDERLY PEOPLE WITH PARKINSON'S DISEASE Leandro, L.A.
 2012
 18 S2 p. S35-
1 p.
 artikel
317 2.224 FACTORS DETERMINING THE MAGNITUDE OF LEVODOPA RESPONSE IN PATIENTS WITH PARKINSON'S DISEASE You, S.
 2012
 18 S2 p. S120-S121
2 p.
 artikel
318 2.340 FACTORS PREDICTING OF THE EFFICACY OF STN-DBS FOR ELDERLY PARKINSON'S DISEASE Suzuki, Y.
 2012
 18 S2 p. S151-
1 p.
 artikel
319 2.282 FACTORS RELATED TO ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASE Perez-Lloret, S.
 2012
 18 S2 p. S136-
1 p.
 artikel
320 1.329 FALLS AND BALANCE ABILITY OF INDEPENDENT AMBULATORY PATIENTS WITH SPINAL CORD INJURY (SCI) Phonthee, S.
 2012
 18 S2 p. S79-
1 p.
 artikel
321 1.048 FATIGUE IS NOT AN INDEPENDENT PREDICTOR OF MORTALITY IN PARKINSON'S DISEASE Skorvanek, M.
 2012
 18 S2 p. S21-S22
2 p.
 artikel
322 3.341 FCγ RECEPTORS ARE REQUIRED FOR ALPHA-SYNUCLEIN-INDUCED PRO-INFLAMMATORY SIGNALING IN MICROGLIA Cao, S.
 2012
 18 S2 p. S229-
1 p.
 artikel
323 1.063 FEATURES OF EXPRESSIVE — AND — IMPRESSIVE ASPECT OF EMOTIONAL SPHERE AMONG PATIENTS WITH PARKINSONISM IN ARAL SEA REGION, UZBEKISTAN Izyumov, D.
 2012
 18 S2 p. S25-
1 p.
 artikel
324 2.035 FEATURES OF MRI IN DIAGNOSING MULTIPLE SYSTEM ATROPHY Piao, Y.
 2012
 18 S2 p. S100-
1 p.
 artikel
325 1.006 FEATURES OF THE BASAL METABOLISM IN PATIENTS WITH PARKINSON'S DISEASE Bogdanov, R.
 2012
 18 S2 p. S11-
1 p.
 artikel
326 2.016 [18F] FP-CIT PET ANALYSIS IN PATIENTS WITH COMBINED POSTURAL AND REST TREMORS: CLINICAL CORRELATION STUDY You, S.
 2012
 18 S2 p. S95-
1 p.
 artikel
327 3.041 FIBROBLAST GROWTH FACTOR 20 (FGF20) POLYMORPHISM IS A RISK FACTOR FOR PARKINSON'S DISEASE IN CHINESE POPULATION Li, H.
 2012
 18 S2 p. S179-
1 p.
 artikel
328 2.268 FIRST 2-YEAR, PLACEBO-CONTROLLED STUDY IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS INDICATES SAFINAMIDE MAY BENEFIT PATIENTS WITH MORE SEVERE DYSKINESIA Anand, R.
 2012
 18 S2 p. S132-S133
2 p.
 artikel
329 2.014 FP-CIT DATSCAN DID NOT USEFUL IN DIFFERENTIAL DIAGNOSES OF PARKINSON'S DISEASE SUBGROUPS Ribacoba, R.
 2012
 18 S2 p. S94-
1 p.
 artikel
330 1.215 FREEZING OF GAIT IN PATIENTS WITH WHITE MATTER CHANGES IS RELATED WITH WIDE DISRUPTION OF WHITE MATTER Youn, J.
 2012
 18 S2 p. S50-
1 p.
 artikel
331 3.023 FREQUENCY OF THE MUTATIONS IN THE PARK2, PINK1 AND DJ-1 GENES IN POLISH PATIENTS WITH THE EARLY-ONSET PARKINSON DISEASE Koziorowski, D.
 2012
 18 S2 p. S174-S175
2 p.
 artikel
332 2.2.2 FRONTO-PARIETAL COHERENCE AND IMPAIRED VOLUNTARY SACCADES IN PARKINSON DISEASE (PD) Bodis-Wollner, I.
 2012
 18 S2 p. S82-
1 p.
 artikel
333 1.022 FUNCTIONAL AMBULATORY PROFILE (FAP) GAIT CHANGES DURING INCREASED COGNITIVE LOAD IN PARKINSON DISEASE LaPointe, L.L.
 2012
 18 S2 p. S15-
1 p.
 artikel
334 2.365 FUNCTIONAL AND CLINICAL MEASURES CORRELATING WITH DRIVING ABILITY IN INDIVIDUALS WITH PARKINSON'S DISEASE Masterson, M.
 2012
 18 S2 p. S157-
1 p.
 artikel
335 3.154 FUNCTIONAL AND MORPHOLOGICAL MODIFICATIONS OF BILATERAL INTRASTRIATAL BOTULINUM NEUROTOXIN A APPLICATION IN WISTAR RATS Draeger, D.-L.
 2012
 18 S2 p. S202-
1 p.
 artikel
336 2.027 FUNCTIONAL IMAGING OF NIGROSTRIATAL DOPAMINERGIC SYSTEM WITH POSITRON EMISSION TOMOGRAPHY IN ADULT-ONSET DYSTONIA-PARKINSONISM (PARK14) DUE TO PLA2G6 MUTATION Agarwal, P.A.
 2012
 18 S2 p. S98-
1 p.
 artikel
337 1.263 FUNCTIONAL OUTCOME OF DEFEROXAMINE PRIMED HUMAN ADIPOSE DERIVED MESENCHYMAL STEM CELL TRANSPLANTS IN A RAT MODEL OF HUNTINGTON'S DISEASE Edalatmanesh, M.A.
 2012
 18 S2 p. S62-S63
2 p.
 artikel
338 3.264 FURTHER EVIDENCES OF EXERCISE-INDUCED NEUROPROTECTION IN 6-OHDA-HEMIPARKINSONIAN MICE Aguiar Jr, A.S.
 2012
 18 S2 p. S219-
1 p.
 artikel
339 1.306 GAIT ANALYSIS IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS IN DIFFERENT WALKWAYS: GAITRITE SYSTEM Bhidayasiri, R.
 2012
 18 S2 p. S73-
1 p.
 artikel
340 2.329 GAIT ASYMMETRY ASSESSMENT IN PARKINSON DISEASE PATIENTS BEFORE AND AFTER DBS-STN Stathis, P.
 2012
 18 S2 p. S148-S149
2 p.
 artikel
341 1.039 GASTROINTESTINAL DYSFUNCTION IN PARKINSON'S DISEASE: ASSOCIATION WITH SEVERITY AND DISABILITY Anand, K.S.
 2012
 18 S2 p. S19-
1 p.
 artikel
342 2.248 GASTRORETENTIVE EXTENDED-RELEASE FORMULATIONS IMPROVE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PATIENTS WITH PARKINSON'S DISEASE Chen, C.
 2012
 18 S2 p. S127-
1 p.
 artikel
343 3.010 GENE EXPRESSION PROFILING OF PERIPHERAL BLOOD FOR DETECTION OF PARKINSON'S DISEASE Karlsson, M.K.
 2012
 18 S2 p. S171-S172
2 p.
 artikel
344 1.240 GENERALIZED CHOREA WITH ABNORMAL FDG-PET FINDINGS IN A PATIENT WITH HYPERTHYROIDISM Chung, E.J.
 2012
 18 S2 p. S56-
1 p.
 artikel
345 3.055 GENETIC ANALYSIS OF THE LINGO4 GENE IN PATIENTS WITH ESSENTIAL TREMOR Liang, H.
 2012
 18 S2 p. S182-
1 p.
 artikel
346 3.7.2 GENETIC LRRK2 MODELS: DISSECTING PATHOGENIC PATHWAY AND EXPLORING CLINICAL APPLICATIONS IN PD Yue, Z.
 2012
 18 S2 p. S164-
1 p.
 artikel
347 3.7.1 GENETIC REDUCTION OF THE E3 UBIQUITIN LIGASE ELEMENT, SKP1A, AND ENVIRONMENTAL MANIPULATION TO EMULATE CARDINAL FEATURES OF PARKINSON'S DISEASE Mandel, S.A.
 2012
 18 S2 p. S164-
1 p.
 artikel
348 1.5.1 GENETICS Tang, B.
 2012
 18 S2 p. S3-
1 p.
 artikel
349 2.13.2 GENETICS OF ESSENTIAL TREMOR Jasinska-Myga, B.
 2012
 18 S2 p. S86-S87
2 p.
 artikel
350 3.001 GENETICS OF PARKINSON'S DISEASE Le, W.
 2012
 18 S2 p. S169-
1 p.
 artikel
351 3.008 GENETIC SUSCEPTIBILITY OF EASTERN INDIANS TOWARDS PARKINSON'S DISEASE Ray, J.
 2012
 18 S2 p. S171-
1 p.
 artikel
352 3.011 GENETIC VARIATION OF BDNF IN PARKINSON'S DISEASE Prakash, K.M.
 2012
 18 S2 p. S172-
1 p.
 artikel
353 3.234 GINSENOSIDE RD PROTECTS NEURONS AGAINST GLUTAMATE-INDUCED EXCITOTOXICITY BY INHIBITING CA2+ INFLUX Zhang, C.
 2012
 18 S2 p. S212-
1 p.
 artikel
354 3.306 GLYCOSAMINOGLYCANS MODULATE ALPHA-SYNUCLEIN AGGREGATION AND APOPTOSIS IN MPP TREATED CELLS Lehri-Boufala, S.
 2012
 18 S2 p. S220-
1 p.
 artikel
355 3.105 GLYPHOSATE INDUCED CELL DEATH THROUGH APOPTOTIC AND AUTOPHAGIC MECHANISMS Wang, G.
 2012
 18 S2 p. S190-
1 p.
 artikel
356 1.283 GPI AND STN DBS FOR GENERAL DYSTONIA Mandat, T.
 2012
 18 S2 p. S67-S68
2 p.
 artikel
357 1.122 GSK-3β EXPRESSION IN CEREBROSPINAL FLUID IN PARKINSON'S DISEASE Molina-Arjona, J.A.
 2012
 18 S2 p. S40-S41
2 p.
 artikel
358 2.5.1 GUIDELINE IN CHINA Sun, S.
 2012
 18 S2 p. S83-
1 p.
 artikel
359 1.090 HALLUCINATIONS IN DRUG-NAÍVE, NEWLY-DIAGNOSED PARKINSON'S DISEASE Pagonabarraga, J.
 2012
 18 S2 p. S32-
1 p.
 artikel
360 1.221 HASHIMOTO ENCEPHALOPATHY WITH PARKINSONISM Mercan, F.N.
 2012
 18 S2 p. S51-
1 p.
 artikel
361 1.036 HEART RATE VARIABILITY IN PATIENTS WITH IDIOPATHIC PARKINSON'S DISEASE WITH AND WITHOUT OBSTRUCTIVE SLEEP APNEA SYNDROME Valko, P.O.
 2012
 18 S2 p. S19-
1 p.
 artikel
362 1.249 HEMICHOREA AFTER STROKE: CLINICO-RADIOLOGIC CORRELATION WITH MAGNETIC RESONANCE IMAGE Faqih, S. Al
 2012
 18 S2 p. S59-
1 p.
 artikel
363 1.245 HEMICHOREA-HEMIBALLISM: NON KETOTIC HYPERGLYCEMIA SYMPTOM Hernando, C.
 2012
 18 S2 p. S58-
1 p.
 artikel
364 1.247 HEMICHOREA IN NON-KETOTIC HYPERGLYCEMIA WITH BILATERAL HYPERINTENSITY IN BASAL GANGLIA ON T1-WEIGHTED BRAIN MRI Ha, C.K.
 2012
 18 S2 p. S58-
1 p.
 artikel
365 1.217 HEMIPARKINSONISM-HEMIATROPHY SYNDROME: NEUROIMAGING AND GENETICS Oh, E.S.
 2012
 18 S2 p. S50-S51
2 p.
 artikel
366 3.5.2 HERBAL MEDICINE Cai, D.
 2012
 18 S2 p. S163-
1 p.
 artikel
367 3.043 HER2 POLYMORPHIC ASSOCIATION WITH PARKINSON'S DISEASE AT CODONS 655 AND 1170 Wang, V.
 2012
 18 S2 p. S179-
1 p.
 artikel
368 1.004 HETEROGENEITY OF PARKINSON'S DISEASE Kracunova, K.
 2012
 18 S2 p. S11-
1 p.
 artikel
369 1.301 HIGHER LEVEL GAIT DISORDERS IN THE ELDERLY SUBJECT: POSTURAL INSTABILITY, CORTICAL AND SUBCORTICAL ABNORMALITIES Demain, A.
 2012
 18 S2 p. S72-
1 p.
 artikel
370 3.143 HIGH FAT CONSUMPTION AGGRAVATES DOPAMINERGIC DEPLETION IN A MOUSE MODEL OF PARKINSON'S DISEASE Bousquet, M.
 2012
 18 S2 p. S200-
1 p.
 artikel
371 3.2.2 HOT TOPICS IN DBS: COGNITIVE AND BEHAVIOURAL SIDE EFFECTS Witt, K.
 2012
 18 S2 p. S162-
1 p.
 artikel
372 2.315 HOW DOES STN-DBS AFFECT MOOD STATUS IN PD PATIENTS? AN UPDATE OF THE LITERATURE Papanastasiou, A.
 2012
 18 S2 p. S145-
1 p.
 artikel
373 2.8.2 HOW MUCH CAN WE INFLUENCE CLINICAL PROGRESSION OF PARKINSON'S DISEASE? Stocchi, F.
 2012
 18 S2 p. S85-
1 p.
 artikel
374 3.354 HTRA2 IS INVOLVED IN 6-OHDA INDUCED ENDOPLASMIC RETICULUM STRESS Luo, F.
 2012
 18 S2 p. S232-
1 p.
 artikel
375 3.340 HUMAN MIDBRAIN PRECURSORS DIFFERENTIATE TO MATURE FUNCTIONAL A9 DOPAMINE NEURONS IN VITRO. SHORT AND LONG-TERM ENHANCEMENT BY BCL-XL Seiz, E.G.
 2012
 18 S2 p. S229-
1 p.
 artikel
376 3.9.3 HUNTINGTON'S DISEASE AND NEUROACANTHOCYTOSIS SYNDROMES Shang, H.
 2012
 18 S2 p. S165-
1 p.
 artikel
377 3.18.2 HUNTINGTON'S DISEASE - CLINICAL FEATURES OF PATIENTS WITH HUNTINGTON'S DISEASE INITIALLY DIAGNOSED AS SPINOCEREBELLAR ATAXIA Dong, Y.
 2012
 18 S2 p. S169-
1 p.
 artikel
378 2.3.2 HUNTINGTON'S DISEASE IN CHINA Shang, H.
 2012
 18 S2 p. S82-S83
2 p.
 artikel
379 1.253 HYPERHOMOCYSTEINEMIA AS A POSSIBLE CAUSE OF HEMICHOREA-HEMIBALLISMUS-SYNDROME Santos, M.A.
 2012
 18 S2 p. S60-
1 p.
 artikel
380 2.108 IDENTIFICATION AND CHARACTERIZATION OF PARKINSON'S DISEASE IN ASYMPTOMATIC PATIENTS Pasinetti, G.M.
 2012
 18 S2 p. S103-
1 p.
 artikel
381 2.145 IDENTIFICATION OF PLASMA GLYCOPROTEINS AS BIOMARKERS OF PATIENTS WITH PARKINSON'S DISEASE Pan, C.
 2012
 18 S2 p. S113-
1 p.
 artikel
382 1.321 IMBALANCE ASSESSMENT IN PREMANIFEST AND SYMPTOMATIC SPINOCEREBELLAR ATAXIA PATIENTS – THE USEFULNESS OF STATIC POSTUROGRAPHY Rakowicz, M.
 2012
 18 S2 p. S77-
1 p.
 artikel
383 3.14.4 IMMUNIZATION STRATEGIES IN PD Gendelman, H.
 2012
 18 S2 p. S167-
1 p.
 artikel
384 1.226 IMPACT OF APOE GENOTYPE ON COGNITION OF ESSENTIAL TREMOR Oh, Y.-S.
 2012
 18 S2 p. S52-S53
2 p.
 artikel
385 2.013 IMPACT OF DATSCAN™ ON CLINICAL MANAGEMENT, DIAGNOSIS, AND DIAGNOSTIC CONFIDENCE IN PATIENTS WITH CLINICALLY UNCERTAIN PARKINSONIAN SYNDROMES: A 1-YEAR FOLLOW-UP Bajaj, N.
 2012
 18 S2 p. S94-
1 p.
 artikel
386 2.319 IMPACT OF DEEP BRAIN STIMULATION ON QUALITY OF LIFE IN PARKINSON'S DISEASE: LONG-TERM FOLLOW-UP Morand, D.
 2012
 18 S2 p. S146-
1 p.
 artikel
387 2.251 IMPACT OF LEVODOPA ON IMPROVING LIMB SYMMETRY DURING WALKING IN PARKINSON DISEASE Jog, M.S.
 2012
 18 S2 p. S127-S128
2 p.
 artikel
388 2.214 IMPAIRED CONSOLIDATION OF MOTOR LEARNING IN PARKINSON'S DISEASE Leow, L.-A.
 2012
 18 S2 p. S118-
1 p.
 artikel
389 3.223 IMPAIRMENTS OF ERK SIGNAL TRANSDUCTION IN THE BRAIN IN A RAT MODEL OF ANTIDEPRESSANT SENSITIVE CHRONIC DEPRESSION Mondal, A.C.
 2012
 18 S2 p. S209-
1 p.
 artikel
390 2.259 IMPROVEMENT OF ICDS AND SLEEP DISORDERS IN PD PATIENTS TREATED WITH ROTIGOTINE PATCH SWITCHING FROM OTHER DOPAMINE-AGONISTS Riboldazzi, G.
 2012
 18 S2 p. S130-
1 p.
 artikel
391 2.255 IMPROVEMENT OF IMPULSIVE CONTROL DISORDERS IN PARKINSON'S DISEASE WITH JEJUNAL LEVODOPA INFUSION Lopez-Valdes, E.
 2012
 18 S2 p. S129-
1 p.
 artikel
392 2.351 IMPROVING FUNCTIONAL OUTCOMES WITH MULTIDISCIPLINARY TEAM ASSESSMENT AND INTERVENTION IN PARKINSON'S DISEASE Padmakumar, C.P.
 2012
 18 S2 p. S153-S154
2 p.
 artikel
393 1.14.4 IMPULSE CONTROL DISORDERS Tolosa, E.
 2012
 18 S2 p. S8-
1 p.
 artikel
394 2.284 IMPULSE-CONTROL DISORDERS IN PARKINSON'S DISEASE PATIENTS Perez-Lloret, S.
 2012
 18 S2 p. S136-
1 p.
 artikel
395 1.071 INCIDENCE AND CHARACTERISTICS OF DEPRESSION IN PARKINSON'S DISEASE Telarovic, S.
 2012
 18 S2 p. S27-
1 p.
 artikel
396 3.047 INCREASED APOPTOSIS OF PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH LRRK2-ASSOCIATED PARKINSON'S DISEASE Pchelina, S.
 2012
 18 S2 p. S180-
1 p.
 artikel
397 2.247 INCREASED DOPAMINE OUTPUT AND ALTERED METABOLIC PROFILE OF DOPAMINE FOLLOWING DEUTERIUM SUBSTITUTIONS IN THE L-DOPA MOLECULE Malmlöf, T.
 2012
 18 S2 p. S126-S127
2 p.
 artikel
398 3.255 INCREASED HISTAMINE BY THIOPERAMIDE EXERTS ITS NEURONAL PROTECTIVE EFFECT THROUGH POSTSYNAPTIC H1 RECEPTOR IN NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY RAT MODEL Jia, F.
 2012
 18 S2 p. S217-
1 p.
 artikel
399 1.112 INCREASED MEDIAL ORBITOFRONTAL DOPAMINE FUNCTION IN PARKINSON'S DISEASE PATIENTS WITH IMPULSE CONTROL DISORDERS Joutsa, J.
 2012
 18 S2 p. S38-
1 p.
 artikel
400 2.026 INCREASED MICROGLIAL ACTIVATION AND AMYLOID DEPOSITION IN PARKINSON'S DISEASE SUBJECTS AT HIGH RISK OF DEMENTIA: A PET STUDY Simpson, B.S.
 2012
 18 S2 p. S97-
1 p.
 artikel
401 3.243 INCREASING ENDOGENOUS NEUROGENESIS USING NEUROSTEROIDS: A NOVEL THERAPEUTIC STRATEGY TO TREAT PARKINSON'S DISEASE Adeosun, S.
 2012
 18 S2 p. S214-
1 p.
 artikel
402 3.14.3 INFLAMMATION-MEDIATED DEGENERATION OF DOPAMINERGIC NEURONS: MECHANISMS, INTERVENTIONS AND RELEVANCE TO PARKINSON'S DISEASE Hong, J.-S.
 2012
 18 S2 p. S167-
1 p.
 artikel
403 2.369 INFLUENCE OF DEVELOPMENTAL QUOTIENT AND AGE OF INITIAL REHABILITATION ON MOTOR ABILITY IMPROVEMENT IN CHILDREN WITH CEREBRAL PALSY Jia, F.
 2012
 18 S2 p. S158-
1 p.
 artikel
404 1.101 INFLUENCE OF PATIENTS' EXPECTATIONS ON NON-MOTOR SYMPTOMS AND QUALITY OF LIFE IN PARKINSON'S DISEASE: A MIXED-METHOD STUDY Lenihan, N.
 2012
 18 S2 p. S35-
1 p.
 artikel
405 2.17.2 INFLUENZA VIRUS AND PARKINSON'S DISEASE Sadasivan, S.
 2012
 18 S2 p. S89-
1 p.
 artikel
406 3.242 INHIBITION OF MONOAMINE OXIDASE-B BY CURCUMIN AND TETRAHYDROCURCUMIN IN THE MICE MODEL OF PARKINSON'S DISEASE Muthukumaran, S. Sabesan
 2012
 18 S2 p. S214-
1 p.
 artikel
407 3.302 INHIBITORY FUNCTIONS IN PARKINSON'S DISEASE Gamboz, N.
 2012
 18 S2 p. S219-S220
2 p.
 artikel
408 3.320 INSIGHTS INTO THE MECHANISM OF PARADOXICAL KINESIA FROM SUBTHALAMIC NUCLEUS RECORDINGS IN PARKINSON'S DISEASE Anzak, A.
 2012
 18 S2 p. S224-
1 p.
 artikel
409 1.051 INSOMNIA IS LINKED MORE TO AFFECTIVE THAN MOTOR SYMPTOMS IN PARKINSON'S DISEASE Tavadyan, Z.
 2012
 18 S2 p. S22-
1 p.
 artikel
410 2.107 INSTRUMENTED TIMED-UP AND GO TEST WITH A 3D CAMERA FOR MOBILITY DETECTION Yao, X.
 2012
 18 S2 p. S103-
1 p.
 artikel
411 3.014 INTEGRATION OF CLINICAL AND MICROARRAY DATA WITH CANONICAL PARTIAL LEAST SQUARES FOR PREDICTION OF PARKINSON'S DISEASE Karlsson, M.K.
 2012
 18 S2 p. S172-
1 p.
 artikel
412 2.254 INTERIM RESULTS FROM ONGOING, LONG-TERM, OPEN-LABEL STUDY OF LEVODOPA/CARBIDOPA INTESTINAL GEL IN PATIENTS WITH PARKINSON'S DISEASE AND SEVERE MOTOR FLUCTUATIONS Odin, P.
 2012
 18 S2 p. S128-
1 p.
 artikel
413 2.152 INTEROBSERVER RELIABILITY OF PULSE DIAGNOSIS USING TRADITIONAL KOREAN MEDICINE FOR STROKE PATIENTS Ko, M.
 2012
 18 S2 p. S114-
1 p.
 artikel
414 2.233 INTERPRETATION OF RESPONSE CATEGORIES IN PATIENT-REPORTED RATING SCALES: A TEST-RETEST STUDY AMONG PEOPLE WITH PARKINSON'S DISEASE AND OTHER NEUROLOGICAL DISORDERS Knutsson, I.
 2012
 18 S2 p. S123-
1 p.
 artikel
415 3.303 INTRACELLULAR AND EXTRACELLULAR MECHANISM OF α-SYNUCLEIN METABOLISM Watanabe, Y.
 2012
 18 S2 p. S220-
1 p.
 artikel
416 3.034 INTRACELLULAR TRAFFICKING OF A53T MUTANT ALPHA-SYNUCLEIN INVOLVED IN MICROGLIAL PERSISTENT ACTIVATION Wu, Y.-W.
 2012
 18 S2 p. S177-
1 p.
 artikel
417 2.253 INTRAJEJUNAL LEVODOPA INFUSION IN THE UK: COMPARATIVE REVIEW OF MOTOR AND NON-MOTOR EFFECTS IN TREATED VERSUS UNTREATED ADVANCED PARKINSON'S PATIENTS Reddy, P.
 2012
 18 S2 p. S128-
1 p.
 artikel
418 1.234 INTRAOPERATIVE SMILE IN A MULTIPLE SCLEROSIS PATIENT WITH MEDICATION-REFRACTORY TREMOR Thompson, A.
 2012
 18 S2 p. S55-
1 p.
 artikel
419 1.130 INVERSE RELATIONSHIP BETWEEN THE CONTENTS OF NEUROMELANIN PIGMENT AND THE VESICULAR MONOAMINE TRANSPORTER-2 AMONG SUBSTANTIA NIGRA AND VENTERAL TEGMENTAL AREA Pasbakhsh, P.
 2012
 18 S2 p. S42-S43
2 p.
 artikel
420 1.133 INVESTIGATING THE ROLE OF OLIGODENDROCYTE PRECURSOR CELLS IN MULTIPLE SYSTEM ATROPHY AND RELATED DISORDERS Asi, Y.
 2012
 18 S2 p. S43-
1 p.
 artikel
421 3.218 INVESTIGATION OF POTENTIAL NEUROPROTECTIVE EFFECTS OF HEMANTANE ON DNA DAMAGE AND LIPID PEROXIDATION IN MICE WITH MPTP-INDUCED PARKINSONISM Nepoklonov, A.
 2012
 18 S2 p. S208-
1 p.
 artikel
422 1.308 INVESTIGATION OF THE NEUROFUNCTIONAL SUBSTRATES BEHIND PRESERVED BICYCLING ABILITIES IN PARKINSON'S DISEASE PATIENTS WITH SEVERE GAIT DISTURBANCES Maliia, M.
 2012
 18 S2 p. S74-
1 p.
 artikel
423 1.066 INVESTIGATION ON THE RELATIONSHIP BETWEEN ANXIETY AND THE MOTOR SYMPTOMS OR NON-MOTOR SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE Liu, Z.
 2012
 18 S2 p. S26-
1 p.
 artikel
424 3.307 IN VITRO AMPLIFICATION OF VARIOUS ALPHA SYNUCLEIN FIBRILS Aravinthan, A.
 2012
 18 S2 p. S221-
1 p.
 artikel
425 3.328 IN VITRO AND IN VIVO EVALUATION OF COQ10 LOADED POLYMERIC NANOPARTICLES: AN ATTEMPT TO RESCUE THE CELLS FROM OXIDATIVE STRESS Swarnakar, N.K.
 2012
 18 S2 p. S226-
1 p.
 artikel
426 3.136 IN VIVO STRIATAL ACTIVITY DURING SELF ROTATION FOLLOWING UNILATERAL DOPAMINE DEPLETION Yu, C.
 2012
 18 S2 p. S198-
1 p.
 artikel
427 3.249 INVOLVEMENT OF ESTROGEN RECEPTORS AND OXIDATIVE STRESS IN NEUROPROTECTIVE EFFECT OF SILYMARIN IN HEMI-PARKINSONIAN RATS Baluchnejadmojarad, T.
 2012
 18 S2 p. S215-S216
2 p.
 artikel
428 3.079 ISAACS SYNDROME: REPORT OF TWO CASES Cavalcanti, C.E.
 2012
 18 S2 p. S189-
1 p.
 artikel
429 3.081 IS AUTONOMIC INTESTINE DYSFUNCTION IN CHILDHOOD GENETICALLY LINKED TO NEUROLOGICAL DYSFUNCTION? Ghaffari, H.
 2012
 18 S2 p. S189-
1 p.
 artikel
430 2.106 IS MDS-UPDRS USEFUL IN ELDERLY PATIENTS? Geny, C.
 2012
 18 S2 p. S102-S103
2 p.
 artikel
431 3.235 ISOTHIOCYANATES PROTECT AGAINST DOPAMINERGIC CELL DEATH IN IN VITRO AND IN VIVO MODELS OF PARKINSON'S DISEASE Morroni, F.
 2012
 18 S2 p. S212-
1 p.
 artikel
432 1.269 IS PERSISTENT TARDIVE DYSTONIA A WORTH PRICE TO PAY FOR? Pavlic, G.
 2012
 18 S2 p. S64-
1 p.
 artikel
433 2.219 KETOGENIC DIET: A POSSIBLE THERAPEUTIC TARGET FOR PARKINSON'S DISEASE? Sharma, V.K.
 2012
 18 S2 p. S119-
1 p.
 artikel
434 1.305 KINEMATIC AND ELECTROMYOGRAPHIC CHARICTERISTICS OF OBSTACLE GAIT IN PARKINSON PATIENTS Kim, C.H.
 2012
 18 S2 p. S73-
1 p.
 artikel
435 3.037 LACK OF ASSOCIATION BETWEEN POLYMORPHISMS IN USP24 AND USP40 GENES AND PARKINSON'S DISEASE IN CHINESE SUBJECTS Huang, R.
 2012
 18 S2 p. S178-
1 p.
 artikel
436 3.030 LACK OF ASSOCIATION BETWEEN THREE SNPS ON PARK9, PARK15 AND BST1 GENES AND PARKINSON'S DISEASE IN NORTHERN HAN CHINESE POPULATION Zhu, L.
 2012
 18 S2 p. S176-
1 p.
 artikel
437 1.017 LANGUAGE ABILITY AFFECTED AND RELATED TO MOTOR SKILLS IN PARKINSON'S DISEASE — A PRELIMINARY REPORT Liu, L.
 2012
 18 S2 p. S14-
1 p.
 artikel
438 2.5.3 LATE STAGE OF PARKINSON'S DISEASE Xiao, Q.
 2012
 18 S2 p. S83-
1 p.
 artikel
439 1.323 LEVETIRACETAM AMELIORATES CHOREOATHETOSIS IN CHILDREN WITH DYSKINETIC CEREBRAL PALSY Jia, F.
 2012
 18 S2 p. S77-S78
2 p.
 artikel
440 1.324 LEVETIRACETAM PREVENT LEVODOPA-INDUCED DYSKINESIA IN HEMIPARKINSONIAN MICE Du, H.
 2012
 18 S2 p. S78-
1 p.
 artikel
441 2.211 LEVO-CARNITORS AS EMERGING NEUROPROTECTIVE EPIGENETIC MOLECULAR MEDICINES Kumar, P.
 2012
 18 S2 p. S117-
1 p.
 artikel
442 3.049 LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE PATIENTS CARRYING THE LEUCINE-RICH REPEAT KINASE 2 (LRRK2) G2019S MUTATION Yahalom, G.
 2012
 18 S2 p. S181-
1 p.
 artikel
443 2.252 LEVODOPA MEDICATION IMPROVES IMPLICIT SEQUENCE LEARNING ON THE SERIAL REACTION TIME TASK IN PARKINSON'S DISEASE Beigi, M.
 2012
 18 S2 p. S128-
1 p.
 artikel
444 2.235 “LEVODOPA PHOBIA” CAUSING FLEXED POSTURE IN PARKINSON'S DISEASE Takahasahi, H.
 2012
 18 S2 p. S123-
1 p.
 artikel
445 3.348 LEWY PATHOLOGY IS NOT BE THE FIRST SIGN OF DEGENERATION IN SELECTIVELY VULNERABLE NEURONS IN PARKINSON'S DISEASE Duda, J.
 2012
 18 S2 p. S231-
1 p.
 artikel
446 3.308 LINKS BETWEEN SMALL UBIQUITIN-LIKE MODIFIER, SUMO-1, HSP90 AND THE AUTOPHAGY-LYSOSOME SYSTEM IN ALPHA-SYNUCLEINOPATHY AND TAUOPATHY Wong, M.B.
 2012
 18 S2 p. S221-
1 p.
 artikel
447 3.316 LMX1B CAN PROMOTE DOPAMINERGIC NEURONS DIFFERENTIATION FROM EMBRYONIC STEM CELLS Tian, L.-P.
 2012
 18 S2 p. S223-
1 p.
 artikel
448 2.258 LONG ACTING DOPAMINE AGONISTS IN CLINICAL PRACTICE: A COMPARATIVE MULTICENTRE EUROPEAN SURVEY IN YOUNG AND OLD PD Rizos, A.
 2012
 18 S2 p. S129-S130
2 p.
 artikel
449 2.039 LONGITUDINAL PET STUDIES OF MICROGLIAL ACTIVATION IN HUNTINGTON'S DISEASE Tai, Y.F.
 2012
 18 S2 p. S101-
1 p.
 artikel
450 2.335 LONG TERM EFFECT OF SUBTHALAMIC NUCLEUS STIMULATION (STN) IN PARKINSON'S DISEASE Lee, K.J.
 2012
 18 S2 p. S150-
1 p.
 artikel
451 1.286 LONG TERM EFFICACY OF PALLIDAL DEEP BRAIN STIMULATION IN PATIENT WITH DYT 6 DYSTONIA FROM INDIA Sankhla, C. Savant
 2012
 18 S2 p. S68-
1 p.
 artikel
452 2.267 LONG-TERM EFFICACY OF SAFINAMIDE AS ADD-ON TO LEVODOPA IN PARKINSON'S DISEASE (PD) USING AN ‘ON’ AND ‘ON-OFF’ TREATMENT ANALYSIS Anand, R.
 2012
 18 S2 p. S132-
1 p.
 artikel
453 1.255 LONG-TERM EXPOSURE TO TETRABENAZINE (TBZ) HAS NO ADVERSE OR FAVORABLE IMPACT ON CHOREA AFTER IT IS WITHDRAWN Marshall, F.J.
 2012
 18 S2 p. S60-
1 p.
 artikel
454 1.290 LONG-TERM NEUROPSYCHOLOGICAL OUTCOMES OF SUBTHALAMIC NUCLEUS (STN) DEEP BRAIN STIMULATION (DBS) IN PRIMARY CRANIAL CERVICAL DYSTONIA (CCD) Racine, C.A.
 2012
 18 S2 p. S69-
1 p.
 artikel
455 2.305 LONG-TERM RECORDINGS OF LOCAL FIELD POTENTIALS FROM DEEP BRAIN STIMULATING ELECTRODES IMPLANTED IN THE SUBTHALAMIC NUCLEUS Abosch, A.
 2012
 18 S2 p. S142-
1 p.
 artikel
456 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE Poewe, W.
 2012
 18 S2 p. S131-S132
2 p.
 artikel
457 1.295 LONG-TERM TREATMENT OF WRITER'S CRAMP WITH BOTULINUM TOXIN A; RETROSPECTIVE ASSESSMENT OF THE CLINICAL IMPACT Baláž, M.
 2012
 18 S2 p. S70-
1 p.
 artikel
458 3.031 LOSS OF PINK1 FUNCTION PROMOTES AUTOPHAGY VIA PP2A DOWNREGULATION IN DOPAMINERGIC CELLS AND A MURINE MODEL Yang, W.
 2012
 18 S2 p. S176-S177
2 p.
 artikel
459 3.155 LOW CONCENTRATIONS OF LEAD MAY AFFECT ON PENTYLENETETRAZOLE INDUCED SEIZURE THRESHOLD IN MICE Mesdaghinia, A.
 2012
 18 S2 p. S202-S203
2 p.
 artikel
460 3.244 LOW-DOSE RADIATION STIMULATES NEUROCHEMICAL RESPONSE AND CELL PROLIFERATION OF BOTH NEURAL STEM CELLS AND GLIOMA STEM CELLS IN VITRO Ding, Y.X.
 2012
 18 S2 p. S214-
1 p.
 artikel
461 2.294 LOW FREQUENCY REPETITIVE DEEP TRANSCRANIAL MAGNETIC STIMULATION IMPROVES MOTOR PERFORMANCE IN PATIENTS WITH PARKINSON'S DISEASE Cohen, O.S.
 2012
 18 S2 p. S139-
1 p.
 artikel
462 1.291 LOW FREQUENCY RTMS OVER THE PREMOTOR CORTEX SUPPRESS DYSTONIA AND ABNORMAL CORTICAL EXCITABILITY: A CASE REPORT Kim, Y.-H.
 2012
 18 S2 p. S69-S70
2 p.
 artikel
463 3.027 LRRK2 DIRECTLY PHOSPHORYLATES AKT1 AS A POSSIBLE PHYSIOLOGICAL SUBSTRATE: IMPAIRMENT OF THE KINASE ACTIVITY BY PARKINSON'S DISEASE-ASSOCIATED MUTATIONS Ohta, E.
 2012
 18 S2 p. S175-S176
2 p.
 artikel
464 3.028 LRRK2 MODULATES NOTCH SIGNALING THROUGH ENDOSOMAL PATHWAY Kobayashi, Y.
 2012
 18 S2 p. S176-
1 p.
 artikel
465 3.207 LYCOPENE ATTENUATES OXIDATIVE STRESS AND COGNITIVE DECLINE IN ROTENONE-INDUCED PARKINSON'S DISEASE Sandhir, R.
 2012
 18 S2 p. S205-
1 p.
 artikel
466 2.342 MAJOR CAUSES OF POOR SELECTION IN RETROSPECT IN SUBTHALAMIC DEEP BRAIN STIMULATION FOR PARKINSON'S DISEASE Jeon, B.S.
 2012
 18 S2 p. S151-
1 p.
 artikel
467 3.325 MEASURES DEALING WITH EMERGENCIES FOR PATIENTS WITH INTRACTABLE NEUROLOGICAL DISEASE IN SAGAMIHARA AREA Saruwatari, M.
 2012
 18 S2 p. S225-
1 p.
 artikel
468 1.303 MEASURING ARM SWING DURING GAIT IN PATIENTS WITH PARKINSON'S DISEASE USING WEARABLE SENSORS – A FEASIBILITY STUDY Mirelman, A.
 2012
 18 S2 p. S72-S73
2 p.
 artikel
469 2.001 MEDICAL IMAGING DIAGNOSIS OF PARKINSON SYNDROME Zhang, P.
 2012
 18 S2 p. S91-
1 p.
 artikel
470 2.5.2 MEDICAL MANAGEMENT OF EARLY PARKINSON'S DISEASE Liu, Z.
 2012
 18 S2 p. S83-
1 p.
 artikel
471 2.202 MEDICAL MANAGEMENT OF EARLY PARKINSON'S DISEASE Liu, Z.
 2012
 18 S2 p. S115-
1 p.
 artikel
472 1.002 MEDICO LEGAL ASPECTS OF PARKINSON'S DISEASE Babu, R.Y.P.
 2012
 18 S2 p. S10-
1 p.
 artikel
473 1.126 MEMBRANE RESONANCE IN SUBTHALAMIC NUCLEUS NEURONS Zhi-qiang, Y.
 2012
 18 S2 p. S41-S42
2 p.
 artikel
474 1.077 MEMORY MONITORING AND EPISODIC MEMORY OF PARKINSON'S PATIENTS Lv, X.
 2012
 18 S2 p. S29-
1 p.
 artikel
475 3.147 MESENCEPHALIC CELL CULTURES FROM CYP2E1 KNOCKOUT MICE: A MODEL FOR MPP+ METABOLIC AND TOXICITY STUDIES Corsini, G.U.
 2012
 18 S2 p. S200-S201
2 p.
 artikel
476 3.052 META ANALYSIS BETWEEN VAL166MET LOCUS POLYMORPHISM IN BDNF GENE AND DEMENTIA WITH LEWY BODIES Le, H.
 2012
 18 S2 p. S181-S182
2 p.
 artikel
477 1.095 METABOLIC CHANGES INDUCED BY THETA BURST STIMULATION OF THE CEREBELLUM IN DYSKINETIC PARKINSON'S DISEASE PATIENTS Koch, G.
 2012
 18 S2 p. S33-S34
2 p.
 artikel
478 1.5.3 METABOLIC NETWORKING IN CHINESE PATIENTS WITH PARKINSON'S DISEASE IN VARIOUS HOEHN & YAHR STAGES Wang, J.
 2012
 18 S2 p. S3-
1 p.
 artikel
479 1.279 MICROELECTRODE RECORDINGS IN THE BASAL GANGLIA AND THALAMUS IN PATIENTS WITH DYSTONIA Zhuang, P.
 2012
 18 S2 p. S66-S67
2 p.
 artikel
480 3.14.1 MICROGLIA AND NEUROINFLAMMATION IN PD Przedborski, S.
 2012
 18 S2 p. S167-
1 p.
 artikel
481 3.355 MICROGLIAL NOX2: A POTENTIAL TARGET OF IRON-INDUCED DOPAMINERGIC NEURODEGENERATION Gao, J.
 2012
 18 S2 p. S232-
1 p.
 artikel
482 2.302 MICRORECORDING OPTIMIZES FINAL ELECTRODE PLACEMENT FOR SUBTHALAMIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE Mandat, T.
 2012
 18 S2 p. S141-
1 p.
 artikel
483 2.286 MIGRATORY EDEMA REALATED TO RASAGILINE TREATMENT Catalan, M.J.
 2012
 18 S2 p. S137-
1 p.
 artikel
484 1.11.1 MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH UNDERLYING ALZHEIMER'S DISEASE VERSUS LEWY BODY DISEASE Boeve, B.
 2012
 18 S2 p. S5-
1 p.
 artikel
485 2.19.2 MILESTONES IN THE INTRODUCTION OF CONTINUOUS DOPAMINERGIC STIMULATION THERAPY FOR ADVANCED PARKINSON'S DISEASE Mouradian, M.
 2012
 18 S2 p. S90-
1 p.
 artikel
486 3.254 MINOCYCLINE ATTENUATED MICROGLIAL ACTIVATION AND DEGENERATIVE LOSS OF DOPAMINERGIC NEURONS IN THE SUBSTANTIA NIGRA OF A LACTACYSTIN RAT MODEL Duan, L.
 2012
 18 S2 p. S216-S217
2 p.
 artikel
487 1.2.3 MISFOLDED α-SYNUCLEIN AND NEUROINFLAMMATION AS THERAPEUTIC TARGETS FOR PARKINSON'S DISEASE Maguire-Zeiss, K.A.
 2012
 18 S2 p. S2-
1 p.
 artikel
488 3.080 MITOCHONDRIAL D-LOOP HOMOPLASMIC T16519C POINT MUTATION AND IDENTIFICATION OF NOVEL MARKERS ASSOCIATED WITH FRDA PATIENTS IN INDIAN POPULATION Mudila, I.S.
 2012
 18 S2 p. S189-
1 p.
 artikel
489 3.349 MIXED LINEAGE KINASE 2 AND HIPPOCALCIN ARE LOCALIZED IN LEWY BODIES OF PARKINSON'S DISEASE Nagao, M.
 2012
 18 S2 p. S231-
1 p.
 artikel
490 3.216 MNP125EA PROTECTS THE DIFFERENTIATED SH-SY5Y CELLS AGAINST MPP+ TOXICITY IN PART BY DOWNREGULATION OF CASP3 EXPRESSION Song, M.O.
 2012
 18 S2 p. S207-
1 p.
 artikel
491 2.222 MODIFICATION OF DOPAMINE OXIDATIVE METABOLISM BY MAO SUBTYPES A AND B FOLLOWING DOPAMINERGIC AND SEROTONERGIC STRIATAL DENERVATION Sader-Mazbar, O.
 2012
 18 S2 p. S120-
1 p.
 artikel
492 3.146 MODULATION OF ADULT NEUROGENESIS IN THE OLFACTORY BULB IN AN ACUTE MOUSE MODEL OF PARKINSON'S DISEASE Chiu, W.-H.
 2012
 18 S2 p. S200-
1 p.
 artikel
493 3.247 MODULATION OF CYTOKINES PRODUCTION AND MICROGLIAL PPAR-GAMMA LEVELS BY ROSIGLIAZONE IN PARKINSON'S DISEASE Pisanu, A.
 2012
 18 S2 p. S215-
1 p.
 artikel
494 1.235 MOLECULAR GENETICS OF HERITABLE ESSENTIAL TREMOR-IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS (ETINPH) Zhang, J.
 2012
 18 S2 p. S55-
1 p.
 artikel
495 3.068 MOLECULAR GENETIC STUDIES ON INDIAN WILSON'S DISEASE PATIENTS Ray, K.
 2012
 18 S2 p. S186-
1 p.
 artikel
496 1.13.4 MOLECULAR PATHWAYS IN SPORADIC PD Valente, E.M.
 2012
 18 S2 p. S7-
1 p.
 artikel
497 1.062 MOOD AND BEHAVIOURAL EVALUATION IN PARKINSON'S DISEASE — VALIDATION OF A NEW SCALE Rieu, I.
 2012
 18 S2 p. S25-
1 p.
 artikel
498 1.14.1 MOOD DISORDERS Tan, L.
 2012
 18 S2 p. S7-
1 p.
 artikel
499 1.209 MOOD DISORDERS AND SEXUAL DYSFUNCTION IN RESTLESS LEGS SYNDROME Cinar, N.
 2012
 18 S2 p. S48-S49
2 p.
 artikel
500 3.057 MOVEMENT DISORDERS ARE PREVALENT IN PATIENTS WITH FAMILIAL CREUTZFELDT-JAKOB DISEASE (F-CJD) CARRYING THE E200K MUTATION Cohen, O.
 2012
 18 S2 p. S183-
1 p.
 artikel
501 1.225 MOVEMENT DISORDERS: PRIMARY WRITING TREMOR ABOUT TWO CASES Cavalcanti, C.E.
 2012
 18 S2 p. S52-
1 p.
 artikel
502 1.216 MOYAMOYA DISEASE INITIALLY MANIFESTING AS VASCULAR PARKINSONISM Cho, H.J.
 2012
 18 S2 p. S50-
1 p.
 artikel
503 2.008 MR IMAGING BIOMARKERS FOR DIFFERENTIATION OF PARKINSON DISEASE FROM HEALTHY CONTROLS USING DIFFUSION TENSOR IMAGING ON 3 TESLA MRI Kumari, R.
 2012
 18 S2 p. S92-S93
2 p.
 artikel
504 2.007 MR VOLUMETRIC ANALYSIS OF THE CORPUS CALLOSUM IN PATIENTS WITH PARKINSONISM Chan, L.-L.
 2012
 18 S2 p. S92-
1 p.
 artikel
505 3.330 MTOR SIGNALING PLAY A KEY ROLE IN NEURODEGENERATIVE DISORDERS OF SAMP8 VIA AUTOPHAGY REGULATION Ma, Q.
 2012
 18 S2 p. S226-S227
2 p.
 artikel
506 2.371 MULTIORGAN FAILURE WITH RENAL INFARCTION AFTER TREATMENT OF CEREBRAL INFARCTION Joo, M.-C.
 2012
 18 S2 p. S159-
1 p.
 artikel
507 1.17.3 MULTIPLE SYSTEM ATROPHY Shao, M.
 2012
 18 S2 p. S8-S9
2 p.
 artikel
508 3.18.4 MULTIPLE SYSTEM ATROPHY - ADVANCES IN IMAGING Chen, H.
 2012
 18 S2 p. S169-
1 p.
 artikel
509 3.026 MUTATIONAL ANALYSIS OF PARK2, SNCA AND LRRK2 IN PARKINSON'S DISEASE PATIENTS OF SOUTH INDIA Vishwanathan, P.
 2012
 18 S2 p. S175-
1 p.
 artikel
510 1.271 MUTATION SPECTRUM OF GENE ENCODING EPSILON-SARCOGLYCAN IN MYOCLONUS-DYSTONIA SYNDROME Rudzińska, M.
 2012
 18 S2 p. S64-S65
2 p.
 artikel
511 3.3.3 MYOCLONUS: CLINICAL PRESENTATION Roze, E.
 2012
 18 S2 p. S163-
1 p.
 artikel
512 3.3.2 MYOCLONUS: ELECTRO-CLINICAL MYOCLONUS SYNDROMES Caviness, J.N.
 2012
 18 S2 p. S163-
1 p.
 artikel
513 1.109 MYOTONOMETRY REVEALED MEDICATION-INDUCED DECREASE IN RESTING MUSCLE STIFFNESS IN PARKINSON'S DISEASE Marusiak, J.
 2012
 18 S2 p. S37-
1 p.
 artikel
514 3.213 NANOWIRED DELIVERY OF CEREBROLYSIN INDUCES RAPID BRAIN PROTECTION IN A MOUSE MODEL OF PARKINSON'S DISEASE Sharma, H.S.
 2012
 18 S2 p. S206-S207
2 p.
 artikel
515 3.212 NBM-T-L-BMX-OS01, A NOVEL HISTONE DEACETYLASE INHIBITOR HAS PROTECTIVE EFFECTS ON MPTP-INDUCED PARKINSON'S DISEASE MOUSE MODEL Yang, Y.-C.
 2012
 18 S2 p. S206-
1 p.
 artikel
516 3.205 NECDIN PREVENTS LOSS OF DOPAMINERGIC NEURONS IN ANIMAL MODELS OF PARKINSON'S DISEASE Yasuda, T.
 2012
 18 S2 p. S204-
1 p.
 artikel
517 2.3.4 NEUROACANTHOCYTOSIS SYNDROMES AND OTHER HD-PHENOCOPIES Danek, A.
 2012
 18 S2 p. S83-
1 p.
 artikel
518 2.101 NEUROCAM – AUTOMATED ASSISTANCE TO NEUROLOGICAL PRACTICIONERS Kostek, B.
 2012
 18 S2 p. S101-
1 p.
 artikel
519 3.134 NEUROCHEMICAL AND BEHAVIORAL CHANGES CORRESPONDING TO THE ADVANCED PARKINSON'S DISEASE WITH COEXISTENT DEPRESSION IN RATS TREATED UNILATERALLY WITH 6-OHDA Lorenc-Koci, E.
 2012
 18 S2 p. S197-S198
2 p.
 artikel
520 3.130 NEUROCHEMICAL AND BEHAVIOURAL CHARACTERISATION OF SINGLE INTRANIGRAL INJECTION OF LPS INDUCED NEUROINFLAMMATORY RAT MODEL OF PD Sharma, N.
 2012
 18 S2 p. S196-
1 p.
 artikel
521 3.128 NEUROCHEMICAL RESPONSES AND DYNAMIC CHANGES OF GLIAL AND NEURONAL CELLS IN THE SUBSTANTIA NIGRA OF A LACTACYSTIN RAT MODEL Chen, L.W.
 2012
 18 S2 p. S196-
1 p.
 artikel
522 1.12.4 NEUROIMAGING IN PARKINSON'S DISEASE Stoessl, A.J.
 2012
 18 S2 p. S6-
1 p.
 artikel
523 3.14.2 NEUROINFLAMMATION AND PD Hirsch, E.C.
 2012
 18 S2 p. S167-
1 p.
 artikel
524 1.222 NEUROLEPTIC MALIGNANT SYNDROME WITH ATYPICAL NEUROLEPTICS AND DOPAMINE MODULATING DRUGS: SEVEN CASE REPORTS Sharms, J.B.
 2012
 18 S2 p. S52-
1 p.
 artikel
525 1.314 NEUROLOGICAL SYNDROMES ASSOCIATED WITH GLUTAMIC ACID DECARBOXYLASE ANTIBODIES: A BRAZILIAN SERIES Teive, H.A.G.
 2012
 18 S2 p. S75-
1 p.
 artikel
526 1.242 NEUROMUSCULAR FINDINGS IN CHOREA-ACANTHOCYTOSIS Liu, J.
 2012
 18 S2 p. S57-
1 p.
 artikel
527 2.362 NEUROMUSCULAR TAPING FOR THE TREATMENT OF DROP HEAD SYNDROME IN MULTISYSTEM ATROPHY Pilleri, M.
 2012
 18 S2 p. S156-S157
2 p.
 artikel
528 1.12.3 NEURONAL VULNERABILITY IN PARKINSON'S DISEASE Double, K.L.
 2012
 18 S2 p. S6-
1 p.
 artikel
529 2.133 NEURON-SPECIFIC PROTEIN ENOLASE AS DIAGNOSTIC MARKER OF PARKINSON DISEASE Usmanova, D.
 2012
 18 S2 p. S109-S110
2 p.
 artikel
530 1.7.1 NEUROPATHOLOGY IN THE PREMOTOR STAGES AND SUBTYPES OF PARKINSON'S DISEASE van de Berg, W.D.J.
 2012
 18 S2 p. S4-
1 p.
 artikel
531 2.031 NEUROPHYSIOLOGICAL CORRELATES OF COGNITIVE DECLINE IN PARKINSON'S DISEASE: A LONGITUDINAL MAGNETOENCEPHALOGRAPHIC STUDY Dubbelink, K.T.E. Olde
 2012
 18 S2 p. S99-
1 p.
 artikel
532 3.225 NEUROPROTECTION BY BDNF AGAINST GLUCOSE DEPRIVATION-INDUCED CELL DEATH IS MEDIATED BY ERK1/2 AND PI3-KINASE PATHWAYS Zahir, N. Vakili
 2012
 18 S2 p. S209-
1 p.
 artikel
533 3.5.4 NEUROPROTECTION FROM NUTRIENTS IN NEURAL CULTURE Rausch, W.
 2012
 18 S2 p. S163-S164
2 p.
 artikel
534 2.14.1 NEUROPROTECTIVE AND NEUROREGENERATIVE TROPHIC PROTEINS IN PARKINSON'S DISEASE Hoffer, B.
 2012
 18 S2 p. S87-
1 p.
 artikel
535 3.239 NEUROPROTECTIVE AND NEURORESCUE EFFECT OF NARINGIN IN 6-HYDROXYDOPAMINE-LESIONED RAT MODEL OF PARKINSON'S DISEASE: EVIDENCE FOR INVOLVEMENT OF POSSIBLE MECHANISMS Golechha, M.
 2012
 18 S2 p. S213-
1 p.
 artikel
536 3.226 NEUROPROTECTIVE EFFECT OF DIPEPTIDE ANALOGUE OF BDNF - GSB-106 IN VITRO AND ITS INFLUENCE ON THE SYNTHESIS OF HEME OXYGENASE-1 Logvinov, I.O.
 2012
 18 S2 p. S209-S210
2 p.
 artikel
537 3.237 NEUROPROTECTIVE RFFECT OF L-CARNITINE AND CENTELLA ASIATICA EXTRACT ON 6-HYDROXYDOPAMINE (6-OHDA)-INDUCED CHANGES IN THE REPAIR-MECHANISM AND GENOTOXICITY IN AGED RATS Ponnusamy, K.
 2012
 18 S2 p. S212-S213
2 p.
 artikel
538 3.250 NEUROPROTECTIVE ROLE OF 17β-ESTRADIOL ADMINISTRATION ON ALTERED AGE RELATED NEURONAL PARAMETERS IN FEMALE RATS Kumar, P.
 2012
 18 S2 p. S216-
1 p.
 artikel
539 2.264 NEUROPSYCHIATRIC PROFILE OF PATIENTS ON TREATMENT WITH PRAMIPEXOLE, ROPINIROLE OR LEVODOPA IN MONOTHERAPY: HEAD-TO-HEAD COMPARISON Perez, J.P.
 2012
 18 S2 p. S131-
1 p.
 artikel
540 1.097 NEUROPSYCHOGICAL AND NEUROANATOMIC BASES DIFFER BETWEEN PARKINSON'S DISEASE WITH STABLE MCI AND MCI TO DEMENTIA CONVERTER Lee, J.E.
 2012
 18 S2 p. S34-
1 p.
 artikel
541 2.311 NEUROPSYCHOLOGICAL FINDINGS IN PATIENTS WITH PARKINSON'S DISEASE SUBMITTED TO BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION Heluani, A.
 2012
 18 S2 p. S144-
1 p.
 artikel
542 2.310 NEUROPSYCHOLOGICAL FINDINGS IN PATIENTS WITH PARKINSON'S DISEASE SUBMITTED TO UNILATERAL ABLATIVE PROCEDURES Heluani, A.
 2012
 18 S2 p. S143-S144
2 p.
 artikel
543 1.067 NEUROPSYCHOLOGICAL PROFILE OF PATIENTS WITH IDIOPATHIC PARKINSON'S DISEASE Chatterjee, P.
 2012
 18 S2 p. S26-
1 p.
 artikel
544 2.11.1 NEURO-REHABILITATION IN PD Calne, S.M.
 2012
 18 S2 p. S85-
1 p.
 artikel
545 2.14.2 NEURORESTORATION BY PHYSICAL EXERCISE Zigmond, M.
 2012
 18 S2 p. S87-
1 p.
 artikel
546 2.14.3 NEURORESTORATIVE, NEUROPROTECTIVE AND CELL CYCLE ARREST ACTIVITY OF NOVEL MULTI TARGET DRUGS IN ANIMAL MODELS OF PARKINSON'S DISEASE Youdim, M.B.H.
 2012
 18 S2 p. S88-
1 p.
 artikel
547 1.219 NEUROSYPHILIS PRESENTING WITH PARKINSONISM Fan, L.
 2012
 18 S2 p. S51-
1 p.
 artikel
548 1.123 NEUROTRANSMITTERS-MEDIATING ENZYME — DOPAMINE-β-HYDROXYLASE AND ITS COFACTORS IN THE SERUM OF BANGLADESHI PATIENTS WITH PARKINSON'S DISEASE, MENTAL RETARDATION AND ARSENICOSIS Rahman, M.K.
 2012
 18 S2 p. S41-
1 p.
 artikel
549 1.047 NEW OBJECTIVE APATHY SCALE FOR PARKINSON'S DISEASE Kumon, A.
 2012
 18 S2 p. S21-
1 p.
 artikel
550 2.352 NEW STRATEGIES FOR LIVING WELL AMONG PATIENTS WITH PARKINSON'S DISEASE Kaadan, M.I.
 2012
 18 S2 p. S154-
1 p.
 artikel
551 1.2.4 NEW TARGETS FOR DBS Benabid, A.L.
 2012
 18 S2 p. S2-
1 p.
 artikel
552 3.11.1 NEW TARGETS FOR DBS Benabid, A.L.
 2012
 18 S2 p. S165-
1 p.
 artikel
553 2.236 NEW TREATMENT FOR CLINICAL STABILIZATION IN PARKINSON'S DISEASE de Font-Réaulx, E.
 2012
 18 S2 p. S123-S124
2 p.
 artikel
554 2.3.1 NEW VIEWS ON HUNTINGTON'S DISEASE PHENOTYPE Burgunder, J.-M.
 2012
 18 S2 p. S82-
1 p.
 artikel
555 2.223 NICOTINE AMELIORATES BEHAVIORAL DEFICITS AND OXIDATIVE STRESS IN A 6-HYDROXYDOPAMINE RAT MODEL OF PARKINSON'S DISEASE Ciobica, A.
 2012
 18 S2 p. S120-
1 p.
 artikel
556 1.009 NIGRAL IRON DEPOSITION OCCURS ACROSS MOTOR PHENOTYPIC EXPRESSIONS OF PARKINSON'S DISEASE Jin, L.
 2012
 18 S2 p. S12-
1 p.
 artikel
557 3.220 NIGROSTRIATAL DOPAMINERGIC SYSTEM OF CONDITIONAL GDNF KNOCK-OUT MICE DOES NOT DISPLAY INCREASED VULNERABILITY TO AGING Kopra, J.
 2012
 18 S2 p. S208-
1 p.
 artikel
558 1.057 NOCTURNAL DISTURBANCES IN PARKINSON'S DISEASE: A VALIDATION STUDY OF PARKINSON'S DISEASE SLEEP SCALE-2 JAPANESE VERSION Suzuki, K.
 2012
 18 S2 p. S24-
1 p.
 artikel
559 2.332 NON-MOTOR EFFECTS OF SUBTHALAMIC NUCLES DEEP BRAIN STIMULATION FOR ADVANCED PARKINSON'S DISEASE PATIENTS Toda, H.
 2012
 18 S2 p. S149-
1 p.
 artikel
560 1.032 NON-MOTOR SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE Joshi, D.
 2012
 18 S2 p. S18-
1 p.
 artikel
561 1.8.3 NON MOTOR SYMPTOMS IN PD: IMPACT ON QUALITY OF LIFE AND MEDICAL TREATMENT Barone, P.
 2012
 18 S2 p. S5-
1 p.
 artikel
562 1.034 NON MOTOR SYMPTOMS IN TURKISH PATIENTS WITH PARKINSON'S DISEASE Koksal, A.
 2012
 18 S2 p. S18-
1 p.
 artikel
563 2.5.4 NON-MOTOR SYMPTOMS OF PD: CLINICAL RECOGNITION AND TREATMENT OF AUTONOMIC NERVE DYSFUNCTION Wang, M.-W.
 2012
 18 S2 p. S83-S84
2 p.
 artikel
564 1.302 NOVEL OF GAIT ANALYSIS IN EARLY PARKINSON'S DISEASE Suputtitada, A.
 2012
 18 S2 p. S72-
1 p.
 artikel
565 3.077 NOVEL PLA2G6 GENE MUTATION IS ASSOCIATED WITH AUTOSOMAL RECESSIVE EARLY-ONSET PARKINSONISM Yan, X.
 2012
 18 S2 p. S188-
1 p.
 artikel
566 3.060 NOVEL VARIANTS IN HTRA2 GENE ASSOCIATED WITH PARKINSON'S DISEASE AND MITOCHONDRIAL DYSFUNCTION Chen, M.-L.
 2012
 18 S2 p. S183-S184
2 p.
 artikel
567 3.141 NURR1 DETERMINES THE PREFERENTIAL DEGENERATION OF MIDBRAIN DOPAMINERGIC NEURONS IN A PARKINSON'S DISEASE MOUSE MODEL Lin, X.
 2012
 18 S2 p. S199-
1 p.
 artikel
568 2.037 OBJECTIVES: TO EVALUATE LOCALISED SHAPE DIFFERENCES OF SUB-CORTICAL & LIMBIC STRUCTURES IN PROGRESSIVE SUPRANUCLEAR PALSY PATIENTS Saini, J.
 2012
 18 S2 p. S100-
1 p.
 artikel
569 1.080 OCCIPITAL LOBE AND POSTERIOR CINGULATE METABOLIC CHANGES OCCUR IN PARKINSON'S DISEASE WITH THE MILD COGNITIVE IMPAIRMENT Nie, K.
 2012
 18 S2 p. S29-S30
2 p.
 artikel
570 2.17.1 OCCUPATIONAL CHEMICAL EXPOSURES & RISK FOR PARKINSON'S DISEASE Tanner, C.M.
 2012
 18 S2 p. S89-
1 p.
 artikel
571 2.346 OCCUPATIONAL THERAPY SURVEY OF PEOPLE LIVING WITH PARKINSON'S DISEASE Jansa, J.
 2012
 18 S2 p. S152-S153
2 p.
 artikel
572 1.037 OLFACTION AND PROFILE OF WEIGHT CHANGE IN PARKINSON'S DISEASE: IDENTIFYING A PHENOTYPE Sharma, J.C.
 2012
 18 S2 p. S19-
1 p.
 artikel
573 1.8.4 ONCE DAILY TREATMENTS IN PD: AN UPDATE Hattori, N.
 2012
 18 S2 p. S5-
1 p.
 artikel
574 2.290 ONCE YEARLY ZOLEDRONIC ACID IN OSTEOPOROTIC PD PATIENTS COMPARED TO OSTEOPOROTIC POSTMENOPAUSAL WOMEN Invernizzi, M.
 2012
 18 S2 p. S138-
1 p.
 artikel
575 2.226 ONE OUT OF TEN PATIENTS DISCONTINUE ANTI-PARKINSON TREATMENT DUE TO NOCEBO ADVERSE EVENTS: A META-ANALYSIS OF 47 RANDOMIZED TRIALS Stathis, P.
 2012
 18 S2 p. S121-
1 p.
 artikel
576 2.243 OPICAPONE: CHARACTERIZATION OF A NOVEL PERIPHERAL LONG-ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR Bonifacio, M.J.
 2012
 18 S2 p. S125-
1 p.
 artikel
577 1.239 OPSOCLONUS-MYOCLONUS SYNDROME ASSOCIATED WITH IRRITABILITY AND EXAGGERATED STARTLE RESPONSE IN AN ADULT Dulamea, A.
 2012
 18 S2 p. S56-
1 p.
 artikel
578 2.277 OPTIMIZATION OF PHASE III STUDY DESIGN FOR PIMAVANSERIN IN THE TREATMENT OF PARKINSON'S DISEASE PSYCHOSIS (PDP) Mills, R.
 2012
 18 S2 p. S134-
1 p.
 artikel
579 3.238 ORAL PELARGONIDIN EXERTS DOSE-DEPENDENT NEUROPROTECTION IN 6-HYDROXYDOPAMINE RAT MODEL OF HEMI-PARKINSONISM Roghani, M.
 2012
 18 S2 p. S213-
1 p.
 artikel
580 1.318 OTONEUROLOGICAL FINDINGS IN SPINOCEREBELLAR ATAXIA Zeigeilboim, B.S.
 2012
 18 S2 p. S76-
1 p.
 artikel
581 1.289 OUTCOME OF TREATMENT WITH NEURONOX IN HEMIFACIAL SPASM PATIENTS Tiamkao, S.
 2012
 18 S2 p. S69-
1 p.
 artikel
582 3.339 OVEREXPRESSION OF HDAC2 ACTIVATED GSK-3BETA WITHOUT DIRECT INTERACTION Wang, X.
 2012
 18 S2 p. S228-
1 p.
 artikel
583 3.1.1 OVERVIEW OF PRIMARY MONOGENIC DYSTONIA Spatola, M.
 2012
 18 S2 p. S161-
1 p.
 artikel
584 3.137 OXIDATIVE STRESS, ALPHA-SYNUCLEIN, AND EPIGENETIC AFFECTS IN THE PARKINSONIAN BRAIN Siddiqui, A.
 2012
 18 S2 p. S198-
1 p.
 artikel
585 3.312 PAIN MEASUREMENT OF PATIENTS WITH PARKINSON'S DISEASE BY SKIN IMPEDANCE Kagechika, K.
 2012
 18 S2 p. S222-
1 p.
 artikel
586 2.040 PALLIDO-RETICULAR NECROSIS AND POST-ANOXIC LEUKOENCEPHALOPATHY: PERSPECTIVES FROM CLINIC AND PATHOLOGIC MOVEMENT DISORDERS DIAGNOSTICS Mendieta, S.G. Echebarria
 2012
 18 S2 p. S101-
1 p.
 artikel
587 3.107 PARAQUAT ACTIVATES THE IRE1/ASK1/JNK CASCADE ASSOCIATED WITH APOPTOSIS IN SH-SY5Y CELLS Son, I.
 2012
 18 S2 p. S191-
1 p.
 artikel
588 3.106 PARAQUAT NEUROTOXICITY IS MEDIATED BY THE DOPAMINE TRANSPORTER AND ORGANIC CATION TRANSPORTER-3 Rappold, P.
 2012
 18 S2 p. S190-S191
2 p.
 artikel
589 3.311 PARKINSON DISEASE AND PAIN: DOPAMINERGIC MODULATION ON THE MECHANICAL HYPERALGESIA IN HEMIPARKINSONIAN RATS Maciel, S.T.
 2012
 18 S2 p. S222-
1 p.
 artikel
590 3.111 PARKINSON DISEASE DERIVED hONS CELLS ARE MORE SENSITIVE TO ROTENONE TOXICITY THAN CONTROL CELLS Shan, J.
 2012
 18 S2 p. S192-
1 p.
 artikel
591 1.015 PARKINSON DISEASE IN THE YOUNG: A REPORT OF FOUR CASES IN A TEACHING HOSPITAL IN SOUTHERN NIGERIA Ekeh, B.C.
 2012
 18 S2 p. S13-S14
2 p.
 artikel
592 2.136 PARKINSON DISEASE OR ESSENTIAL TREMOR Fedorova, K.
 2012
 18 S2 p. S110-S111
2 p.
 artikel
593 2.1.1 PARKINSON DISEASE TREMOR: PATHOPHYSIOLOGY Hallett, M.
 2012
 18 S2 p. S81-
1 p.
 artikel
594 1.018 PARKINSONIAN RIGIDITY IN ELBOW JOINT IS MOST PRONOUNCED IN DISTAL PHASE OF EXTENSION Endo, T.
 2012
 18 S2 p. S14-
1 p.
 artikel
595 1.013 PARKINSONISM IN GHANA: OBJECTIVES, CLINICAL AND GENETICS FINDINGS FROM A 3-YEAR INTERNATIONAL PROJECT Cilia, R.
 2012
 18 S2 p. S13-
1 p.
 artikel
596 3.002 PARKINSON'S DISEASE AND GENETICS Shaafi, S.
 2012
 18 S2 p. S169-S170
2 p.
 artikel
597 1.107 PARKINSON'S DISEASE AND MYASTHENIA GRAVIS Martinkova, J.
 2012
 18 S2 p. S36-S37
2 p.
 artikel
598 2.17.4 PARKINSON'S DISEASE AND PROFESSIONAL EXPOSURE TO ORGANOCHLORINE INSECTICIDES Elbaz, A.
 2012
 18 S2 p. S89-
1 p.
 artikel
599 3.125 PARKINSON'S DISEASE-INDUCED HEART ATROPHY AND VAGAL WITHDRAWAL IN TRANSGENIC MICE: A SHORT COMMUNICATION Ladd, F.V.L.
 2012
 18 S2 p. S195-
1 p.
 artikel
600 1.001 PARKINSON'S DISEASE IN HISTORY Kaadan, A.
 2012
 18 S2 p. S10-
1 p.
 artikel
601 1.12.1 PARKINSON'S DISEASE: MOLECULAR RISK FACTORS Grünblatt, E.
 2012
 18 S2 p. S5-
1 p.
 artikel
602 2.225 PARKINSON'S UK PATIENT SURVEY AND MEDICINES' MANAGEMENT AUDIT IN THE ROYAL DEVON AND EXETER HOSPITAL, UK, 2011 Goff, A.
 2012
 18 S2 p. S121-
1 p.
 artikel
603 1.144 PARKINSON SUMMER SCHOOL III, WARSAW JULY 2011 Maliia, M.
 2012
 18 S2 p. S46-
1 p.
 artikel
604 3.18.3 PAROXYSMAL MOVEMENT DISORDERS Liu, C.-F.
 2012
 18 S2 p. S169-
1 p.
 artikel
605 1.113 PATHOLOGICAL GAMBLING AND RISK FOR IMPULSE CONTROL DISORDERS IN PARKINSON'S DISEASE: A COMMUNITY BASED STUDY Joutsa, J.
 2012
 18 S2 p. S38-
1 p.
 artikel
606 2.13.1 PATHOLOGY IN ESSENTIAL TREMOR Shill, H.
 2012
 18 S2 p. S86-
1 p.
 artikel
607 3.15.2 PATHOPHYSIOLOGY IN PARKINSON'S DISEASE PAIN AND FATIGUE Berardelli, A.
 2012
 18 S2 p. S168-
1 p.
 artikel
608 2.228 PATHOPHYSIOLOGY OF MOTOR COMPLICATIONS IN PARKINSON'S DISEASE Li, Y.M.
 2012
 18 S2 p. S121-S122
2 p.
 artikel
609 2.263 PATIENT-REPORTED CONVENIENCE OF ONCE-DAILY VS TID DOSING DURING LONG-TERM STUDIES OF PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE Schapira, A.
 2012
 18 S2 p. S131-
1 p.
 artikel
610 1.014 PATIENTS PRESENTING WITH PARKINSON'S DISEASE: CLINICAL SCENARIO IN PAKISTAN AND SOUTH EAST ASIAN COUNTRIES Hussain, T.
 2012
 18 S2 p. S13-
1 p.
 artikel
611 1.086 PATTERN OF PSYCHOSIS IN PARKINSON'S DISEASE Yadav, R.
 2012
 18 S2 p. S31-
1 p.
 artikel
612 2.030 PATTERNS OF CORTICAL AND SUB-CORTICAL THINNING IN PARKINSON'S DISEASE Biundo, R.
 2012
 18 S2 p. S98-S99
2 p.
 artikel
613 1.19.2 PD IN EVOLUTION: PRODROME TO DEGENERATION Schapira, A.
 2012
 18 S2 p. S9-
1 p.
 artikel
614 3.133 PERGOLIDE ATTENUATES MEMORY DEFICIENCIES AND OXIDATIVE STRESS INDUCED BY A 6-HYDROXYDOPAMINE MODEL OF PARKINSON'S DISEASE Padurariu, M.
 2012
 18 S2 p. S197-
1 p.
 artikel
615 3.102 PERINATAL LPS EXPOSURE INCREASES THE RISK FOR DOPAMINERGIC DISORDERS IN ADULT LIFE Cai, Z.
 2012
 18 S2 p. S190-
1 p.
 artikel
616 2.115 PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS IN PATIENTS WITH PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY Balash, Y.
 2012
 18 S2 p. S105-
1 p.
 artikel
617 2.114 PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS IN PATIENTS WITH PARKINSON'S DISEASE, PATIENTS WITH DIFFERENT GENETICS STATUS Gurevich, T.
 2012
 18 S2 p. S105-
1 p.
 artikel
618 2.2.1 PET STUDIES IN PARKINSON'S DISEASE MOTOR AND COGNITIVE DYSFUNCTION Pavese, N.
 2012
 18 S2 p. S82-
1 p.
 artikel
619 2.217 PHARMACOKINETIC PROFILE OF THE SELECTIVE DOPAMINE D4 RECEPTOR ANTAGONIST L-745,870 IN THE MPTP-LESIONED NON-HUMAN PRIMATE MODEL OF PARKINSON'S DISEASE Huot, P.
 2012
 18 S2 p. S119-
1 p.
 artikel
620 2.244 PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF OPICAPONE, A NOVEL COMT INHIBITOR, DURING FIRST ADMINISTRATION TO HEALTHY MALE SUBJECTS Nunes, T.
 2012
 18 S2 p. S126-
1 p.
 artikel
621 2.245 PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF OPICAPONE, A NOVEL COMT INHIBITOR, DURING MULTIPLE RISING DOSE REGIMENS IN HEALTHY MALE SUBJECTS Rocha, J.F.
 2012
 18 S2 p. S126-
1 p.
 artikel
622 3.1.3 PHARMACOLOGICAL TREATMENT FOR DYSTONIA Baba, Y.
 2012
 18 S2 p. S161-
1 p.
 artikel
623 2.1.2 PHENOTYPES OF PARKINSONIAN TREMOR Deuschl, G.
 2012
 18 S2 p. S81-
1 p.
 artikel
624 1.026 PHONETORY CHARACTERISTICS IN INDIVIDUALS WITH DYSARTHRIA — DYSARTHROPHONIA Anakkathil, P.A.
 2012
 18 S2 p. S16-
1 p.
 artikel
625 3.327 PHOSPHOPROTEOME STUDY REVEALS HSP27 AS A NOVEL SIGNALING MOLECULE INVOLVED IN GDNF-INDUCED NEURITE OUTGROWTH Hong, Z.
 2012
 18 S2 p. S226-
1 p.
 artikel
626 3.215 PHOTOBIOMODULATION NEUROPROTECTS MIDBRAIN DOPAMINERGIC CELLS IN A CHRONIC MPTP MOUSE MODEL OF PARKINSON DISEASE Peoples, C.
 2012
 18 S2 p. S207-
1 p.
 artikel
627 2.361 PHYSICAL THERAPY IMPROVES SYMPTOMS IN CERVICAL DYSTONIA PATIENTS WITH INCOMPLETE RESPONSE TO ONOBOTULINUM INJECTION Griffith, A.
 2012
 18 S2 p. S156-
1 p.
 artikel
628 3.210 PHYTOCANNABINOIDS TETRAHYDROCANNABINOL AND CANNABIDIOL ACT AGAINST ROTENONE INDUCED DAMAGES IN MURINE CELL CULTURES Moldzio, R.
 2012
 18 S2 p. S205-S206
2 p.
 artikel
629 1.204 PILOT COMPARATIVE STUDY IN PSP AND FTD OF THE EFFECTS OF NEUROFEEDBACK IN COGNITIVE SYMPTOMS Hergueta, T.
 2012
 18 S2 p. S47-
1 p.
 artikel
630 3.015 PLA2G6 POLYMORPHISMS AND HAPLOTYPES IN PREDICTING PARKINSON'S DISEASE RISK IN CHINESE POPULATION Zhanyun, L.
 2012
 18 S2 p. S172-S173
2 p.
 artikel
631 2.297 PLASTICITY INDUCTION BY PAIRING SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION AND MOTOR CORTICAL TRANSCRANIAL MAGNETIC STIMULATION IN PARKINSON'S DISEASE Udupa, K.
 2012
 18 S2 p. S140-
1 p.
 artikel
632 3.012 POLYGENIC DETERMINANTS OF PARKINSON'S DISEASE Guo, J.
 2012
 18 S2 p. S172-
1 p.
 artikel
633 3.051 POLYMORPHISMS IN THE SLC6A3 GENE ENCODING FOR THE DOPAMINE TRANSPORTER ARE ASSOCIATED WITH LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE Hassin, S.
 2012
 18 S2 p. S181-
1 p.
 artikel
634 2.348 POPULATION-BASED STUDY ON RISK OF PARKINSON'S DISEASE ASSOCIATED WITH DEMENTIA AND DEPRESSION Liao, C.-C.
 2012
 18 S2 p. S153-
1 p.
 artikel
635 3.013 POPULATION STUDY OF (CAG/CAA)N ALLELE VARIATION IN THE TATA BOX-BINDING PROTEIN AND ATXN2-TBP MUTATIONS IN A FAMILIY WITH TYPICAL PARKINSON Laffita, J.
 2012
 18 S2 p. S172-
1 p.
 artikel
636 2.356 POSSIBILITIES AND LIMITS OF REHABILITATION PROGRAM IN PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES Nica, A.S.
 2012
 18 S2 p. S155-
1 p.
 artikel
637 3.324 POSTERIOR HYPOTHALAMIC NUCLEUS AS A NOVEL TARGET FOR DEEP BRAIN STIMULATION: PHYSIOLOGICAL CHANGES IN THE BASAL GANGLIA AND THALAMO-CORTICAL SYSTEMS Young, C.K.
 2012
 18 S2 p. S225-
1 p.
 artikel
638 1.020 POSTURAL ABNORMALITIES IN PARKINSON'S DISEASE: A DESCRIPTIVE STUDY Peralta, M.
 2012
 18 S2 p. S15-
1 p.
 artikel
639 1.021 POSTURAL ABNORMALITY IN PARKINSON'S DISEASE IS A RISK FACTOR FOR LEG DEEP VEIN THROMBOSIS Yamane, K.
 2012
 18 S2 p. S15-
1 p.
 artikel
640 2.358 POSTURAL STABILITY IN PARKINSON'S DISEASE PATIENTS AFTER TAI CHI TRAINING: A RANDOMIZED CONTROLLED TRIAL Li, F.
 2012
 18 S2 p. S155-
1 p.
 artikel
641 2.117 POSTUROGRAPHIC EVALUATION OF DIZZINESS COMPLAINING PATIENTS UNDER SUSPICION TO DEVELOP PARKINSON'S DISEASE Cho, H.
 2012
 18 S2 p. S106-
1 p.
 artikel
642 2.203 PRECLINICAL EVALUATION OF KOM-1962, A POTENT SELECTIVE INHIBITOR OF CATECHOL-O-METHYLTRANSFERASE, AS A NOVEL DRUG CANDIDATE FOR PARKINSON'S DISEASE Wanajo, I.
 2012
 18 S2 p. S115-
1 p.
 artikel
643 2.002 PRECLINICAL TO CLINICAL NEURAL CHANGES IN PARKINSON'S DISEASE Wu, T.
 2012
 18 S2 p. S91-
1 p.
 artikel
644 3.103 PREDICTION AND CHARACTERIZATION OF ARABIDOPSIS THALIANA HOMOLOGS OF PARKINSON DISEASE-ASSOCIATED GENES BASED ON SEQUENCE SIMILARITIES AND MOLECULAR MODELING Kwon, K.
 2012
 18 S2 p. S190-
1 p.
 artikel
645 1.079 PREDICTORS FOR COGNITIVE DECLINE IN CHINESE PATIENTS WITH PARKINSON'S DISEASE Mok, V.
 2012
 18 S2 p. S29-
1 p.
 artikel
646 1.076 PREDISPOSING FACTORS FOR COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE: ASSESSMENT OF 67 PATIENTS Dahani, G.S.
 2012
 18 S2 p. S28-S29
2 p.
 artikel
647 3.063 PRENATAL DIAGNOSIS FOR TWO PATIENTS AND ONE PRESYMPTOMATIC PATIENT WITH SCA3/MJD Shi, Y.T.
 2012
 18 S2 p. S184-S185
2 p.
 artikel
648 3.101 PRENATAL SENSITIZATION AND POSTNATAL PRECIPITATION IN A MODEL OF PARKINSONISM Charlton, C.G.
 2012
 18 S2 p. S189-S190
2 p.
 artikel
649 2.328 PRE-POST GAIT KINEMATIC AND STATIC BALANCE ANALYSIS FOR PARKINSON DISEASE PATIENTS UNDERWENT DBS-STN OPERATION Stathis, P.
 2012
 18 S2 p. S148-
1 p.
 artikel
650 1.065 PREVALENCE AND CLINICAL CORRELATES OF ANXIETY IN PARKINSON'S DISEASE Yamanishi, T.
 2012
 18 S2 p. S26-
1 p.
 artikel
651 1.088 PREVALENCE AND RISK FACTORS OF HALLUCINATION IN PATIENTS WITH PARKINSON'S DISEASE Zhang, R.
 2012
 18 S2 p. S31-S32
2 p.
 artikel
652 3.018 PREVALENCE OF PARKIN (PARK2) MUTATIONS AND DELETIONS IN PARKINSON'S DISEASE PATIENTS FROM EXTREMADURE (SOUTHERN SPAIN) Ronco-Barrantes, R.
 2012
 18 S2 p. S173-
1 p.
 artikel
653 1.044 PRIMARY PAIN SYNDROMES IN PATIENTS WITH PARKINSON'S DISEASE Alekseev, A.V.
 2012
 18 S2 p. S20-S21
2 p.
 artikel
654 3.118 PRIMATE AND RODENT MODELS OF PARKINSON'S DISEASE BASED ON VIRAL VECTOR MEDIATED OVEREXPRESSION OF ALPHA SYNUCLEIN Koprich, J.B.
 2012
 18 S2 p. S193-
1 p.
 artikel
655 1.246 PROFUSE SIALORRHEA AND HEMIBALLISM IN A CASE OF ANTI N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS Montero, R. Salazar
 2012
 18 S2 p. S58-
1 p.
 artikel
656 2.032 PROGESSION OF RECOGNITION MEMORY CEREBRAL NETWORK DYSFUNCTION IN EARLY PARKINSON'S DISEASE Segura, B.
 2012
 18 S2 p. S99-
1 p.
 artikel
657 1.138 PRO-INFLAMMATORY CYTOKINES INCREASE IRON INFLUX AND DECREASE IRON EFFLUX OF VENTRAL MESENCEPHALIC NEURONS Wang, J.
 2012
 18 S2 p. S45-
1 p.
 artikel
658 3.208 PROPHYLACTIC NEUROMODULATORY EFFECT OF FISH OIL SUPPLEMENTS AND SYNERGISTIC ACTION WITH QUERCETIN AGAINST ROTENONE INDUCED OXIDAITVE IMPAIRMENTS IN RAT BRAIN Joseph, K.M. Denny
 2012
 18 S2 p. S205-
1 p.
 artikel
659 1.276 PROSODIC DEFICITS IN MIXED DYSARTHRIA (WILSON'S DISEASE) Kaipa, R.
 2012
 18 S2 p. S66-
1 p.
 artikel
660 1.260 PROTECTIVE EFFECT OF ROFECOXIB AND NIMESULIDE AGAINST INTRA-STRIATAL QUINOLINIC ACID INDUCED BEHAVIORAL, OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTIONS IN RATS Kalonia, H.
 2012
 18 S2 p. S62-
1 p.
 artikel
661 1.023 PROTECTIVE STEPPING RESPONSES ON A MOVING PLATFORM IN PARKINSON'S DISEASE (PD) Lee, P.-Y.
 2012
 18 S2 p. S15-S16
2 p.
 artikel
662 3.021 PROTEOMIC ANALYSIS OF DJ-1 INTERACTING PROTEINS IN PARKINSON'S Zhang, Y.
 2012
 18 S2 p. S174-
1 p.
 artikel
663 2.344 PROTEOMIC ANALYSIS OF VARIATION IN THE CEREBROSPINAL FLUID OF PARKINSON'S DISEASE PATIENTS PRE- AND POST-DBS Wang, E.-S.
 2012
 18 S2 p. S152-
1 p.
 artikel
664 3.336 PROTEOMIC STUDIES OF THE DIFFERENTIATED SH-SY5Y CELLS TREATED BY PROTEASOMAL INHIBITOR Jia, F.
 2012
 18 S2 p. S228-
1 p.
 artikel
665 3.337 PROTEOMIC STUDIES OF THE UNDIFFERENTIATED SH-SY5Y CELLS TREATED BY PROTEASOMAL INHIBITOR Jia, F.
 2012
 18 S2 p. S228-
1 p.
 artikel
666 2.336 PSYCHOGENIC LEVODOPA-INDUCED DYSKINESIA EMERGING AFTER SUCCESSFUL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION (STN-DBS): CASE REPORT AND VIDEO Hu, W.
 2012
 18 S2 p. S150-
1 p.
 artikel
667 1.300 PSYCHOGENIC MOVEMENT DISORDER DURING THE FIRST GREAT WAR Geny, C.
 2012
 18 S2 p. S72-
1 p.
 artikel
668 2.15.2 PSYCHOGENIC MOVEMENT DISORDERS (2) Kompoliti, K.
 2012
 18 S2 p. S88-S89
2 p.
 artikel
669 2.15.1 PSYCHOGENIC MOVEMENT DISORDERS (1) Hallett, M.
 2012
 18 S2 p. S88-
1 p.
 artikel
670 2.295 PSYCHOGENIC MOVEMENT DISORDERS AND RECOVERY AFTER MOTOR CORTEX TRANSCRANIAL MAGNETIC STIMULATION Chastan, N.
 2012
 18 S2 p. S139-
1 p.
 artikel
671 1.087 PSYCHOSIS: ONE OF THE MOST COMMON NON-MOTOR MANIFESTATIONS IN PD Meng, L.
 2012
 18 S2 p. S31-
1 p.
 artikel
672 2.7.3 PULSATILE OR CONTINUOUS DOPAMINOMIMETIC STRATEGIES Antonini, A.
 2012
 18 S2 p. S84-
1 p.
 artikel
673 2.230 PYM50028, AN ORALLY ACTIVE NEUROTROPHIC FACTOR MODULATOR, ENHANCES THE EFFECT OF L-DOPA AND REDUCES L-DOPA-INDUCED DYSKINESIA IN MPTP-LESIONED MACAQUES Johnston, T.H.
 2012
 18 S2 p. S122-
1 p.
 artikel
674 2.363 QI DANCE IN PATIENT WITH PARKINSON'S DISEASE Lee, H.J.
 2012
 18 S2 p. S157-
1 p.
 artikel
675 2.318 QUALITY OF LIFE IN PATIENTS SUBMITTED TO ABLATIVE AND NEUROMODULATORY SURGERY FOR PARKINSON'S DISEASE Heluani, A.
 2012
 18 S2 p. S145-S146
2 p.
 artikel
676 2.314 QUALITY OF LIFE IN PATIENTS WITH MEDICALLY REFRACTORY PARKINSON'S DISEASE WHO WERE CANDIDATES FOR SURGERY Heluani, A.
 2012
 18 S2 p. S144-S145
2 p.
 artikel
677 2.359 QUALITY OF LIFE SCALE IN PARKINSON'S DISEASE IN RELATION TO AMBULATORY INDEPENDENCY Kwok, C.M.
 2012
 18 S2 p. S155-S156
2 p.
 artikel
678 1.7.3 QUALITY TREATMENT OF PARKINSON'S DISEASE Uitti, R.J.
 2012
 18 S2 p. S4-
1 p.
 artikel
679 1.025 QUANTATIVE ASSESSMENT OF GAIT USING PORTABLE GAIT RHYMOGRAM ON MUSIC THERAPY FOR PARKINSON'S DISEASE Hayashi, A.
 2012
 18 S2 p. S16-
1 p.
 artikel
680 1.229 QUANTITATIVE ASSESSMENT OF REST AND ACTION TREMOR AND THE EFFECT OF CUEING IN PARKINSON'S PATIENTS TREATED WITH DEEP BRAIN STIMULATION Heida, T.
 2012
 18 S2 p. S53-S54
2 p.
 artikel
681 2.023 QUANTITATIVE MAPPING OF RCBF IN THE PATIENTS WITH PARKINSON DISEASE: OBJECTIVE EVALUATION USING STEREOTACTIC EXTRACTION ESTIMATION ANALYSIS IN 123I-IMP SPECT Kajita, Y.
 2012
 18 S2 p. S97-
1 p.
 artikel
682 2.276 QUETIAPINE USE FOR PSYCHOSIS IN PARKINSON'S DISEASE: A RETROSPECTIVE STUDY IN A TERTIARY MOVEMENT DISORDER CENTRE, SINGAPORE Li, W.
 2012
 18 S2 p. S134-
1 p.
 artikel
683 2.240 RASAGILINE IMPROVES THE QUALITY OF SLEEP IN PATIENTS WITH PARKINSON'S DISEASE: RESULTS OF THE RASAGILINE EFFECT ON SLEEP TRIAL (REST) Panisset, M.
 2012
 18 S2 p. S124-S125
2 p.
 artikel
684 2.355 RATIONALE AND DESIGN OF SPIRITT: A RANDOMISED CONTROLLED TRIAL OF A DOMICILIARY-BASED SPECIALIST PARKINSON'S INTEGRATED REHABILITATION TEAM Gage, H.
 2012
 18 S2 p. S154-S155
2 p.
 artikel
685 2.201 RECENT PHARMACOTHERAPY FOR PARKINSON'S DISEASE, A REVIEW Wang, J.
 2012
 18 S2 p. S114-S115
2 p.
 artikel
686 1.228 RECORDING PATHOLOGICAL TREMOR WITH A SMARTPHONE Carignan, B.
 2012
 18 S2 p. S53-
1 p.
 artikel
687 3.222 REGULATION OF BDNF SIGNALING CASCADES IN RAT BRAIN BY CHRONIC UNPREDICTABLE STRESS AND ANTIDEPRESSANT TREATMENT Banerjee, R.
 2012
 18 S2 p. S209-
1 p.
 artikel
688 3.357 REGULATION ROLE OF OVEREXPRESSION OF ΔFOSB TO THE SIGNAL PATHWAYS IN THE STRIATUM OF LEVODOPA-INDUCED DYSKINESIA OF HEMIPARKINSONIAN RATS Cao, X.
 2012
 18 S2 p. S233-
1 p.
 artikel
689 2.280 RELATIONSHIP BETWEEN POLYPHARMACY AND FREQUENCY OF ADVERSE EVENTS TO ANTIPARKINSONIAN DRUGS: A PRELIMINARY STUDY Rey, M.V.
 2012
 18 S2 p. S135-
1 p.
 artikel
690 2.312 RELATIONSHIP BETWEEN QUALITY OF LIFE, PHYSICAL ACTIVITY AND LIFE-SPACE IN ADVANCED PARKINSON'S DISEASE BEFORE AND AFTER STN DBS Daneault, J.-F.
 2012
 18 S2 p. S144-
1 p.
 artikel
691 2.017 RELATIONSHIP BETWEEN VISUAL HALLUCINATIONS AND CEREBRAL BLOOD FLOW ABNORMALITY IN PARKINSON'S DISEASE Okada, K.
 2012
 18 S2 p. S95-
1 p.
 artikel
692 2.151 RELIABILITY AND VALIDITY OF A PATTERN IDENTIFICATION QUESTIONNAIRE FOR KOREAN STROKE PATIENTS Kang, B.
 2012
 18 S2 p. S114-
1 p.
 artikel
693 2.333 REMISSION OF L-DOPA RESPONSIVE PAIN IN PARKINSON'S DISEASE AFTER SUBTHALAMIC DEEP BRAIN STIMULATION Sueruecue, O.
 2012
 18 S2 p. S149-
1 p.
 artikel
694 1.293 REPORT OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF WRITER'S CRAMP UNDER EMG GUIDANCE Song, C.
 2012
 18 S2 p. S70-
1 p.
 artikel
695 2.038 RESTLESS LEGS SYNDROME AS A MANIFESTATION OF ACUTE PONTINE INFARCTION Shin, H.-W.
 2012
 18 S2 p. S100-S101
2 p.
 artikel
696 1.238 RESTLESS LEGS SYNDROME IN PATIENTS WITH ARTERIAL HYPERTENSION Khachatryan, S.
 2012
 18 S2 p. S56-
1 p.
 artikel
697 3.232 RESTORATION OF THE DOPAMINERGIC ACTIVITY IN THE BRAIN OF PARKINSON'S DISEASE PATIENTS USING SV40-BASED VIRAL GENE DELIVERY VECTORS Haan, P. de
 2012
 18 S2 p. S211-
1 p.
 artikel
698 3.258 RESVERATROL INCREASES THE LIFE SPAN OF MANGANESETREATED DROSOPHILA MELANOGASTER Bonilla, E.
 2012
 18 S2 p. S217-S218
2 p.
 artikel
699 3.252 RETINAL PIGMENT EPITHELIAL (RPE) CELL TRANSPLANTATION RESTORES MOTOR COORDINATION IN THE RAT MODEL OF PARKINSON'S DISEASE (PD) Gambhir, H.S.
 2012
 18 S2 p. S216-
1 p.
 artikel
700 2.283 REVERSIBLE ANTECOLLIS ASSOCIATED WITH DOPAMINE AGONIST IN A PATIENT WITH PARKINSON'S DISEASE Kim, H.J.
 2012
 18 S2 p. S136-
1 p.
 artikel
701 1.281 REVERSIBLE PISA SYNDROME IN A PATIENT WITH PARKINSON'S DISEASE ON PRAMIPEXOLE De Pablo-Fernandez, E.
 2012
 18 S2 p. S67-
1 p.
 artikel
702 2.234 RISK FACTORS FOR LEVODOPA-RELATED DYSKINESIAS IN PARKINSON'S DISEASE Zhang, H.
 2012
 18 S2 p. S123-
1 p.
 artikel
703 1.212 RISK INDEX OF INFARCT STROKE BASED ON MODIFIABLE RISK FACTORS Martini, S.
 2012
 18 S2 p. S49-
1 p.
 artikel
704 1.118 RISKS OF PARKINSON DISEASE IN PATIENTS WITH AUTOIMMUNE DISORDERS: A NATION-WIDE EPIDEMIOLOGICAL STUDY FROM SWEDEN Li, X.
 2012
 18 S2 p. S40-
1 p.
 artikel
705 1.259 RISPERIDONE VERSUS BEHAVIOUR THERAPY IN THE TREATMENT OF TIC DISORDERS – A RANDOMIZED SINGLE-BLINDED TRIAL de Bruijn, S.
 2012
 18 S2 p. S61-S62
2 p.
 artikel
706 3.004 ROLE OF ESTROGEN RECEPTORS IN THE NIGROSTRIATAL DOPAMINE SYSTEM Haixia, D.
 2012
 18 S2 p. S170-
1 p.
 artikel
707 2.019 ROLE OF 18-FDG PET SCAN IN DIFERENTIAL DIAGNOSIS OF PARKINSONIAN SYNDROMES Borrue-Fernandez, C.
 2012
 18 S2 p. S95-S96
2 p.
 artikel
708 1.13.3 ROLE OF MENDELIAN GENES IN SPORADIC PD Brice, A.
 2012
 18 S2 p. S6-S7
2 p.
 artikel
709 3.153 ROLE OF SLEEP HOMEOSTASIS ON THE DEVELOPMENT OF LEVODOPA-INDUCED DYSKINESIA: A LOCAL-FIELD CORTICAL ACTIVITY STUDY IN THE 6-OHDA RAT Galati, S.
 2012
 18 S2 p. S202-
1 p.
 artikel
710 3.353 ROLE OF SOMATODENDRITIC AND POSTSYNAPTIC SEROTONIN-1A RECEPTORS IN THE ATTENUATION OF HALOPERIDOL-INDUCED PARKINSONIAN LIKE EFFECTS Shireen, E.
 2012
 18 S2 p. S232-
1 p.
 artikel
711 3.110 ROTENONE INDUCED NIGROSTRIATAL DEGENERATION IN RODENTS AS A MODEL FOR NEUROPROTECTIVE STRATEGIES FOR PARKINSON'S DISEASE Norazit, A.
 2012
 18 S2 p. S191-S192
2 p.
 artikel
712 2.261 ROTIGOTINE DO NOT AFFECT COGNITIVE FUNCTIONS IN EARLY-MILD DE NOVO PARKINSON'S DISEASE PATIENTS Brusa, L.
 2012
 18 S2 p. S130-
1 p.
 artikel
713 2.287 ROTIGOTINE-INDUCED NAIL DYSCHROMIA IN A PATIENT WITH PARKINSONS DISEASE Munhoz, R.P.
 2012
 18 S2 p. S137-
1 p.
 artikel
714 2.300 SAFETY DATA IN A RANDOMIZED CONTROLLED TRIAL OF CONSTANT CURRENT DBS VERSUS LEAD PLACEMENT ALONE FOR PARKINSON'S DISEASE MOTOR FLUCTUATIONS Tagliati, M.
 2012
 18 S2 p. S141-
1 p.
 artikel
715 2.269 SAFINAMIDE AS ADD-ON TO LEVODOPA IN PARKINSON'S DISEASE WITH MOTOR FLUCTUATIONS MAY IMPROVE RESPONDER RATES VERSUS PLACEBO DURING LONG-TERM TREATMENT Anand, R.
 2012
 18 S2 p. S133-
1 p.
 artikel
716 3.148 SALSOLINOL DAMAGES INTESTINAL MYENTERIC PLEXUS NEURONS IN RATS Kurnik, M.
 2012
 18 S2 p. S201-
1 p.
 artikel
717 3.046 SEARCHING FOR MODIFIER GENES IN A GENOME-WIDE ASSOCIATION STUDY OF LRRK2 G2019S CARRIERS Nicodemus, K.
 2012
 18 S2 p. S180-
1 p.
 artikel
718 2.205 SELENITE BENEFITS EMBRYONIC STEM CELLS THERAPY IN PARKINSON'S DISEASE THROUGH INHIBITING INFLAMMATION Tian, L.-P.
 2012
 18 S2 p. S115-S116
2 p.
 artikel
719 1.069 SELF ASSESSMENT SCALE FOR DOPAMINE DEPENDENT BEHAVIOURS IN PARKINSON'S DISEASE Schmitt, E.
 2012
 18 S2 p. S27-
1 p.
 artikel
720 2.020 SEMI-AUTOMATED SYNTHESIS, BIODISTRIBUTION AND MICROPET IMAGING OF 18F-FP-DTBZ AS A VESICULAR MONOAMINE TRANSPORTER LIGAND Chen, Z.
 2012
 18 S2 p. S96-
1 p.
 artikel
721 1.141 SEROTONERGIC DRUGS IN THE TREATMENT OF PARKINSONISM: STUDIES ON RAT MODEL Haleem, D.J.
 2012
 18 S2 p. S45-S46
2 p.
 artikel
722 2.12.3 SEROTONERGIC MECHANISMS OF STRIATAL SYNAPTIC PLASTICITY Mathur, B.N.
 2012
 18 S2 p. S86-
1 p.
 artikel
723 1.231 SEVERITY OF HEMIFACIAL SPASM CORRELATES WITH THE USE OF COMPLEMENTARY THERAPIES Cheong, W.T.P.
 2012
 18 S2 p. S54-
1 p.
 artikel
724 1.042 SIGNIFICANCE OF BODY WEIGHT IN PARKINSON'S DISEASE — RELATIONSHIP WITH DYSKINESIA Sharma, J.C.
 2012
 18 S2 p. S20-
1 p.
 artikel
725 3.323 SIMULATING MICRO ELECTRODE RECORDINGS FROM DEEP BRAIN SURGERY FOR APPLICATIONS IN A CLINICAL FRAMEWORK Weegink, K.J.
 2012
 18 S2 p. S225-
1 p.
 artikel
726 3.201 SIMVASTATIN PREVENTS DOPAMINERGIC NEURODEGENERATION IN EXPERIMENTAL PARKINSONIAN MODELS: THE ASSOCIATION WITH ANTI-INFLAMMATORY RESPONSES Wang, Q.
 2012
 18 S2 p. S203-
1 p.
 artikel
727 2.124 SINGLE-TRIAL EXTRACTION OF MEG BETA SYNCHRONIZATION IN NORMAL AND PARKINSON'S PATIENT USING INDEPENDENT COMPONENT ANALYSIS Lee, P.-L.
 2012
 18 S2 p. S107-
1 p.
 artikel
728 1.327 SIT-TO-STAND PERFORMANCE IN INDEPENDENT AMBULATORY PATIENTS WITH SPINAL CORD INJURY (SCI) Poncumhak, P.
 2012
 18 S2 p. S78-
1 p.
 artikel
729 1.056 SLEEP DESTRUCTURATION IN EARLY EXECUTIVE DYSFUNCTIONS: A VIRTUAL AND NEUROPSYCHOLOGICAL STUDY IN PARKINSON'S DISEASE Albani, G.
 2012
 18 S2 p. S23-S24
2 p.
 artikel
730 1.052 SLEEP DISORDERS IN DIFFERENT CLINICAL SUBGROUPS OF PARKINSON'S DISEASE Fan, L.
 2012
 18 S2 p. S22-S23
2 p.
 artikel
731 1.050 SLEEP DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE Krasakov, I.
 2012
 18 S2 p. S22-
1 p.
 artikel
732 1.060 SLEEP REGULATORY CENTRES DYSFUNCTION IN PARKINSON'S DISEASE PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS. AN IN VIVO PET STUDY Pavese, N.
 2012
 18 S2 p. S24-S25
2 p.
 artikel
733 1.054 SLEEP, SLEEPINESS AND VIGILANCE IN DOPAMINE- AND HYPOCRETIN DEFICIENT DISORDERS Wienecke, M.
 2012
 18 S2 p. S23-
1 p.
 artikel
734 3.038 SNP RS2046571 OF THE HAS2 GENE WITH PARKINSON'S DISEASE IN THE CHINESE POPULATION Rili, Y.
 2012
 18 S2 p. S178-
1 p.
 artikel
735 1.13.2 SNP VARIANTS IN PARKINSON'S DISEASE Tan, E.K.
 2012
 18 S2 p. S6-
1 p.
 artikel
736 3.009 SOME GENETIC ASPECTS OF PARKINSON'S DISEASE IDENTIFIED IN THE ARAL SEA REGION, THE REPUBLIC OF UZBEKISTAN Izyumov, D.
 2012
 18 S2 p. S171-
1 p.
 artikel
737 1.297 SPASTIC DYSTONIA OF HIP ADDUCTOR IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS TREATED WITH BOTULINUM TOXIN TYPE A Ochudło, S.G.
 2012
 18 S2 p. S71-
1 p.
 artikel
738 3.121 SPATIAL AND WORKING MEMORY IS IMPAIRED IN ALPHA-SYNUCLEIN KNOCKOUT MICE Kokhan, V.S.
 2012
 18 S2 p. S194-
1 p.
 artikel
739 3.064 SPINOCEREBELLAR ATAXIAS - GENOTYPE-PHENOTYPE CORRELATION IN 104 BRAZILIAN FAMILIES Munhoz, R.P.
 2012
 18 S2 p. S185-
1 p.
 artikel
740 1.320 SPINOCEREBELLAR ATAXIA TYPE 10: DISPROPORTIONATE CEREBELLAR SYMPTOMS AMONG AT-RISK SUBJECTS INDUCED BY SMALL AMOUNTS OF ALCOHOL Teive, H.A.G.
 2012
 18 S2 p. S77-
1 p.
 artikel
741 3.209 S-SULFHYDRATION OF β-TUBULIN BY HYDROGEN SULFIDE INCREASES MICROTUBULE STABILITY AND PROTECTS CELLS AGAINST ROTENONE-INDUCED CELL INJURY Xie, L.
 2012
 18 S2 p. S205-
1 p.
 artikel
742 3.356 STAGE-DEPENDENT DOPAMINERGIC CELL LOSS IN THE SUBSTANTIA NIGRA DURING PARKINSON'S DISEASE Dijkstra, A.A.
 2012
 18 S2 p. S233-
1 p.
 artikel
743 1.307 STATIC AND TASK-ORIENTED BALANCE TESTS IN EARLY STAGES OF PARKINSON'S DISEASE Valkovic, P.
 2012
 18 S2 p. S74-
1 p.
 artikel
744 3.202 STATINS PROTECT NEURONAL CELLS AGAINST L-DOPA NEUROTOXICITY THROUGH THE ACTIVATION OF PI3K AND FREE RADICAL SCAVENGING IN PC12 CELL CULTURE Koh, S.-H.
 2012
 18 S2 p. S203-S204
2 p.
 artikel
745 1.19.4 STEM CELLS AND GENE THERAPY IN PD: FUTURE DIRECTIONS Kordower, J.H.
 2012
 18 S2 p. S10-
1 p.
 artikel
746 2.298 STEREOTACTIC NEUROSURGERY FOR MOVEMENT DISORDERS IN A WORLD PERSPECTIVE, SIMILARITIES AND DIFFERENCES. RESULTS FROM THE WSSFN-SUPPORTED SURVEY Jourdain, V.
 2012
 18 S2 p. S140-
1 p.
 artikel
747 1.313 STIFF PERSON SYNDROME ASSOCIATED WITH AUTOIMMUNE THYROIDITIS AND SARCOIDOSIS OF INTRATHORACIC LYMPH NODES: CASE REPORT Zalyalova, Z.A.
 2012
 18 S2 p. S75-
1 p.
 artikel
748 1.125 STOCHASTIC RESONANCE IN THE FIRING PATTERNS OF SUBTHALAMIC NUCLEUS NEURONS Wang, Y.
 2012
 18 S2 p. S41-
1 p.
 artikel
749 3.119 STRIATAL LONG-TERM DEPRESSION AND DOPAMINE SIGNALING IMPAIRMENT IN A53T-ALPHA-SYNUCLEIN OVEREXPRESSING MICE Auburger, G.
 2012
 18 S2 p. S193-S194
2 p.
 artikel
750 2.12.1 STRIATAL PLASTICITY IN PARKINSON'S DISEASE AND L-DOPA INDUCED DYSKINESIA Jenner, P.G.
 2012
 18 S2 p. S85-S86
2 p.
 artikel
751 3.214 STRUCTURAL SPECIFICITY OF AKT-MEDIATED NEUROPROTECTION BY OXICAM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AGAINST 1-METHYL-4-PHENYL PYRIDINIUM-INDUCED CELL DEATH Tasaki, Y.
 2012
 18 S2 p. S207-
1 p.
 artikel
752 3.350 STUDIES ON THE PROTECTIVE ROLE OF URIC ACID IN 6-HYDROXYDOPAMINE-INDUCED INJURY OF PC12 CELLS Luo, W.
 2012
 18 S2 p. S231-
1 p.
 artikel
753 3.227 STUDY OF GLYCOSAMINOGLYCANS IN PARKINSON'S DISEASE AND THEIR IMPLICATIONS IN GDNF INDUCED PLASTICITY IN VITRO Ouidja, M.O.
 2012
 18 S2 p. S210-
1 p.
 artikel
754 1.273 STUDY OF IMPROVED SOMATOSENSORY EVOKED POTENTIALS IN PATIENTS WITH MEIGE SYNDROME AND CERVICAL DYSTONIA Zhou, L.
 2012
 18 S2 p. S65-
1 p.
 artikel
755 2.360 STUDY OF PLANTAR PRESSURE IN PARKINSON SISEASE PATIENTS Chen, X.
 2012
 18 S2 p. S156-
1 p.
 artikel
756 1.053 STUDY ON OBJECTIVE SLEEP DISTURBANCE IN PARKINSON'S DISEASE Xiong, K.-P.
 2012
 18 S2 p. S23-
1 p.
 artikel
757 1.288 SUBTHALAMIC DEEP BRAIN STIMULATION FOR PKAN-RELATED DYSTONIA Mandat, T.
 2012
 18 S2 p. S69-
1 p.
 artikel
758 2.303 SUBTHALAMIC NEURON ACTIVITY IN PATIENTS WITH PARKINSON DISEASE: NEUROPHYSIOLOGICAL CRITERIA FOR DBS ELECTRODE IMPLANTATION Kajita, Y.
 2012
 18 S2 p. S141-S142
2 p.
 artikel
759 3.1.4 SUBTHALAMIC NUCLEUS STIMULATION FOR PRIMARY DYSTONIA AND TARDIVE DYSKINESIA: LONG-TERM FOLLOW UP RESULTS Sun, B.
 2012
 18 S2 p. S161-S162
2 p.
 artikel
760 3.029 SUBTLE DIFFERENCES IN COGNITIVE FUNCTION OF HEALTHY G2019S LRRK2 MUTATION CARRIERS Thaler, A.
 2012
 18 S2 p. S176-
1 p.
 artikel
761 1.296 SUCCESSFUL TREATMENT OF REFRACTORY ANTEROCOLLIS WITH BOTULINUM TOXIN TYPE A INTO BILATERAL LOWER PORTION OF STERNOCLEIDOMASTOID MUSCLES Peng, Z.
 2012
 18 S2 p. S71-
1 p.
 artikel
762 2.257 SUICIDE IN PD PATIENT TREATED WITH DUODOPA — SECOND CASE Flisar, D.
 2012
 18 S2 p. S129-
1 p.
 artikel
763 1.105 SUSCEPTIBILITY TO COMPRESSION NEUROPATHY IN PARKINSON'S DISEASE Yilmaz, S.
 2012
 18 S2 p. S36-
1 p.
 artikel
764 2.003 SUSCEPTIBILITY-WEIGHTED IMAGING IN PARKINSONIAN SYNDROMES: A VOXEL-BASED ANALYSIS AND CORRELATIONS WITH CLINICAL SCORES Cabello, S.
 2012
 18 S2 p. S91-S92
2 p.
 artikel
765 1.256 SUSPECTED SEIZURES IN A CASE OF HEMIBALLISMUS RESPONSIVE TO TETRABENAZINE THERAPY Waked, C.
 2012
 18 S2 p. S60-S61
2 p.
 artikel
766 1.268 SUSTAINED DYSTONIA AND CHOREA IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS: A CASE REPORT AND LITERATURE REVIEW Duan, J.G.
 2012
 18 S2 p. S64-
1 p.
 artikel
767 2.239 SUSTAINED-RELEASE FORMULATION OF LEVODOPA METHYL ESTER/BENSERAZIDE REDUCE LEVODOPA-INDUCED DYSKINESIA IN 6-OHDA-LEISONED RATS Yang, X.
 2012
 18 S2 p. S124-
1 p.
 artikel
768 2.256 SYMPTOMATIC NEUROPATHY IN PARKINSON'S DISEASE PATIENTS DURING DUODENAL LEVODOPA INFUSION TREATMENT Mancini, F.
 2012
 18 S2 p. S129-
1 p.
 artikel
769 1.287 SYNERGETIC EFFECT OF INTRATHECAL BACLOFEN AND DEEP BRAIN STIMULATION IN TREATING DYSTONIA Awaad, Y.
 2012
 18 S2 p. S68-
1 p.
 artikel
770 3.305 α-SYNUCLEIN NEUROPATHOLOGY IS CONTROLLED BY NUCLEAR RECEPTORS AND ENHANCED BY DOCOSAHEXANOIC ACID IN A MOUSE MODEL FOR PARKINSON'S DISEASE Yakunin, E.
 2012
 18 S2 p. S220-
1 p.
 artikel
771 1.3.1 SYNUCLEINOPATHIES FROM BENCH TO BEDSIDE (PD, MSA, ADHD, RLS) Puschmann, A.
 2012
 18 S2 p. S2-S3
2 p.
 artikel
772 3.5.3 TAI CHI AND PARKINSON'S DISEASE Wang, Z.-F.
 2012
 18 S2 p. S163-
1 p.
 artikel
773 2.19.1 TARGETING UNMET NEEDS IN PARKINSON'S DISEASE: CONTINUOUS DOPAMINERGIC STIMULATION THERAPY Antonini, A.
 2012
 18 S2 p. S90-
1 p.
 artikel
774 1.15.1 TAUOPATHIES: FROM BENCH TO BEDSIDE Pijnenburg, Y.
 2012
 18 S2 p. S8-
1 p.
 artikel
775 2.103 TECHNOLOGY AND PARKINSON'S DISEASE: STATE-OF-THE-ART AND TRENDS IN REMOTE MONITORING AND REHABILITATION González, J. Cancela
 2012
 18 S2 p. S102-
1 p.
 artikel
776 2.339 TERMINOLATERAL NEURORRAPHY IN NERVE INJURIES Cavalcanti, C.E.
 2012
 18 S2 p. S151-
1 p.
 artikel
777 2.232 TEST-RETEST RELIABILITY OF THE PURDUE PEGBOARD IN DRUG ON AND OFF-PHASE FOR PERSONS WITH PARKINSON'S DISEASE Mehdizadeh, H.
 2012
 18 S2 p. S122-S123
2 p.
 artikel
778 3.035 TGF-β1 POLYMORPHISMS AND RISK OF PARKINSON'S DISEASE IN A HAN CHINESE POPULATION Li, R.
 2012
 18 S2 p. S177-S178
2 p.
 artikel
779 1.261 THAP1/DYT6 SEQUENCE VARIANTS IN NON-DYT1 EARLY ONSET PRIMARY DYSTONIA IN CHINA AND THEIR EFFECTS ON RNA EXPRESSION Cheng, F.B.
 2012
 18 S2 p. S62-
1 p.
 artikel
780 2.292 THE ACUTE EFFECTS OF NON-INVASIVE TRANSCRANIAL PULSED CURRENT STIMULATION (TPCS) ON GAIT AND BALANCE VARIABLES OF PATIENTS WITH PARKINSON'S DISEASE Alon, G.
 2012
 18 S2 p. S138-S139
2 p.
 artikel
781 3.033 THE AGGREGATED WT-α-SYNUCLEIN AND A53T PROMOTE INFLAMMATION THROUGH ACTIVATION OF NADPH OXIDASE COMPLEX IN BV-2 AND PRIMARY MICROGLIA Kang, W.
 2012
 18 S2 p. S177-
1 p.
 artikel
782 1.304 THE ANATOMICAL CORRELATES OF FREEZING OF GAIT IN PARKINSON'S DISEASE Pilleri, M.
 2012
 18 S2 p. S73-
1 p.
 artikel
783 3.263 THE ANTIDYSKINETIC EFFECT OF EXERCISE ON L-DOPA-TREATED HEMIPARKINSONIAN MICE Aguiar Jr, A.S.
 2012
 18 S2 p. S218-S219
2 p.
 artikel
784 3.022 THE ANTI-OXIDANT MECHANISM OF DJ-1 IN THE PATHOGENESIS OF PARKINSON'S DISEASE Wang, Z.
 2012
 18 S2 p. S174-
1 p.
 artikel
785 3.13.4 THE ARIZONA EXPERIENCE Caviness, J.N.
 2012
 18 S2 p. S166-
1 p.
 artikel
786 3.050 THE ASSOCIATION BETWEEN LRRK2 S1647T POLYMORPHISM AND COGNITIVE FUNCTION IN PARKINSON'S DISEASE Zheng, Y.
 2012
 18 S2 p. S181-
1 p.
 artikel
787 1.119 THE ASSOCIATION BETWEEN PARKINSON DISEASE AND FACTORS REFLECTING ENDOGENOUS ESTROGEN ACTIVITY IN WOMEN Chen, R.
 2012
 18 S2 p. S40-
1 p.
 artikel
788 3.036 THE ASSOCIATION BETWEEN PROMOTER POLYMORPHISM OF THE INTERLEUKIN-10 (IL-10) GENE AND PARKINSON'S DISEASE IN CHINESE HAN POPULATION Li, Q.D.
 2012
 18 S2 p. S178-
1 p.
 artikel
789 2.149 THE AVAILABILITY OF FDG PET CT AND ROTATORY CHAIR TEST IN CEREBELLAR TYPE OF MULTIPLE SYSTEMIC ATROPHY: A CASE REPORT Shin, J.H.
 2012
 18 S2 p. S113-S114
2 p.
 artikel
790 2.207 THE BENEFICIAL EFFECT OF INTRASTRIATAL BOTULINUM NEUROTOXIN IN RATS WITH HEMIPARKINSONISM DEPENDS ON THE DEPLETION OF ACETYLCHOLINE Wree, A.
 2012
 18 S2 p. S116-
1 p.
 artikel
791 2.324 THE BILATERAL STN-DBS CAN IMPROVE MOTOR AND NON-MOTOR SYMPTOMS IN MODERATE AND ADVANCED PD PATIENTS: A TWO-YEAR FOLLOW-UP STUDY Fu, X.
 2012
 18 S2 p. S147-
1 p.
 artikel
792 2.325 THE BILATERAL STN-DBS CAN IMPROVE MOTOR AND NONMOTOR SYMPTOMS IN PATIENTS OF PARKINSON'S DISEASE: A ONE-YEAR FOLLOW-UP STUDY Liu, Y.
 2012
 18 S2 p. S147-
1 p.
 artikel
793 3.13.3 THE CHINA EXPERIENCE Chan, P.
 2012
 18 S2 p. S166-
1 p.
 artikel
794 1.078 THE CLINICAL CHARACTER OF COGNITIVE DYSFUNCTION IN PARKINSON' DISEASE PATIENTS Chen, C.
 2012
 18 S2 p. S29-
1 p.
 artikel
795 1.265 THE CLINICAL FEATURES OF DOPA-RESPONSIVE DYSTONIA (DRD) AND THE GCH-I GENE MUTATION IN A CHINESE FAMILY Chen, X.
 2012
 18 S2 p. S63-
1 p.
 artikel
796 1.085 THE COGNITIVE FUNCTION OF DEMENTIA WITH LEWY BODIES, ACCOMPANIED WITH VISUAL HALLUCINATION Le, H.
 2012
 18 S2 p. S31-
1 p.
 artikel
797 1.103 THE COMBINATION OF HOMOCYSTEINE AND C-REACTIVE PROTEIN PREDICTS THE OUTCOMES OF CHINESE PATIENTS WITH PARKINSON'S DISEASE AND VASCULAR PARKINSONISM Wang, Q.
 2012
 18 S2 p. S35-S36
2 p.
 artikel
798 1.19.3 THE CONTRIBUTION OF DOPAMINERGIC AND NON-DOPAMINERGIC PATHWAYS TO THE PATHOPHYSIOLOGY OF PD Wolters, E.C.
 2012
 18 S2 p. S9-S10
2 p.
 artikel
799 3.140 THE CONTRIBUTION OF THE MYD88-DEPENDENT PATHWAY IN ANIMAL MODELS OF PARKINSONISM Drouin-Ouellet, J.
 2012
 18 S2 p. S199-
1 p.
 artikel
800 3.360 THE CONTRIBUTION OF THE SELF POLYQ LOAD [SOMATIC MOSAICISM] IN THE CNS TO THE ONSET, DURATION AND PROGRESSION OF SCA2 Laffita, J.
 2012
 18 S2 p. S234-
1 p.
 artikel
801 2.227 THE CORRELATION ANALYSIS OF INDIVIDUALIZED TREATMENT AND DISEASE PROGRESSION OF PARKINSON DISEASE Zhao, H.
 2012
 18 S2 p. S121-
1 p.
 artikel
802 1.284 THE CURATIVE EFFECT EVALUATIONS FOR BOTULINUM TOXIN-A TREATMENT OF SPASMODIC TORTICOLLIS WITH THE GUIDANCE OF EMG Chen, S.S.
 2012
 18 S2 p. S68-
1 p.
 artikel
803 1.294 THE CURATIVE EFFECT EVALUATIONS FOR BOTULINUM TOXIN-A TREATMENT OF SPASMODIC TORTICOLLIS WITH THE GUIDANCE OF ‘SENSORY TRICK’ COMBINE WITH EMG Ge, H.-M.
 2012
 18 S2 p. S70-
1 p.
 artikel
804 1.17.2 THE DIAGNOSIS AND TREATMENT OF DYSTONIA Wanglijuan, W.L.
 2012
 18 S2 p. S8-
1 p.
 artikel
805 1.127 THE DYNAMIC OF FUNCTIONAL INTERHEMISPHERIC ASYMMETRY IN PATIENTS WITH PARKINSON'S DISEASE Bykanova, M.
 2012
 18 S2 p. S42-
1 p.
 artikel
806 2.304 THE DYNAMIC OF SUBTHALAMIC LOW FREQUENCY OSCILLATIONS AFTER LEVODOPA INTAKE AND DURING ONGOING DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE Rosa, M.
 2012
 18 S2 p. S142-
1 p.
 artikel
807 2.204 THE DYNAMIC STAT EFFECT OF COMPOUND REHMANNIA PRESCRIPTION ON TH AND GENE EXPRESSION OF LD RATS WITH PARKINSON'S DISEASE He, J.-C.
 2012
 18 S2 p. S115-
1 p.
 artikel
808 2.273 THE EFFECTIVE TREATMENT OF PAINFUL DYSTONIC FEET IN PARKINSON'S DISEASE WITH APOMORPHINE Russell, A. Ross
 2012
 18 S2 p. S134-
1 p.
 artikel
809 2.208 THE EFFECT OF LEVODOPA ON PULMONARY DYSFUNCTION IN PARKINSON'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS Monteiro, L.
 2012
 18 S2 p. S116-
1 p.
 artikel
810 3.236 THE EFFECTS OF (−)-EPIGALLOCATECHIN-3-GALLATE IN PARKINSONIAN RATS WITH PARTIAL UNILATERAL 6-HYDROXYDOPAMINE-LESION Kääriäinen, T.M.
 2012
 18 S2 p. S212-
1 p.
 artikel
811 2.347 THE EFFECTS OF HOME EXERCISE PROGRAM ON BALANCE AND ACTIVITY' OF DAILY LIVING IN PARKINSONIAN PATIENTS Koc, A.
 2012
 18 S2 p. S153-
1 p.
 artikel
812 3.351 THE EFFECTS OF INTRANIGRAL INJECTION OF GHRELIN ON HALOPERIDOL-INDUCED CATALEPSY IN RATS Shi, L.
 2012
 18 S2 p. S231-
1 p.
 artikel
813 1.134 THE EFFECTS OF URIC ACID ON NEURONAL DIFFERENTIATED PC12 CELLS AGAINST THE TOXICITY INDUCED BY ROTENONE Zheng, L.
 2012
 18 S2 p. S43-S44
2 p.
 artikel
814 2.260 THE EFFICACY AND SAFETY OF 24 HOUR ROTIGOTINE TRANSDERMAL PATCH IN THE TREATMENT OF EARLY PARKINSON'S DISEASE: A META-ANALYSIS Ramiro, G.M.
 2012
 18 S2 p. S130-
1 p.
 artikel
815 2.262 THE EFFICACY AND SAFETY OF PRAMIPEXOLE IN CLINICAL RESEARCH OF PARKINSON'S DISEASE Li, C.
 2012
 18 S2 p. S130-S131
2 p.
 artikel
816 2.246 THE EFFICACY AND SAFETY OF TOLCAPONE IN PATIENTS WITH PARKINSON'S DISEASE Zhang, C.
 2012
 18 S2 p. S126-
1 p.
 artikel
817 3.13.1 THE EUROPEAN EXPERIENCE Berg, D.
 2012
 18 S2 p. S166-
1 p.
 artikel
818 2.141 THE 18[F]-FDG PET STUDY ON THE IDIOPATHIC PARKINSON'S DISEASE AND SEVERAL PARKINSONIAN-PLUS SYNDROME Zhao, P.
 2012
 18 S2 p. S112-
1 p.
 artikel
819 2.2.3 THE FRONTOSTRIATAL CIRCUITRY AND BEHAVIORAL COMPLICATIONS IN PD Strafella, A.P.
 2012
 18 S2 p. S82-
1 p.
 artikel
820 1.267 THE GENOTYPIC-PHENOTYPIC SPECTRUM OF THAP1 DYSTONIA: SYSTEMATIC REVIEW AND DESCRIPTION OF NEW CASES LeDoux, M.S.
 2012
 18 S2 p. S63-S64
2 p.
 artikel
821 3.309 THE GUANINE NUCLEOTIDE EXCHANGE FACTOR KALIRIN-7 IS A NOVEL SYNPHILIN-1 INTERACTING PROTEIN Tsai, Y.C.
 2012
 18 S2 p. S221-
1 p.
 artikel
822 1.13.1 THE GWAS PERSPECTIVE AND BEYOND Gasser, T.
 2012
 18 S2 p. S6-
1 p.
 artikel
823 3.13.2 THE HONOLULU-ASIA EXPERIENCE Ross, W.
 2012
 18 S2 p. S166-
1 p.
 artikel
824 1.099 THE IMPACT OF EMOTIONAL DISORDERS AND COGNITIVE IMPAIRMENT ON THE QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE Huang, X.
 2012
 18 S2 p. S34-S35
2 p.
 artikel
825 1.224 THE IMPACT OF NONMOTOR SYMPTOMS ON HEALTH-RELATED QUALITY OF LIFE IN DRUG-INDUCED PARKINSONISM: COMPARISON TO PARKINSON'S DISEASE Jang, J.-W.
 2012
 18 S2 p. S52-
1 p.
 artikel
826 1.033 THE IMPACT OF NON-MOTOR SYMPTOMS ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ATYPICAL PARKINSONISM Lee, C.-N.
 2012
 18 S2 p. S18-
1 p.
 artikel
827 1.031 THE IMPACT OF NON-MOTOR SYMPTOMS ON QUALITY OF LIFE OF PATIENTS WITH PARKINSON'S DISEASE Kim, H.S.
 2012
 18 S2 p. S17-
1 p.
 artikel
828 1.223 THE INFLUENCE OF DRUG CLASS ON THE MOTOR FEATURES OF DRUG-INDUCED PARKINSONISM Munhoz, R.P.
 2012
 18 S2 p. S52-
1 p.
 artikel
829 2.10.1 THE IRON STORY Riederer, P.F.
 2012
 18 S2 p. S85-
1 p.
 artikel
830 1.129 THE MECHANISM OF SYNERGISTIC ACTIVATION OF PI3K/AKT SIGNAL PATHWAY IN INJURED DOPAMINERGIC NEURONS Wang, M.
 2012
 18 S2 p. S42-
1 p.
 artikel
831 2.143 THE MESENCEPHALIC AREA MEASURED BY BRAIN SONOGRAPHY IN THE DIFFERENTIAL DIAGNOSIS OF PARKINSONISMS Vazquez, J.F.
 2012
 18 S2 p. S112-
1 p.
 artikel
832 2.307 THE MOTOR CONTROL NETWORKS ACTIVATED BY EFFECTIVE DEEP BRAIN STIMULATION OF SUBTHALAMIC NUCLEUS IN MPTP MONKEYS, A H2 15O-PET STUDY Asakawa, T.
 2012
 18 S2 p. S143-
1 p.
 artikel
833 3.9.1 THE NEURODEGENERATIONS: GENOMICS FROM A PERPLEXED CLINICIAN Stern, G.
 2012
 18 S2 p. S165-
1 p.
 artikel
834 3.257 THE NEUROPROTECTIVE EFFECTS OF JNK3-N-TAT THROUGH INHIBITING THE ACTIVATION OF JNK3 AND PROTECTING MITOCHODRIA Pan, J.
 2012
 18 S2 p. S217-
1 p.
 artikel
835 2.216 THE NEW NEUROPROTECTIVE AGENT HEMANTANE REDUCES L-DOPA-INDUCED DYSKINESIA IN HEMIPARKINSONIAN RATS Kapitsa, I.
 2012
 18 S2 p. S118-S119
2 p.
 artikel
836 3.078 THE NOVEL THAP1 GENE MUTATION, CHARACTERIZED BY PHENOTYPICAL HETEROGENEITY Koziorowski, D.
 2012
 18 S2 p. S188-S189
2 p.
 artikel
837 3.230 THE OBSERVATION OF SYNERGISTIC PROTECTION BY GDNF AND E2 ON INJURED DOPAMINERGIC NEURONS VIA ELECTRON MICROSCOPY Shi, Z.
 2012
 18 S2 p. S211-
1 p.
 artikel
838 2.112 THE ODOR STICK IDENTIFICATION TEST FOR JAPANESE DIFFERENTIATES PARKINSON'S DISEASE FROM MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRA NUCLEAR PALSY Suzuki, M.
 2012
 18 S2 p. S104-
1 p.
 artikel
839 3.326 THE OXIDATIVE MODIFICATION OF CYTOSKELETAL PROTEIN IN PC12 CELL MODEL OF PD TREATED WITH PSI Zhang, Y.
 2012
 18 S2 p. S225-S226
2 p.
 artikel
840 1.074 THE PATTERN OF CORTICAL ATROPHY IN PARKINSON'S DISEASE WITH MILD COGNITIVE IMPAIRMENT ACCORDING TO THE TIMING OF COGNITIVE DYSFUNCTION Lee, P.H.
 2012
 18 S2 p. S28-
1 p.
 artikel
841 3.054 THE PREVALENCE OF CANCER IN PATIENTS WITH PARKINSON'S DISEASE WHO ARE CARRIERS OF THE G2019S MUTATION IN THE LRRK2 GENE Mirelman, A.
 2012
 18 S2 p. S182-
1 p.
 artikel
842 1.094 THE PREVALENCE OF NON MOTOR SYMPTOMS AND RESTLESS LEGS SYNDROME IN PARKINSON'S DISEASE: CORRELATION WITH QUALITY OF LIFE Manaf, K.A. Abdul
 2012
 18 S2 p. S33-
1 p.
 artikel
843 3.310 THE PUZZLE OF BOTULINUM TOXIN AND PAIN Lackovic, Z.
 2012
 18 S2 p. S221-
1 p.
 artikel
844 2.7.1 THERAPEUTIC STRATEGIES FOR NON-MOTOR SYMPTOMS IN EARLY PARKINSON'S DISEASE Bhidayasiri, R.
 2012
 18 S2 p. S84-
1 p.
 artikel
845 1.059 THE RELATIONSHIP BETWEEN DISRUPTED SLEEP AND COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE: A SYSTEMATIC REVIEW Kroczek, M.
 2012
 18 S2 p. S24-
1 p.
 artikel
846 1.058 THE RELATIONSHIP BETWEEN FATIGUE AND SLEEP DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE Zhang, X.
 2012
 18 S2 p. S24-
1 p.
 artikel
847 1.096 THE RELATIONSHIP BETWEEN JOINT CONFIGURATION AND HAPTIC SENSITIVITY IN PATIENTS WITH PARKINSON'S DISEASE Chu, P.-Y.
 2012
 18 S2 p. S34-
1 p.
 artikel
848 1.010 THE RELATIONSHIP BETWEEN SIDE OF MOTOR SYMPTOM ONSET AND CLINICAL SEVERITY OF DISEASE IN PARKINSON'S DISEASE Aygun, D.
 2012
 18 S2 p. S12-
1 p.
 artikel
849 3.321 THE RELATIONSHIP OF TAU ACETYLATION AND TAU PHOSPHORYLATION IN ALZHEIMER'S DISEASE Tan, L.
 2012
 18 S2 p. S224-
1 p.
 artikel
850 1.136 THE RESEARCH OF POTENTIAL ROLE OF KIR6.2 ON MECHANISM AND TREATMENT OF PARKINSON'S DISEASE Liu, X.K.
 2012
 18 S2 p. S44-
1 p.
 artikel
851 1.8.2 THE ROLE OF DOPAMINE AGONISTS IN THE TREATMENT OF EARLY AND ADVANCED PD Schapira, A.
 2012
 18 S2 p. S5-
1 p.
 artikel
852 3.129 THE ROLE OF NDFIP1 IN IRON-INDUCED CELL DAMAGE IN MES23.5 DOPAMINERGIC CELLS Jia, W.
 2012
 18 S2 p. S196-
1 p.
 artikel
853 2.215 THE ROLE OF THE CENTRAL CHOLINERGIC NEUROTRANSMITTER SYSTEM IN SLEEP DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE Krasakov, I.V.
 2012
 18 S2 p. S118-
1 p.
 artikel
854 1.064 THE ROLE OF THE OLFACTORY BULB DA NEURONS ON DEPRESSION IN PARKINSON'S DISEASE Wang, C.-H.
 2012
 18 S2 p. S26-
1 p.
 artikel
855 2.308 THE ROLE OF THE SUBTHALAMIC NUCLEUS IN COGNITIVE FUNCTIONS. A VIEWPOINT BASED ON DEPTH RECORDINGS Rektor, I.
 2012
 18 S2 p. S143-
1 p.
 artikel
856 2.12.2 THE SEROTONIN SYSTEM: A POTENTIAL TARGET FOR ANTI-DYSKINETIC TREATMENTS AND BIOMARKER DISCOVERY Rylander, D.
 2012
 18 S2 p. S86-
1 p.
 artikel
857 1.210 THE SHARE OF VASCULAR PARKINSONISM (VP) IN PATIENTS WITH STROKE Aliyev, R.
 2012
 18 S2 p. S49-
1 p.
 artikel
858 3.317 THE SIMULATED MICROGRAVITY ENHANCES THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS INTO NEURONS Chen, J.
 2012
 18 S2 p. S223-
1 p.
 artikel
859 1.241 THE SITUATION OF NEUROACANTHOCYTOSIS SYNDROMES IN CHINA Liu, J.
 2012
 18 S2 p. S56-S57
2 p.
 artikel
860 1.072 THE SLOVAKIA ASSISTED LIVING STUDY: PREVALENCE, RECOGNITION AND TREATMENT OF DEMENTIA, PARKINSONISM AND DEPRESSION IN THE ASSISTED LIVING POPULATION Sutovsky, S.
 2012
 18 S2 p. S27-S28
2 p.
 artikel
861 2.123 THE SPECIFICITY OF POWER-LAW EXPONENT TO EVALUATE THE SEVERITY OF MOVEMENT DISORDERS FOR PARKINSON'S DISEASE Wu, C.
 2012
 18 S2 p. S107-
1 p.
 artikel
862 1.236 THE SPECTRUM OF MYOCLONUS IN BLACK AFRICAN PATIENTS - A RETROSPECTIVE ANALYSIS Wynand, L.M.
 2012
 18 S2 p. S55-
1 p.
 artikel
863 2.147 THE STUDY OF ANORECTAL MANOMETRY FOR MULTIPLE SYSTEM ATROPHY AND PARKINSON DISEASE Liu, X.
 2012
 18 S2 p. S113-
1 p.
 artikel
864 3.304 THE STUDY ON SAFETY AND IMMUNIZATION EFFECT AFTER INOCULATION WITH OPTIMIZED HUMAN α-SYNUCLEIN DNA VACCINE Peng, G.
 2012
 18 S2 p. S220-
1 p.
 artikel
865 3.342 THE SUPPRESSION EFFECTS OF ROPINIROLE ON NEOCORTICAL HIGH-VOLTAGE SPINDLES IN THE FREELY MOVING 6-OHDA-LESIONED RATS Yang, C.
 2012
 18 S2 p. S229-
1 p.
 artikel
866 1.135 THE TREATMENT EFFECTS OF HUMAN α-SYNUCLEIN DNA VACCINE IN CHRONIC ROTENONE MOUSE OF PARKINSON'S DISEASE Xu, Y.
 2012
 18 S2 p. S44-
1 p.
 artikel
867 2.272 THE TREATMENT OF PAINFUL DIAPHRAGMATIC DYSTONIA IN IDIOPATHIC PARKINSON'S DISEASE WITH APOMORPHINE Pollock, C.E.
 2012
 18 S2 p. S133-
1 p.
 artikel
868 2.299 THE USEFULLNESS OF INTRAOPERATIVE COMPUTED TOMOGRAPHY FOR DEEP BRAIN STIMULATION Park, Y.S.
 2012
 18 S2 p. S140-
1 p.
 artikel
869 2.19.4 THE VALUE OF CARE IN PARKINSON'S DISEASE Bloem, B.
 2012
 18 S2 p. S91-
1 p.
 artikel
870 2.8.3 THE VALUE OF DELAYING CLINICAL PROGRESSION OF PARKINSON'S DISEASE FROM A CLINICIAN, PATIENT, AND SOCIETAL PERSPECTIVE Reichmann, H.
 2012
 18 S2 p. S85-
1 p.
 artikel
871 1.214 THROMBOEMBOLIC RISK AND THERAPY IN A PATIENT WITH PARKINSON'S DISEASE Thomas, L.
 2012
 18 S2 p. S50-
1 p.
 artikel
872 2.142 TO DISCUSS THE MRI DIFFERENCE OF HEREDITARY SPINOCEREBELLAR ATAXIA AND PARKINSON PLUS SYNDROME PATIENTS Zhang, P.
 2012
 18 S2 p. S112-
1 p.
 artikel
873 2.250 TOLCAPONE FOR THE TREATMENT OF PARKINSON'S DISEASE WITH MOTOR FLUCTUATIONS Wang, Y.
 2012
 18 S2 p. S127-
1 p.
 artikel
874 3.138 TOXIC EFFECTS OF OVER-LOAD COPPER CHLORIDE ON PRIMARY CULTURED RAT ASTROCYTES Hu, H.-L.
 2012
 18 S2 p. S198-S199
2 p.
 artikel
875 3.322 TOXICITY OF ALUMINUM AND ALZHEIMER DISEASE Djebli, N.
 2012
 18 S2 p. S224-
1 p.
 artikel
876 1.116 TRACE METALS IN PATIENTS WITH PARKINSON'S DISEASE: A MULTI-CENTER CASE-CONTROL STUDY IN NIGERIAN PATIENTS Ogunrin, O.A.
 2012
 18 S2 p. S39-
1 p.
 artikel
877 2.14.4 TRADITIONAL CHINESE HERBAL MEDICINE AND ELECTRO-ACUPUNCTURE Wang, X.M.
 2012
 18 S2 p. S88-
1 p.
 artikel
878 2.015 TRANSCRANIAL SONOGRAPHY AND 123I FP-CIT SPECT IN MOVEMENT DISORDERS Bartova, P.
 2012
 18 S2 p. S94-
1 p.
 artikel
879 3.112 TRANSCRIPTOME PROFILING OF BLOOD MONONUCLEAR CELLS FROM RATS EXPOSED TO CUMULATIVE LOW DOSES OF THE PARKINSON'S DISEASE-LINKED PESTICIDE ROTENONE Vanbesien-Mailliot, C.
 2012
 18 S2 p. S192-
1 p.
 artikel
880 3.074 TRANSCRIPTOME PROFILING OF BLOOD MONONUCLEAR CELLS FROM SCA2 PATIENTS ACCORDING TO CEREBELLAR OR PARKINSONIAN PHENOTYPES Simonin, C.
 2012
 18 S2 p. S187-S188
2 p.
 artikel
881 2.285 TRANSDERMAL ROTIGOTINE CAUSES IMPULSE CONTROL DISORDERS IN PATIENTS WITH RESTLESS LEGS SYNDROME Schreglmann, S.R.
 2012
 18 S2 p. S136-S137
2 p.
 artikel
882 3.124 TRANSGENIC ZEBRAFISH MODELS FOR THE STUDY OF DOPAMINE NEURON DEVELOPMENT, DEGENERATION AND REGENERATION Xi, Y.
 2012
 18 S2 p. S195-
1 p.
 artikel
883 2.353 TREATMENT OF ARTICULATORY DYSFUNCTION IN PARKISON'S DISEASE USING REPETATIVE TRANSCRANIAL MAGNETIC STIMULATION Murdoch, B.
 2012
 18 S2 p. S154-
1 p.
 artikel
884 2.13.4 TREATMENT OF ESSENTIAL TREMOR: ARE THERE ISSUES WE ARE OVERLOOKING? Louis, E.D.
 2012
 18 S2 p. S87-
1 p.
 artikel
885 2.337 TREATMENT OF STATUS DYSTONICUS WITH PALLIDAL DEEP BRAIN STIMULATION — CASE REPORT Mandat, T.
 2012
 18 S2 p. S150-
1 p.
 artikel
886 1.232 TREMOR AND HIV INFECTION Quilez-Ferrer, P.
 2012
 18 S2 p. S54-
1 p.
 artikel
887 2.1.4 TREMOR REVISITED: TREATMENT OF PD TREMOR Jiménez, M. Castro
 2012
 18 S2 p. S81-
1 p.
 artikel
888 2.17.3 TRICHLOROETHYLENE (TCE) EXPOSURE AND PARKINSON'S DISEASE (PD) RISK Goldman, S.M.
 2012
 18 S2 p. S89-
1 p.
 artikel
889 1.272 TRIGEMINAL SOMATOSENSORY EVOKED POTENTIALS RESEARCH IN PATIENTS WITH MEIGE SYNDROME Kaiyue, W.
 2012
 18 S2 p. S65-
1 p.
 artikel
890 1.218 TWO CASES OF DURAL ARTERIOVENOUS FISTULA (DAVF) PRESENTING WITH PARKINSONISM AND PROGRESSIVE COGNITIVE DYSFUNCTION Luo, Y.
 2012
 18 S2 p. S51-
1 p.
 artikel
891 2.266 TWO-YEAR, PLACEBO-CONTROLLED SAFETY AND TOLERABILITY DATA FOR SAFINAMIDE AS ADD-ON TO LEVODOPA IN PATIENTS WITH PARKINSON'S DISEASE (PD) Borgohain, R.
 2012
 18 S2 p. S132-
1 p.
 artikel
892 1.132 TYROSINE HYDROXYLASE INTERACTING WITH PHOSPHOLIPID MEMBRANES: A MOLECULAR DYNAMICS STUDY Skjevik, Å.A.
 2012
 18 S2 p. S43-
1 p.
 artikel
893 3.256 UNCOUPLING PROTEIN-4 (UCP4) INCREASES NEURONAL ATP PRODUCTION VIA RESPIRATORY COMPLEX-II ACTIVATION — A BIOENERGETIC STUDY Ho, P.W.-L.
 2012
 18 S2 p. S217-
1 p.
 artikel
894 3.048 UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING LEUCINE-RICH REPEAT KINASE 2 (LRRK2)-RELATED PARKINSON'S DISEASE (PD) Liu, H.
 2012
 18 S2 p. S180-S181
2 p.
 artikel
895 3.075 UNEXPANDED AND INTERMEDIATE POLYMORPHISMS AT SCA2 LOCUS (ATXN2) IN THE CUBAN POPULATION: EVIDENCES ABOUT THE ORIGIN OF EXPANDED ALLELES Laffita, J.
 2012
 18 S2 p. S188-
1 p.
 artikel
896 1.7.4 UPCOMING TREATMENTS IN PARKINSON'S DISEASE, INCLUDING GENE THERAPY Rodnitzky, R.
 2012
 18 S2 p. S4-
1 p.
 artikel
897 1.206 UPDATE IN THE CLINICAL PRESENTATION AND NATURAL HISTORY OF DCB AND PSP PATIENTS Bloch, F.
 2012
 18 S2 p. S48-
1 p.
 artikel
898 3.157 UPREGULATION OF ETK AFTER RAT TRAUMATIC BRAIN INJURY Chen, K.-Y.
 2012
 18 S2 p. S203-
1 p.
 artikel
899 2.278 USE OF BOTULIUM TOXIN TYPE A IN A MOVEMENT DISORDERS CLINIC: EXPANDING THE USES. A 24 MONTH FOLLOW-UP Borrue-Fernandez, C.
 2012
 18 S2 p. S134-S135
2 p.
 artikel
900 2.357 USING ECOLOGICAL EVENT-BASED ACOUSTIC GUIDES TO CUE GAIT IN PARKINSON'S DISEASE PATIENTS Young, W.
 2012
 18 S2 p. S155-
1 p.
 artikel
901 1.2.2 USING STEM CELLS AND IPS CELLS TO DISCOVER NEW TREATMENTS FOR PARKINSON'S DISEASE Cooper, O.
 2012
 18 S2 p. S2-
1 p.
 artikel
902 1.2.1 VACCINES IN PARKINSON'S DISEASE Schneeberger, A.
 2012
 18 S2 p. S2-
1 p.
 artikel
903 1.084 VALIDATION OF THE BEIJING VERSION OF THE MONTREAL COGNITIVE ASSESSMENT (BJ-MOCA) FOR PARKINSON'S DISEASE: RESULTS FROM A CHINESE PILOT STUDY Nie, K.
 2012
 18 S2 p. S30-S31
2 p.
 artikel
904 1.083 VALIDATION OF THE MONTREAL COGNITIVE ASSESSMENT (MOCA) IN DETECTING COGNITIVE IMPAIRMENT IN SINGAPOREAN PARKINSON DISEASE PATIENTS — PILOT DATA Lim, E.C.H.
 2012
 18 S2 p. S30-
1 p.
 artikel
905 3.044 VARIANT IN THE 3' REGION OF SNCA ASSOCIATED WITH PARKINSON'S DISEASE AND SERUM α-SYNUCLEIN LEVELS Hu, Y.
 2012
 18 S2 p. S179-S180
2 p.
 artikel
906 1.280 VARIOUS TARGETS FOR DEEP BRAIN STIMULATION FOR VARIOUS TYPES OF DYSTONIA Mandat, T.
 2012
 18 S2 p. S67-
1 p.
 artikel
907 2.129 VERIFICATION OF EXPRESSIONS OF KIR2 AS POTENTIAL PERIPHERAL BIOMARKERS IN LYMPHOCYTES FROM PATIENTS WITH PARKINSON'S DISEASE Chen, S.-D.
 2012
 18 S2 p. S108-S109
2 p.
 artikel
908 1.027 VESTIBULAR EVOKED MYOGENIC POTENTIALS IN OLDER PEOPLE WITH PARKINSON'S DISEASE Lee, G.-H.
 2012
 18 S2 p. S16-S17
2 p.
 artikel
909 2.116 VESTIBULOMETRIC FUNCTION TESTS IN PATIENTS WITH VEGETATIVE DYSFUNCTION Maryenko, I.P.
 2012
 18 S2 p. S105-
1 p.
 artikel
910 1.089 VISUAL INFORMATION PROCESSINGS ARE SELECTIVELY IMPAIRED FROM THE EARLY STAGE OF COGNITIVE DECLINE IN HALLUCINATORY PATIENTS WITH LEWY BODY DISEASE Kurita, A.
 2012
 18 S2 p. S32-
1 p.
 artikel
911 1.114 VISUALLY-DEPENDENT, DIRECTIONAL EEG CONNECTIVITY CHANGES IN PARKINSON'S DISEASE AT REST Tropini, G.
 2012
 18 S2 p. S38-S39
2 p.
 artikel
912 2.345 WALKING AND LOW INTENSITY STRENGTHENING PROGRAM FACILITATE AMBULATORY, MOTOR AND QUALITY OF LIFE IMPROVEMENT IN PEOPLE WITH PARKINSON'S DISEASE Kwok, C.M.
 2012
 18 S2 p. S152-
1 p.
 artikel
913 1.098 WELLBEING OF SPOUSES OF PATIENTS WITH PARKINSON'S DISEASE EXHIBITING IMPULSE CONTROL DISORDERS Lerman, S.F.
 2012
 18 S2 p. S34-
1 p.
 artikel
914 1.10.1 WHAT ABOUT BRAAK Alafuzoff, I.
 2012
 18 S2 p. S5-
1 p.
 artikel
915 3.12.1 WHAT ARE THE PITFALLS OF CLINICAL TRIALS IN PARKINSON'S DISEASE? Korczyn, A.D.
 2012
 18 S2 p. S166-
1 p.
 artikel
916 2.296 WHAT IS PREFERRING HIGH OR LOW FREQUENCY RTMS STIMULATION IN PARKINSON'S DISEASE? Málly, J.
 2012
 18 S2 p. S139-S140
2 p.
 artikel
917 2.8.1 WHAT REALLY MATTERS IN EARLY AND ADVANCED PARKINSON'S DISEASE Wolters, E.C.
 2012
 18 S2 p. S85-
1 p.
 artikel
918 2.306 WHAT THE SUBTHALAMIC LOCAL FIELD POTENTIALS SAY AFTER YEARS OF CHRONIC STIMULATION IN PARKINSON'S DISEASE? Giannicola, G.
 2012
 18 S2 p. S142-S143
2 p.
 artikel
919 3.2.1 WHICH DBS TARGET: GPI, STN, OR PPN? Follett, K.
 2012
 18 S2 p. S162-
1 p.
 artikel
920 1.266 WHOLE-EXOME CAPTURE AND NEXT-GEN SEQUENCING IN FAMILIAL ADULT-ONSET PRIMARY CERVICAL DYSTONIA Xiao, J.
 2012
 18 S2 p. S63-
1 p.
 artikel
921 3.066 WILSON'S DISEASE IN SOUTHERN BRAZIL: MUTATIONAL ANALYSIS, GENOTYPE-PHENOTYPE CORRELATION AND DESCRIPTION OF TWO NOVEL MUTATIONS IN THE ATP7B GENE Teive, H.A.G.
 2012
 18 S2 p. S185-
1 p.
 artikel
922 1.277 WILSON'S DISEASE IN THE SOUTH OF BRAZIL: A 40 YEARS FOLLOW-UP STUDY Teive, H.A.G.
 2012
 18 S2 p. S66-
1 p.
 artikel
923 1.278 WILSON'S DISEASE: UPDATE ON INTEGRATED TRADITIONAL CHINESE MEDICINAL HERBS AND WESTERN MEDICINE IN CHINA Wang, X.-P.
 2012
 18 S2 p. S66-
1 p.
 artikel
                             923 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland